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Antibiotikums Moenomycin A12 ausgehend von b-D-Galactose-pentaacetat hergestellt. Das 
Ausgangmaterial wurde in D-Galactoheptonamid übergeführt. Die Einheit F des  
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1. INTRODUCTION 1
1 INTRODUCTION 
In view of the problem of antibiotic resistance1 antiinfectives with novel modes of action are 
desperately needed. The transglycosylation reaction,2 the second last step in the biosynthesis of 
peptidoglycan (the main structural polymer of the bacterial cell wall) occurs at the outside of the 
cytoplasmic membrane and is catalysed by membrane proteins designated as bifunctional (class 
A) high molecular mass penicillin-binding proteins (PBPs).3 The reaction came recently into 
focus as a promising new target for a number of reasons: (i) the methods for isolating the 
enzyme(s) involved have improved considerably,4,5 (ii) one substrate of the transglycosylation 
step, the so-called lipid II, can now be made in sufficient amounts,6 and (iii) new and efficient in-
vitro test systems have been developed which conveniently allow to monitor the inhibition of the 
incorporation of lipid II into uncross-linked peptidoglycan,6,7 and binding of inhibitors to the 
enzyme, respectively.8 
The assembly of the peptidoglycan polysaccharide strands from lipid II is blocked by certain 
glycopeptides,9 ramoplanin,10 the lantibiotics,11 and the moenomycin-type antibiotics.12 Of these, 
the moenomycins (see structures of moenomycin A and moenomycin A12) are the only 
compounds known to inhibit the enzyme itself2 (i. e. the transglycosylase domain of the 
bifunctional high-molecular PBPs) whereas ramoplanin and the lantibiotics interfere with lipid II. 
The moenomycins are, thus, unique tools for investigating both the transglycosylation step and the 
corresponding enzyme(s). In addition, they are highly promosing lead compounds for new 
antiinfectives. 
 
1.1 Existence and structure of the moenomycin antibiotics 
Moenomycins are phosphoglycolipid antibiotics isolated from various strains of Streptomyces (S. 
bambergiensis, S. ghanaensis, S. ederensis and S. geysiriensis) and are commercially available 
(Flavomycinâ). Moenomycin A (1) is the main constituent of this product.13,14 Moenomycin A1215 
(2), C116 (3), C3 (4), C417 (5), pholipomycin (6)17,18 and AC326-a (7)19 were also isolated. The 
family of moenomycin-type antibiotics also includes the prasinomycins,18 diumycins 
(macarbomycins), 11837 R.P., 8036 R.P. (quebemycin), 19402 R.P., ensanchomycin, 
prenomycin and teichomycin20 with mainly unknown structures. 
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Figure 1.1: The moenomycins 
All moenomycin-type members seem to contain an oligosaccharide chain linked via a phosphoric 
acid diester to a lipid unit, which may be either moenocinol (a C25-lipid alcohol, as in the 
moenomycins and prasinomycins) or diumycinol (an isomer of moenocinol with a six-membered 
ring as in AC326-a and the diumycins (macarbomycins)).  
The chemical structures of the isolated moenomycins have been established, based on chemical 
degradation combined with spectroscopic studies (fast atom bombardment MS and 13C 
NMR).15, 16,17, 21 
 
7
H I
A
B C
E
D
G
HO
O
HO
HO O
HO
CO
O
HO
HO
NH
COOH
H
O
O
O
NHAc
HO
O
CONH2
O
HOO
O
P
OH
O
O
H2N O
NHAc
O
O
HO
OH
O
OH
F
 
Figure 1.2: Moenomycin AC326-a 
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1.2 Structural properties of the moenomycin family 
The moenomycin group is characterized by a relatively high molecular weight from 1600 to 2100 
daltons and a phosphorus content of about 2%.20  
Moenomycins and the related antibiotics are acids which form colourless, amorphous salts. They 
are readily soluble in water and lower alcohols, but insoluble in most organic solvents. In aqueous 
solution they are very stable at a pH range of 7-9 and against most enzymes.  
Most of these antibiotics carry the chromophore moiety (UV: 257-258 nm) which is lacking in 
others that may contain glycine instead.16,22  
All components show surface activity and form aggregates in aqueous solutions up to 70000 
daltons dependent on the experimental conditions.20,23 
They can be divided into two classes, depending on whether  unit E carries a glucose moiety as in 
moenomycins A and A12 or not as in moenomycins C1, C3, C4 and pholipomycin. In another 
classification compounds like moenomycin A, C3, C4 contain a glucuronic acid-derived unit F 
whereas the moenomycins A12 and C1 have a D-galacturonic acid-derived ring F. 
HCl-catalysed hydrolysis degrades moenomycin A completely into its components,20 units B and 
F decompose under these conditions.24,25,26 
The b-glycosidic linkage of the N-acetylated amino sugars can be cleaved specifically with 
trifluoroacetic acid. Degradation products containing units A-B-C, D-E, D-E-F-G-H, and F-G 
have been obtained using this method.26,27 
The allyl ether bond between units H and I is acid-labile. The moenocinol part I can be cleaved 
off from the rest of the molecule and the remaining delipido moenomycin A was reported to be 
devoid of any antibiotic activity.12,28 
The reaction of unit A of moenomycin A with an aromatic diazonium salt gave an azo compound 
which underwent a Japp-Klingemann cleavage of the five-membered ring to furnish an 
amidrazone which finally recycled to provide a triazole.29 
Ozonolytic degradation of moenomycin A formed a compound lacking unit A and most of the 
lipid part. Reductive amination of the aldehyde furnished antibiotically inactive tertiary amines.12 
K3[Fe(CN)6] oxidation provides in high yield an antibiotically active compound lacking unit A.12 
The introduction of polar groups at the end of the lipid side-chain destroys the antibiotic activity.30 
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1.3 Antimicrobial properties 
Moenomycin A is active mainly against Gram-positive bacteria, and due to the presence of the 
outer membrane, it acts to a lower degree against Gram-negative bacteria.13,25,31 Moenomycin is 
not applied in human medicine because it is not absorbed by oral application. After intravenous or 
intraperitoneal application the half life time in the body is about 9-10 days.20 Moenomycin also 
diminishes the infection of cells with plasmids, this fact is especially important for the use of 
FlavomycinÒ as a growth promoter in animal nutrition.20 It was reported that moenomycin as a 
feed additive has an excellent effectiveness, even in small doses.32 
 
1.4 Mode of action 
Based on structure-activity relationships,33 a mechanism for their mode of action has been 
proposed.4,34,35,36 Moenomycin and the related antibiotics are known to inhibit the biosynthesis of 
peptidoglycan, the main structural component of the bacterial cell wall. The peptidoglycan layer 
consists of a matrix of polysaccharide chains, composed of alternating N-acetylmuramic acid 
(MurNAc) and N-acetylglucosamine (GlcNAc) sugar residues, cross-linked through oligopeptide 
sidechains attached to the MurNAc residues (Figure 1.3). The sequence of the tetrapeptide in E. 
coli is L-Ala-g-D-Glu-X-D-Ala, where X is usually meso-diaminopimelate (m-DAP) as usual for 
Gram-negative bacteria. In Gram-positive L-Lys bacteria is found instead.37 
During the investigation of the mode of action of these moenomycin antibiotics, their antibiotic 
activity was compared to that of vancomycin and some other antibiotics which inhibit cell well 
synthesis. Vancomycin, as the phosphoglycolipid antibiotics, strongly inhibits the peptidoglycan 
synthesis and causes an accumulation of the lipid intermediate and of UDP-Mur NAc-
pentapeptide.20,38 
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Figure 1.3: Simplified representation of the structure of the peptidoglycan  
layer of bacterial cell walls 
It is assumed that the moenomycins are anchored to the cytoplasmic membrane via the lipid part23 
and bind then highly selectively to the binding site of the growing polysaccharide strand at the 
enzyme via the C-E-F trisaccharide and inhibit the formation of the linear glycan strand of 
peptidoglycan.39,40,41 
The two successive final reactions in the bacterial cell wall synthesis are the transglycosylation (D 
Þ E) that extends the glycan chain and the transpeptidation (E Þ F) that cross-links the glycan 
chain through two peptide units (Scheme 1.1).  
A number of bifunctional enzymes (penicillin-binding proteins, PBP’s) have been identified that 
catalyse both transglycosylation and transpeptidation.39 With cell free systems from E. coli, it was 
demonstrated that the antibiotic moenomycin A selectively inhibits the transglycosylation step by 
its inhibitory effect on penicillin-binding protein 1b (PBP 1b). Both with the cell-free systems 
and purified PBP 1b moenomycin A was inhibitory at concentration between 10–8 and 10–7 
mol/L.39  
The mechanism of the glycopeptides that inhibit the transglycosylation reaction is not clear.42 It 
has been proposed that both the glycan strand and the disaccharide intermediate (lipid II) are 
anchored by their lipid chains into the cytoplasmic membrane. The reaction proceed through the 
displacement of the phosphate of the growing strand by the 4-hydroxyl group of the GlcNAc unit 
of lipid II as indicated in Scheme 1.2.34 
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Scheme 1.1: The biosynthesis of the peptidoglycan of E. coli 
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Scheme 1.2: Schematic representation of the transglycosylation reaction. 
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1.5 Structure-activity relationships of the moenomycins 
Systematic stepwise degradation studies of moenomycins A, A12, C1, C3, and C4, in conjunction 
with assaying the degradation products for antibiotic activity both in the in-vivo and in the E. coli 
cell-free system have proved that: 
· Units E, F, G, H, and I are essential,21,28 in addition, unit C must be present in moenomycins 
A1215 and C1.16 
· The moenocinol part I may be saturated,28 as well as cyclized in its terminal part.19 
· The carbamoyl group in unit F must be present.28, 12 
· The carboxyl group in unit H must be free,21,39 and that in unit F in the carboxamide form.28 
· The phosphate group in unit F must be a-oriented.43 
Many disaccharide and trisaccharide analogues of moenomycins A and A12 have been prepared 
for the estimation of structure-activity relationship, and to define the minimal structural basis of the 
antibiotic activity and the exact mechanism of the transglycosylation reaction.  
In the disaccharide series, unit F should have the D-gluco configuration.44 Compounds 828 and 
933 have full activity (when compared to moenomycin A) as transglycosylase inhibitors in in-vitro 
experiments. They are, however, antibiotically inactive. This result means that the methyl group at 
C-4 of unit F in moenomycin A is not involved in the activity. Thus, compound 9 is the smallest 
structural analogues of the moenomycins that elicits full transglycosylase inhibiting activity known 
to date. It was found that the N-acetyl group of unit E is needed as a prerequisite for the 
transglycosylase inhibiting properties. 45 
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Figure 1.4: Antibiotic active disaccharide analogues of moenomycin A 
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In the trisaccharide series, compounds 1028, 1115, 1216, 1346 represent the minimum structural 
requirements for full in vitro activity as well as antibiotic activity. Unit F may have the D-gluco or 
D-galacto configuration. It was found that the N-acetyl group of unit C is essential.34,47 
C
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Figure 1.5: Antibiotic active trisaccharide analogues of moenomycins A and A12 
 
1.6 Enzymatic degradation moenomycin A 
The moenomycins do not induce resistance readily. However, a weak point in this respect may be 
the phosphate bond at unit F. Its cleavage by a yet poorly characterized enzyme is the only 
enzymatic degradation reaction of the moenomycins that is known to-date.48 
Enzymatic degradation of moenomycin A at the phosphoglycosidic linkage affords units MA, MB 
and MC. MB suffers further enzymatic cleavage to give MA, whereas MC probably contains units 
A through F of moenomycin A.48 The structure of MA is closely related to moenocinol (the 
alcohol corresponding to unit I in moenomycin A).  
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Figure 1.6: Enzymatic degradation products of moenomycin A  
No inhibition of the transglycosylase reaction by Ma was observed, which reflects the importance 
of the phosphoglycosidic linkage to elicit antibiotic activity. Its cleavage furnishes two inactive 
parts. Furthermore, some moenomycin-type analogues which were expected to be antibiotically 
active, were devoid of antibiotic activity, although they contain most of the essential functional 
groups necessary for moenomycin-type activity. It has been speculated, that these compounds 
are used as substrates by the transglycosylase. 35 
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1.7 C-glycosides  
In C-glycosides the oxygen atom of the exo-glycosidic bond is replaced by a carbon atom. The 
methods for their synthesis have been extensively studied.49,50,51 The structural modification 
involved in the transition from O-glycosides to C-glycosides results in a different nomenclature 
system. The C-glycoside derives its name from the largest continuous chain of carbons. 
Compound 14, for example, derives its name from heptitol. As the heptitol is cyclized between C2 
and C6 it is designated as 2,6-anhydro. 
 
CH3
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23
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14  
1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7-deoxy-D-glycero-L-galacto-heptitol 
Figure 1.7: Representative C-glycoside and its nomenclature 
C-glycosides have gained increasing interest in view of their occurrence as fragments in a number 
of natural products. Moreover, because of their resistance to hydrolysis, C-glycosides are 
expected to be stable mimics for natural O-glycosides with biological activity.51 As a result, there 
is now interest in using such C-glycosides for enzymatic and metabolic studies.  
The C-glycoside analogues may answer the question whether the replacement of the oxygen 
linkage between the anomeric carbon and the phosphorous moiety by a CH2 group abolishes the 
transglycosylase inhibiting activity in moenomycin analogues or not. 
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2 PURPOSE OF THE PRESENT WORK 
We started a programme aimed at synthesizing trisaccharide analogues of moenomycin A12 in 
which the phosphate oxygen at C-1 of unit F is replaced by a CH2 group.52  
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Figure 2. 1: Target molecule 15 
 
It seemed important to retain all other functional groups in ring F as present in moenomycin A12 
since they are known to be of major importance as far as antibiotic activity is concerned.33,53 
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3 PREVIOUS WORK 
Some mono- and disaccharide phosphonate models of moenomycin A have already been 
prepared using two different approaches. Qiao and Vederas54 (Scheme 3.1) cyclized compound 
16, obtained via a Wittig approach from a protected glucose derivative by oxymercuration and 
subsequent iodination, whereas Brooks et al.55 (Scheme 3.2) started from an allyl C-glycoside 
which on Pd-mediated rearrangement furnished the corresponding propenyl isomer alongside with 
other rearrangement products or from an allenyl C-glycoside. Both compounds on ozonolysis 
gave the corresponding alcohol in modest yield. Phosphonates were obtained by Arbuzov 
reaction.56 Qiao and Vederas managed to prepare a disaccharide analogue but obviously the 
structure was too simple to elicit antibiotic activity.54,55 
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Scheme 3.1: Preparation of a phosphonate disaccharide by Qiao et al 
 
3. PREVIOUS WORK 12
AcO
AcO
O
OAc
AcO
.
AcO
AcO
O
OAc
AcO
AcO
AcO
O
OAc
AcO
OH
AcO
AcO
O
OAc
AcO
Br
AcO
AcO
O
OAc
AcO
PO(OH)2
i) ClSO2CH3
ii) Bu4N+Br
i) P(OEt)3 / 180 oC
ii) TMS Br/CH2Cl2 
    then H2O
AcO
AcO
O
OAc
AcO
P
O
CH2(CH2)14CH3
O O
or
 
Scheme 3.2: Preparation of a phosphonate monosaccharide by Brooks et al 
Some time ago Welzel et al.57 (Scheme 3.3) reported on a new approach for the synthesis of 
such C-glycosides, which started from D-tartaric acid and a suitable C-3 allyl stannane and used 
also the mercury-induced cyclization. Disaccharide building block 17 was prepared via this route. 
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Scheme 3.3: Preparation of disaccharide building block 17 
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Although this synthesis was conceptually new, there were some draw-backs due to difficulties in 
the protecting group chemistry. We decided, therefore, to explore a somewhat more traditional 
synthesis. Since according to all studies on structure-activity relationships, no antibiotic activity 
can be expected for disaccharide analogues, it was decided to include the synthesis of 
trisaccharide structures.  
The present work describes the synthesis of the two building blocks 18 and 19 for phosphonate 
analogues of moenomycin A12. 
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Figure 3.1: Building blocks 18 and 19 
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4 SYNTHETIC DESIGN 
4.1 Retrosynthetic analysis 
A retrosynthetic analysis (Scheme 4.1) of the target compounds 20 and 15 leads to three 
precursors: 
1. An E-F disaccharide 21 and a C-E-F trisaccharide 22, respectively. 
2. A nucleophilic phosphonic acid equivalent 23, which could be obtained from triethylphosphite 
24. 
3. A 2-O-alkylglyceric acid moiety 25, which could be obtained from 26 either by degradation of 
moenomycin (Flavomycin complex®)17 (R = C25H51) or by synthesis. 58 
The combination of 21 as well as 22 and 24 should be possible getting benefit of the Arbuzov 
reaction.56 The resulting posphonate esters should be converted into the corresponding 
phosphonic acids, and these in turn should couple with 26 after activation of the phosphonic 
acids. Subsequent removal of the protecting groups should furnish the target compound. 
The precursors 21 and 22 could be synthesized by functional group conversion from 27 and 28, 
respectively. It was planned to disconnect these di- and trisaccharide analogues at the glycosidic 
bonds, and to prepare the C-glycosidic homologue of unit F starting from a galactose-derived C-
halomethyl of type 29, which could be obtained from b-D-galactose-pentaacetate 30. For the 
synthesis of the disaccharides, the glycosyl donor 31 could be obtained from D-glucosamine 32, 
while for the trisaccharides, it could be obtained from chitobiose 33. 
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Scheme 4.1: Retrosynthetic analysis of target molecules 15 and 20 
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4.2 Plan of synthesis 
Synthesis of the target analogue of moenomycin A12 can be achieved after three major 
preparations: 
1. Preparation of the glycosyl acceptor, which will represent unit F of the target molecule. 
2. Glycosylation to achieve the desired b-oligosaccharide. 
3. Linkage of the b-di- or trisaccharide via a phosphonic acid diester with a glyceric acid unit to a 
lipid chain. 
Minimizing the number of functional group interchange reactions, as well as minimal use of 
protecting groups are highlights for the overall synthetic efficiency. 
The glycosyl acceptor must be sufficiently protected prior to the glycosylation step; only one 
hydroxyl group should be glycosylated. A variety of protecting groups exists to perform the 
oligosaccharide synthesis. Our synthetic strategy dictated the use of 39 as the glycosyl acceptor. 
The synthesis of the glycosyl acceptor 39 (Scheme 4.2) should begin with the commercially 
available and cheap b-D-galactose-pentaacetate, 30 in the following sequence. It will be 
transformed into the C-glycoside 3459 which should undergo a double bond rearrangement to 
yield its propenyl analogue 36. Ozonolysis of this alkene followed by reduction of the produced 
aldehyde should afford the alcohol 35, which should be converted into its halide derivative 37, 
which is considered to be an important precursor to apply the Arbuzov reaction, through which 
the sugar unit should couple with the lipid unit moieties via a phosphonate bridge. Hydrolysis of 
the acetate groups in compound 37 without harming the primary bromide should afford 
compound 38. â-Selective glycosylation at position-5 requires protection of the other free 
hydroxyl groups. The primary hydroxyl group in compound 38 could be selectively protected as a 
TBDPS ether. This protecting group was selected because of its stability and ease of selective 
introduction. It should be latter selectively deprotected, and the liberated hydroxyl group will be 
then converted into the corresponding amide functional group. Of the several options to protect 
O-3 and O-4 in 40, we decided to select the isopropylidene acetal, a well-known protecting 
group stable during the glycosylation reaction. Thus, further protection of the hydroxyl groups at 
positions 3 and 4 in 40 should yield the glycosyl acceptor 39. 
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Many methods exist for the 1,2-trans glycosylation.60 In this work, 
disaccharide formation will be carried out according to the 
Jacquinet and Blatter method,61 which uses 41 as the glycosyl 
donor. The advantage of this method is the high reactivity of the 2-
trichloromethyloxazoline 41. On the other hand, it constructs the 
disaccharide with an N-trichloroacetyl group, which must be 
transformed to an N- acetyl group, before 
OAc
O
N O
CCl3
AcO
AcO
41  
Figure 4.1: 
Glycosyl donor 41 
applying the Arbuzov reaction. Thus, the reaction of the glycosyl acceptor 39 with the glycosyl 
donor 41 should give the desired disaccharide. 
In another parallel project, trisaccharide formation will 
be carried out using the oxazoline 4262 as the glycosyl 
donor. It could be prepared from chitobiose 
octaacetate, and it generates the desired N-acetyl 
groups directly after the glycosylation step. Thus, the  
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Figure 4.2: Glycosyl donor 42 
reaction between the glycosyl acceptor 39 and the glycosyl donor 42 should yield the desired 
trisaccharide.  
The general synthetic plan for the target molecules is shown in Scheme 4.3.  
Cleavage of the silyl ether in compound 43 could be selectively achieved under acidic conditions 
without disturbing the acetonide to give 44. The primary hydroxyl group should then be oxidised 
to the corresponding acid 45, and this in turn would finally be converted to the amide 46. We 
expected that the 3,4-O-isopropylidene group of 46 can be selectively cleaved under acidic 
conditions furnishing 47. The carbamoyl group was planned to be introduced at position 4 in unit 
F by different methods, depending on the protecting groups, thus giving 48 and leaving the axial 
hydroxyl group at position 3 free. Transformation of the N-trichloroacetyl group in 48 into an N- 
acetyl group should give 49. 
Construction of the phosphonic diester was to be achieved by applying the Arbuzov reaction. 
Thus, on its reaction with triethylphosphite, 49 should be converted into the C-phosphonate 50, 
which should be in turn converted into the corresponding phosphonic acid 51 upon treatment with 
bromotrimethylsilane followed by reaction with water. 
Coupling of 51 to the lipid bearing glycerol acid part using trichloroacetonitrile would complete 
the target skeleton formation 52. Hydrolysis of the acetyl protecting groups under basic 
conditions should furnish the target compounds 20 and 15. 
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Scheme 4.2: Planned synthesis of the glycosyl acceptor 39 
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Scheme 4.3: Planned synthesis of the target molecules 15 and 20 
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5 RESULTS AND DISCUSSION 
5.1 Synthesis of unit F-derived glycosyl acceptor 
The general structural prerequisites for the glycosyl acceptors were given by the retro synthesis, 
i.e. 
· A halide group at C-7 as the phosphonate precursor 
· A free hydroxyl group at position C-5 for the attachment 
of the other carbohydrate units 
· Selectively cleavable protecting groups at C-3 and C-4 
· A selectively removable protecting group for the 1-OH-
group to allow oxidation at any appropriate stage in the 
synthesis. 
Compound 53 shown in Figure 5.1 was chosen as the 
glycosyl acceptor for this work. 
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Figure 5. 1: Glycosyl acceptor 
5.1.1 Synthesis of allyl C-galactopyranoside 34 
The synthesis began with the introduction of the C-glycoside appendage at position 1 of b-D-
galactose-pentaacetate 30. The peracetylated allyl C-galactopyranoside 34 has been prepared 
according to Giannis et al.59 from 30 and allyltrimethylsilane in the presence of borontrifluoride 
ethyl etherate in 67 %. Compound 34 was contaminated with small amounts of the b-isomer, 
which has a slightly higher Rf value. 
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Scheme 5. 1: C-glycosylation with allyltrimethylsilane/ BF3.Et2O 
5.1.2 Double bond rearrangement in compound 34 
5.1.2.1 Palladium catalytic reaction of compound 34 
It is well-known that double bonds can be shifted to thermodynamically more stable positions in 
Palladium-mediated reactions. This approach that has been employed by Brooks et al.55 was 
described to be not completely satisfactory since product mixtures resulted.  
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Scheme 5. 2: Palladium-catalysed rearrangement reaction of compound 34 
In the present work, the same observation was made. When compound 34 was refluxed in 
toluene with varying amounts of bis(benzonitrile)palladium(II) chloride, (PhCN)2PdCl2, TLC using 
several solvent mixtures showed a major spot with exactly the same Rf value as 34 and a minor 
spot similar to that of 34 but slightly higher. The major spot according to 13C NMR corresponds 
to a mixture of 34 and 54. The CH3 signal of 54 appeared at 18 ppm, while the CH2 vinylic 
signals of the starting material appeared at 31 ppm. In the 115-135 ppm range, the olefinic signals 
of the starting material 34 appeared at 118 and 133 ppm, whereas the signals at 119 and 123 are 
assigned to the olefinic carbons of product 54. According to the 13C NMR there was about a 1:1 
ratio of the two isomers. Changing the amount of the catalyst and the reaction time did not affect 
the result. 
The by-product was a white solid, and according to the spectra it has structure 55. 
The main problem was obviously the difficulty to separate and purify compound 54. When a 
mixture of the two compounds 54 and 34 was ozonolyzed, again compounds with very close Rf 
values have been obtained (data not reported). 
As a conclusion, we preferred to look for a more practical route for the double bond 
rearrangement in compound 34.  
5.1.2.2 Ene reaction 
An ene reaction seemed to be a good choice for the rearrangement of the double bond. The first 
attempt was made using singlet oxygen as a reagent. 
5.1.2.2.1 Attempted photooxygenation reaction of compound 34 
The photolysis of 34 has been tested using two different sensitizers; methylene blue, and Rose 
bengal. Methanol and dichloromethane solutions of compound 34 and each of the sensitizers 
were illuminated with an external Philips 1000W halogen lamp while a stream of dry oxygen was 
passed through the solution. After 9 h at RT, no reaction was observed as indicated by TLC, 
using different eluents. 
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Scheme 5. 3: Attempted photooxygenation of compound 34 
Guided by this result we looked for a more reactive reagent. 
5.1.2.2.2 Ene reaction of triazolinedione with compound 34 
The ene reaction of 4-substituted-1,2,4-triazoline-3,5-diones (4-R-TAD) with alkenes was first 
studied by Pirkle and Sticler.63 TADs are highly reactive neutral electrophiles, commonly used to 
detect unsaturation or to introduce nitrogen functionalities.64 TADs undergo Diels-Alder reactions 
with dienes, and aff ord [2+2] adducts, or ene products with alkenes.65 
The ene products were found to be very stable, and to be quite acidic. The NH group of the ene 
product is very reactive, and the product still possesses a carbon-carbon double bond, with 
interesting reactivity. This double bond can undergo reaction with bromine, or with ozone, but it 
has much lower reactivity toward a new molecule of TAD than the corresponding alkene.66 
In our case, compound 34 on reaction with 4-phenyl-3H-1,2,4-triazoline-3,5-dione (PTAD)66 in 
dichloromethane at RT provided 56 in 83 % yield. 13 % of unreacted alkene were recovered. 
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Scheme 5. 4: Reaction of compound 34 with PTAD 
The typical red colour of PTAD was quickly discharged when PTAD was mixed with the alkene.  
The results of double bond rearrangement reactions of compound 34 are summarised in Scheme 
5.5.  
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Scheme 5. 5: Double bond rearrangement of compound 34 
5.1.3 Preparation of alcohol 35 
Compound 35 has been prepared from alkene 56 in two successive steps, ozonolysis followed 
by reduction. Ozonolysis of compound 56 in a dry CH2Cl2-MeOH (10:1) at -70 °C, and 
subsequent quenching with dimetyl sulfide should lead to the aldehyde 57. No effort has been 
made to obtain pure samples of the aldehyde. Brooks55 has reported that modest yields (48 %) 
of a gluco analogue of the desired alcohol 35 were obtained by using sodium acetoxyborohydride 
to reduce the crude ozonolysis products. In agreement with this, reduction of the crude ozonolysis 
products of 56 with sodium acetoxyborohydride (prepared in situ from NaBH4 and AcOH in 
THF) furnished the primary alcohol 35 in a non satisfying yield of 42 %. 
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Scheme 5. 6: Preparation of alcohol 35 
An identified problem was the ready elimination of acetic acid 
to give the a,b-unsaturated aldehyde, 58. The formation of 
this glycal was completely suppressed under dry conditions. 
When the reaction was performed using freshly distilled THF 
and acetic acid, the yield increased up to 85 % with no trace 
of the aldehyde 58 on the TLC. 
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Figure 5. 2: Glycal 58 
 
5.1.4 Preparation of the halide derivatives 
The halide derivative that we wanted to prepare is an important precursor for applying the 
Arbuzov reaction.56 Brooks et al.55 reported that OH ® halide exchange in the gluco analogues 
of 35 by direct displacement of hydroxyl groups with thionyl bromide, or phosphorous tribromide 
in carbon tetrabromide was unsuccessful. They have used a two-step procedure via a sulfonate. 
On the contrary, compound 35 could be converted directly into compound 59 on reaction with 
iodine, in the presence of chlorodiphenylphosphine (Ph2PCl) and imidazole67, but the yield was 
low (31 %). 
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Scheme 5. 7: Synthesis of the iodide 59 
Eventually, the primary hydroxyl group in compound 35 was mesylated, using methanesulfonyl 
chloride in pyridine, in the presence of catalytic amount of p-dimethylaminopyridine (DMAP) at 4 
°C to give methanesulphonate 60 in 60 % yield. 
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Scheme 5. 8: Synthesis of the methanesulphonate 60 
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The mesylate 60 was converted in turn into the halide derivatives 59 (65 %) and 61 (80 %) when 
heated in toluene at 80 °C with tetrabutylammonium iodide and tetrabutylammonium bromide,55 
respectively. 
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Scheme 5. 9: Conversion of the sulphonate 60 into the halides 59 and 61 
 
5.1.5 Hydrolysis of the acetate group 
Hydrolysis of the acetate groups without harming the primary bromide was accomplished making 
use of the Zemplén method.68 Thus, sodium methoxide was added to a solution of compound 61 
in dry methanol (ca 10 mL MeOH for 1 g sugar) at 0 °C, and the mixture was then stirred at RT. 
The reaction mixture was then neutralized with Dowex 50-W X2 (H+), affording the fully 
deprotected compound 62 in quantitative yield. 
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Scheme 5. 10: Ester hydrolysis of compound 61 
 
5.1.6 Preparation of the silyl ether 63 
Silyl ethers have gained considerable importance as protecting groups in natural product 
chemistry. A large variety of triorganosilyl ethers are employed in organic chemistry. As the alkyl 
group becomes larger, silyl groups become more resistant to hydrolysis and also easier to place 
on primary hydroxyls regioselectively. They are normally formed by reaction of an alcohol with 
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the respective silyl chloride under basic catalysis, involving usually pyridine, triethylamine, DMAP 
or imidazole in DMF. 
The need for regioselective protection of the primary hydroxyl group has led us to investigate the 
use of t-butyldiphenylsilyl chloride (TBDPSCl). The value of this reagent for preferentially 
blocking primary alcohols in sugar derivatives has been recognized. When 62 was treated with 
TBDPSCl, using weakly basic catalysts such as pyridine and triethylamine, in the presence of a 
catalytic amount of p-dimethylaminopyridine (DMAP) at 0 °C, the yield of 63 was only 33 %. 
On the other hand, treatment of compound 62 with TBDPSCl in N,N -´dimethylformamide 
(DMF) in the presence of imidazole at 0 °C afforded the 6-(t-butyldiphenylsilyl) ether 63 in 85 % 
yield. 
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Scheme 5. 11: Selective 6-O-silylation in compound 62 
The t-butyldiphenylsilyl (TBDPS) ether is quite stable to acids, and it should survive the acidic 
conditions necessary for the formation and cleavage of isopropylidene acetals.69 It is also stable to 
bases. Cleavage of silyl ethers can be achieved by fluoride ions, using a molar solution of TBAF 
in THF. 
 
5.1.7 Preparation of the isopropylidene derivative 53 
The free hydroxyl groups at O-3 and O-4 in compound 63 have been protected by acetonide 
formation.70 The isopropylidene group can be introduced with dry acetone and an acid71 (mineral 
acids72 or Lewis acids such as Znl2 or dry CuSO2,73 AlCl374 or FeCl375) or in DMF solution with 
2,2-dimethoxypropane76 or 2-ethoxypropene77 and a catalytic amount of an acid, often p-
toluenesulfonic acid (PTS). For energetic reasons, acetone normally reacts only with vicinal 
hydroxy groups which are positioned in a cis-arrangement at the sugar ring to give five-membered 
1,3-dioxolanes. The axial methyl substituent at the acetal centre destabilizes the corresponding 
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1,3-dioxane. In this work, PTS-catalysed isopropylidenation with 2,2-dimethoxypropane in dry 
acetone was used and afforded the 3,4-O-isopropylidine acetal derivative 53 in 88 % yield. 
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Scheme 5. 12: Synthesis of the isopropylidene derivative 53 
 
Work-up of the reactions was carried out using acid-free conditions to avoid acetal hydrolysis. 
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5.2 Synthesis of the disaccharide building block 18 
5.2.1 Glycosylation 
5.2.1.1 Choice of the glycosyl donor 
A multitude of methods and versions is available for the glycosylation of carbohydrates, both with 
and without neighbouring group participation.60 In our case, the glycosyl donor should contain a 
nitrogen functionality which in the final product has to be converted into an N-acetyl group. In 
principle, an N-acetylated donor 64 appears to be suitable. However, N-acetylated amino sugars 
are particularly unsuited as glycosyl donors, because under the glycosidation conditions they tend 
to form stable oxazoline derivatives.78,79 
OAc
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Figure 5. 3: Glycosyl donors 41 and 64 
 
The Jacquinet and Blatter method61 solves this problem and uses the trichloromethyl oxazoline 
41 as the glycosyl donor, and a Lewis acid as promoter. The use of trichloroacetamidates is one 
of the most commonly used glycosylation strategies. The general significance of O-glycosyl 
trichloroacetamidates lies in their ability to act as strong glycosyl donors under relatively mild acid 
catalysts such as borontrifluoride etherate complex (BF3.Et2O) or trimethylsilyl 
trifluoromethanesulfonate (TMSOTf). Despite the inductive effect of the halogens, 
trichoroacetamido derivatives such as 41 give rise to the formation of intermediate oxazolinium 
ions. The electron withdrawing effect of the trichloromethyl group in these intermediates greatly 
increases the electrophilic character of the anomeric carbon, and explains the much greater 
reactivity of 41, compared to its N-acetyl congener 64. However, this method constructs the 
disaccharide with a N-trichloroacetyl group, which must be transformed to a N-acetyl group as 
will be discussed latter. 
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5.2.1.2 Glycosylation mechanism 
In the glycosylation reactions, neighbouring group participation of protecting groups at C-2 is 
usually the dominating effect in anomeric stereocontrol during glycosylation, giving rise to 1,2-
trans glycosides. When non-participating protecting groups are selected, SN2-type reactions can 
be carried out assisted by the use of nonpolar solvents, low reaction temperatures, and weak 
Lewis acid catalysts thus leading to 1,2-trans as well as 1,2-cis glycosides. The general 
glycosylation mechanism60f is shown in Scheme 5.13. 
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Scheme 5. 13: General glycosylation mechanism 
 
5.2.1.3 Synthesis of the glycosyl donor 
Blatter et al.61 (Scheme 5.14) reported the use of the trichloromethyl oxazoline 41 as the 
glycoside donor (prepared in situ from 67) using a catalytic amount of trimethylsilyl triflate 
(TMSOTf), as a promoter, which gave the best glycosidation results. D-glucosamine 
hydrochloride 32 was selectively N-substituted by treatment with trichloroacetyl chloride in 
aqueous media, thus giving 65 which undergoes an acetylation reaction to give 66 as an anomeric 
mixture of á and â isomers. Anomeric deprotection of the mixture with hydrazinium acetate in 
DMF, followed by treatment with trichloroacetonitrile and DBU afforded the trichloroacetamidate 
67. 
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Scheme 5. 14: Synthesis of the glycosyl donor 41 
5.2.1.4 Disaccharide formation  
In the glycosylation step, the glycosyl acceptor and donor are normally mixed in a dry inert 
solvent such as dichloromethane, acetonitrile or 1,2-dichloroethane, then the reaction is started by 
the addition of a catalytic amount of a Lewis acid. The glycoside is usually obtained in high yields 
with only a slight excess of the donor, and with a high degree of 1,2-trans stereoselectivity. In the 
present case, glycosyl acceptor 53 and a moderate excess of 1.2 eq of the glycosyl donor 67 
were treated with 0.1 eq of TMSOTf in dry 1,2-dichloroethane in the presence of activated 3 Å 
molecular sieves at 0 °C for ca 10 min, followed by neutralization with triethylamine (TEA), and 
afforded the desired â-linked disaccharide 68 in 79 % yield. 
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Scheme 5. 15: Glycosylation reaction of 53 
In one reaction (AJ 2-12) compound 69 was isolated as the main product in 44 % yield, 
contaminated with many by-products. Its formation could possibly be explained as shown in the 
following scheme. Compound 68 should be formed, and undergoes a reversible reaction with 
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TMSOTf leading to the intermediate 70, which upon reaction with a nucleophile (possibly water) 
gives compound 68 (pathway a) or compound 69 (pathway b). 
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Scheme 5.16: Explanation for the formation of 69 
 
The reaction conditions have been carefully optimised. 0 °C and a reaction time not longer than 
10 min are required to furnish the main product in a high yield. It was noticed by TLC that on 
longer reaction times decomposition occurs to give many products, and the desired disaccharide 
is obtained in low yields. 
 
5.2.2 Cleavage of the silyl ethers in compounds 68 and 69 
Selective cleavage of only one protecting group in a sugar can be accomplished if not all 
protecting moieties in a carbohydrate derivative have the same reactivity. Cleavage of silyl ethers 
can be achieved by fluoride ions using TBAF,69 for example, which removes the silyl ethers 
without cleavage of other acid-sensitive groups in the same sugar. Removal of the TBDPS group 
from 68 was readily accomplished by treatment of 68 with a molar solution of TBAF in THF at 
room temperature, thus affording 71 in 89 % yield. 
89 %
OAc
AcO
NHCOCCl3
OAcO
O
O
O
O OH
Br
OAc
AcO
NHCOCCl3
OAcO
O
O
O
O OTBDPS
Br
1M TBAF / THF
68 71
 
Scheme 5.17: Cleavage of the silyl ether in compound 68 
 
It should be noted that the bromomethyl group survives the reaction conditions. 
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On the other side, compound 71 was obtained in 95 % yield from 69, upon its reaction with 
Dowex 50-W X-8 (H+) resin at room temperature in methanol.80 
95 %
OAc
AcO
NHCOCCl3
OAcO
O
O
O
O OSi(CH3)3
Br
Dowex, MeOH
OAc
AcO
NHCOCCl3
OAcO
O
O
O
O OH
Br
69 71  
Scheme 5.18: Cleavage of the silyl ether in compound 69 
 
5.2.3 Synthesis of the uronamide 72 
The oxidation of the primary hydroxyl group of carbohydrates to form the corresponding uronic 
acid is often performed as a two-step reaction. For example, Swern-oxidation81 (DMSO, oxalyl 
chloride) to give an aldehyde, and sodium chlorite oxidation82 of the latter to the uronic acid has 
been successfully applied for the synthesis of a moenomycin analogue.83 A further method to be 
mentioned here, is the oxidation with o-iodoxybenzoic acid,84 which has been successfully applied 
by Weigelt85 for the synthesis of an uronic aldehyde. A useful reagent is also 2,2,6,6-tetramethyl-
1-piperidinyloxy-radical (TEMPO). Flitsch86 reported that the primary hydroxyl groups in 
monosaccharides can selectively be oxidised with TEMPO87 in the presence of a phase transfer 
catalyst, leading even directly to the carboxylic acid. Tetrabutylammonium chloride is used as the 
phase transfer catalyst. The consumed oxidizing reagent can be regenerated by hypobromite, 
prepared in situ from hypochlorite and bromide.88 Other workers could also achieve selective 
oxidation of mono- and polysaccharides to the appropriate acids using this method.89 However, 
Kosmol90 found that TEMPO-oxidation under phase transfer catalyst gave only the aldehyde, 
which in turn had to be further oxidised with sodium chlorite to the corresponding acid. A version 
of the TEMPO-oxidation using organic oxoammonium salts generated by acid-promoted 
disproportionation of 4-acetylamino-TEMPO is reported by Bobbitt.91 
The standard method to get the amide is the imidazolide procedure of Staab,92 in which the acid 
is activated with N,N -´carbonyldiimidazole (CDI) in dichloromethane to give the imidazolide, 
which upon its reaction with ammonia93 will be transferred to the amide. Other activating reagents 
are dicyclohexylcarbodiimide and 1-hydroxybenzotriazol,94 or the EEDQ in chloroform. In the 
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latter protocol the amide functional group was generated by the addition of ammonium 
hydrogencarbonate.95 
In the present case the procedure of Kosmol et al.35 was applied. 
First, the primary alcohol 71 was oxidised to the corresponding aldehyde with sodium 
hypobromite (prepared in situ from sodium hypochlorite, and potassium bromide) in the presence 
of TEMPO and tetrabutylammonium chloride. The crude product was then oxidised with sodium 
chlorite to furnish the corresponding acid, which was immediately converted to the amide using 
Staab’s method. The acid was dissolved in dry dichloromethane and activated with CDI. 
Gaseous ammonia was then bubbled through the solution at 0 °C. The required amide 72 was 
obtained in an overall yield of 98 % (based on alcohol 71). 
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Scheme 5. 19: TEMPO, sodium chlorite oxidation and amide formation 
 
5.2.4 Removal of the isopropylidene group from 72 
The isopropylidene group, which is stable under basic-, oxidation- and reduction conditions,96 
can be hydrolysed under acidic conditions, using, for example, aqueous acetic acid, aqueous 
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trifluoroacetic acid (TFA), diluted HCl in THF, sulfuric acid in methanol, silica gel, or acidic ion 
exchange resin.97 A newer method uses DDQ for the acetal cleavage in carbohydrates.98  
The 3,4-O-isopropylidene group of compound 72 has shown resistance again Dowex 50 W X-8 
(H+), as shown in Scheme 5.18 for the cleavage of the trimethylsilyl ether in compound 69. 
Additionally, no reaction was noticed when 72 was treated with 80 % AcOH at room 
temperature for 17 h. In contrast, the acetal was easily cleaved with TFA at room temperature, 
furnishing diol 73 in 89 % yield. 
 
RT X
89 %
OAc
AcO
NHCOCCl3
OAcO
CONH2
O
O
O
O
Br
TFA
AcOH
OAc
AcO
NHCOCCl3
OAcO
CONH2
O
O
Br
HO
OH
72 73  
Scheme 5. 20: Removal of the isopropylidene group from 72 
 
5.2.5 Carbamoylation 
There are different methods to introduce the carbamoyl functional group at position-4F which is 
necessary for the biological activity of moenomycin-type compounds.  
The most versatile method is the addition of alcohols to isocyanates. The unsubstituted carbamoyl 
group can be obtained through the addition of chlorosulfonylisocyanate, followed by hydrolysis.99 
Through a reaction of mono100- or tri-chloroacetylisocyanate (TAI)101 with the alcohol, the 
desired carbamoyl compound is obtained after removal of the mono- or tri-chloroacetyl groups. 
This is possible either hydrolytically in the presence of an ion exchange resin, with Al2O3,101d 
K2CO3,102 or reductively with zinc dust in methanol.103 TAI is very reactive and reacts with OH 
groups in the order:  
primary > secondary > tertiary > phenol. 
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Scheme 5. 21: From diol 73 to urethane 74 
 
Another convenient method for the construction of the carbamoyl group is the McLamore et al. 
method.104 The carbamoyl group is obtained via the phenyl carbonate, itself obtained from the 
alcohol and phenyl chloroformate. On reaction with ammonia,105 the phenyl carbonate is cleaved 
to furnish the urethane. The introduction of the carbamoyl group with p-nitrophenylchloroformate 
and subsequent aminolysis with methanolic ammonia is likewise possible.106,107,108  
An alternative method to form the urethane is the conversion of a 1,2-diol into the corresponding 
cyclic carbonate. The carbonate ring can then be opened with ammonia from both sides in a non-
selective reaction, thus leading to two isomeric O-carbamoyl compounds.106,109 
 
5.2.5.1 Trial based on TAI 
Initial attempts to prepare the 4-O-carbamoyl compound were based on the prior reports stating 
that the reaction of the 3,4-diol grouping in a D-galactose-derived sugar with 
trichloroacetylisocyanate (TAI) leads regioselectively to the desired 4-O-carbamoyl 
compound.34,44,110 The reaction was performed in dry CH2Cl2 using 3 Å molecular sieves, and 1 
eq of TAI at -5 °C. To confirm dry conditions, compound 73 was dissolved in dry CH2Cl2, and 
the solution was refluxed over 3 Å molecular sieves before adding TAI. In spite of the high TAI 
reactivity, its reaction with alcohol 73 was fruitless. No reaction was observed, even using an 
excess amount of TAI, and performing the reaction at room temperature, up to 20 h. The result 
was reproducible. The reason for the low nucleophilicity of 73 in this reaction is unknown. 
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Scheme 5. 22: Trial to construct the carbamoyl group using TAI 
 
5.2.5.2 Trial based on the phenyl carbonate 75 
The alternative method of McLamore et al.104 to form the urethane has been studied. Thus, 
compound 73 was dissolved in dry dichloromethane in the presence of DMAP, and TEA at 0 
°C. Under these conditions, treatment of 73 with phenyl chloroformate furnished the undesired 
cyclic carbonate 76 in 72 % yield. 
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Scheme 5. 23: Trial to construct the carbamoyl group from the phenyl carbonate 75 
Formation of the five-membered ring carbonate 76 can be easily explained by the formation of 
75, followed by cyclization on reaction of the free OH group with the neighbouring 
phenylcarbonate. 
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5.2.5.3 Aminolysis of the cyclic carbonate 76 
The cyclic carbonate 76 was also prepared from diol 73 on reaction with carbonyldiimidazole 
(CDI) in the presence of a catalytic amount of DMAP in dichloromethane. The yield was 84 %. 
Phosgene,106 triphosgene109 as well as trichloromethyl formyl chloride in pyridine111 or in THF 
with collidine112 have also been used to prepare such cyclic carbonates. 
Selective opening of the cyclic carbonate was not a straightforward and the reaction was studied 
in some detail. 
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Scheme 5. 24: Aminolysis of the cyclic carbonate 76 
 
When gaseous ammonia was bubbled through an ethanolic solution of 76 at 0 °C for 1 h, the two 
isomers 74 (18 %), and 77 (20 %) were obtained. In another experiment, the reaction of 76 was 
performed with 0.5 M ethanolic ammonia at 0 °C for 5 h to afford 74 (3 %) and 77 (48 %). This 
result may reflect the greater lability of the equatorial urethane towards nucleophilic attack. When 
the reaction was run in dichloromethane solution (gaseous ammonia, 0 °C, 6 h), 74 was 
produced in a satisfying yield of 62 % alongside with 21 % of the unwanted isomer 77. 
These results are summarized in Table 5.1. 
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Table 5. 1: Results of ring opening of 76 with ammonia 
Reaction code Conditions  Yield (%) 
  74 77 
AJ 2-35 1) EtOH, 0 °C 
2) NH3 (g), 1 h 
18 20 
AJ 2-46 0.5 M ethanolic 
ammonia, 0 °C, 5h 
3 48 
AJ 2-45 1) CH2Cl2, 0 °C 
2) NH3 (g), 6 h 
62 21 
 
Separation of the two isomers was difficult and time consuming. Flash chromatography as well as 
reversed-phase chromatography were unsuccessful. They were separated by MPLC with 
difficulty. Both isomers were fully characterized by 2-dimensional NMR including, COSY, 
HMBC and HMQC. The 3- and the 4-O-carbamoyl derivatives were readily distinguishable. The 
4-H signal of the 4-O-carbamoyl derivative 74 was observed at d 5.68 as dd with coupling 
constants of J = 3.5 and 8.3 Hz, as expected for an axial proton. In contrast, the 3-H signal of the 
3-O-carbamoyl derivative 77 was observed at d 6.47 as a broad singlet, as expected for an 
equatorial proton. 
 
5.2.6 Formation of the acetamide 
The next step in the synthesis was the conversion of the N-trichloroacetyl group into an N-acetyl 
group. This can be achieved either by dehalogenation or by a sequence of amide cleavage and 
acetylation. Dehalogenation of chloro-substituted acetamides has been achieved with tributyltin 
hydride, Bu3SnH,61,113,114 in a radical reaction using AIBN115 as initiator. (Me3Si)3SiH116 can be 
used instead of Bu3SnH. The reductive dehalogenation can also be accomplished by activated 
zinc-acetic acid in THF,117 or activated Zn-Cu couple in acetic acid.33,118  
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Scheme 5. 25: Dehalogenation of the N-trichloroacetyl group 
 
On the other hand, N-trichloro- and N-trifluoro-acetyl groups have been removed to give the 
free amine on reaction with NaBH4 in EtOH at 60 °C119,120 via the hemiaminal, or hydrolytically 
on reaction with LiOH in MeOH-THF.121 
To avoid the danger of harming the bromomethyl group, radical reactions seemed not appropriate 
and we preferred to use the second type of reactions. 
Occasionally, hydrolysis of trifluoroacetamides was achieved by treatment with anhydrous 
methanolic ammonia.122 This route seemed unsuitable for us, since as reported above, the 
trichloacetamidate group of 72 (Scheme 5.19), 74 and 77 (Scheme 5.24) was quite stable 
towards ammonia. 
 
5.2.6.1 Removal of the trichloroacetyl group in compound 76 
5.2.6.1.1 Hydrolysis with LiOH 
Cyclic carbonates are stable towards acidic hydrolysis and were reported to be more stable to 
basic hydrolysis than acyclic esters.123 Therefore, the hydrolysis of the N-trichloroacetamido 
group in compound 76 with LiOH has been studied (Scheme 5.26). Compound 76 was allowed 
to react with a solution of 0.5 M LiOH in MeOH-THF (1:1) at RT for ca 2 h. The crude product 
was then acetylated with Ac2O in dry pyridine. Unfortunately, the reaction did not proceed as 
expected; instead of 78, 80 was the sole product (73 %). 
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Scheme 5. 26: Hydrolysis of 76 with LiOH and subsequent acetylation 
 
5.2.6.1.2 Reduction with NaBH4 
Reductive cleavage of N-trifluoro- and N-trichloro-acetyl groups with sodium borohydride into 
amines and 2,2,2-trihaloethanols should proceed according to Weygand:119 
R-NH-COCX3 
NaBH4
EtOH
R-NH2 + HO-CH2CX3 (X=F, Cl)
 
The reaction is stopped by adding acetic acid. The free amine can then be acetylated to furnish 
the acetamide. 
Conversion of the N-trichloroacetyl group in compound 76 into the N-acetyl group was 
accomplished by the two-step procedure (Scheme 5.27). Reduction of 76 with 1 eq of NaBH4 in 
absolute ethanol was performed at 60 °C for 8 h. The crude product was then acetylated with 
Ac2O in dry pyridine. Under these conditions, the N-trichloroacetyl group was successfully 
converted into the N-acetyl group, but with an undesired interaction of the cyclic carbonate group 
of unit F. 
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Scheme 5. 27: Reduction of 76 with NaBH4 and subsequent acetylation 
 
Obviously, the carbonate is so base-labile under the reaction conditions that it was cleaved under 
the reaction conditions. Acetylation of both the amino and hydroxy groups in 81 furnished then 82 
in 85 % yield.  
Changing the reaction temperature did not affect the result. No reaction was observed at 0 °C for 
15 h using 1 eq of NaBH4 in dry ethanol. When the reaction has been performed at RT for 10 h, 
again 82 was obtained in 83 % yield. 
The product 82 is not a suitable precursor for structural analogues of monoemycins; since it 
seems difficult to hydrolyse selectively the acetate group at C-4F to introduce the carbamoyl 
group which is necessary for the biological activity. 
An alternative pathway had to be found which is the reduction of the N-trichloroacetyl group in 
compound 74. 
 
 
 
 
5. RESULTS AND DISCUSSION 42
5.2.6.2 Reduction of the N-trichloroacetyl group in compound 74 with NaBH4 
Compound 74 has been allowed to react with 1 eq NaBH4 in absolute ethanol at 60 °C for ca 9 
h. The crude product was then acetylated using Ac2O in dry pyridine.  
Under these conditions, the N-trichloroacetyl group was converted into the N-acetyl group, but 
with the unwanted interaction of the carbamoyl group of unit F. Thus, instead of the desired 
product 83, again compound 82 was obtained in 78 % yield. The result demonstrates the base-
sensitivity of the urethane grouping. 
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Scheme 5. 28: Reaction of compound 74 with NaBH4 at 60 °C 
Many factors as the molar ratio of NaBH4 to 74, dryness conditions, reaction temperature, 
reaction time and the reaction solvent have been taken into account. All the reactions were 
performed using a 1 molar ratio of NaBH4 to 74. The solvents as well as the acetic acid which 
was used to stop the reaction were freshly distilled. There was no observed reaction at 0 °C, 
even by leaving the reaction mixture for 48 h.  
However, in one experiment (AJ 2-41), the N-trichloroacetyl group was successfully converted 
at RT (13 h) to the N-acetyl group, giving compound 83 in 42 % yield, in which the carbamoyl 
group is still present, and the O-3 hydroxyl group in unit F is acetylated. But again the fully 
acetylated product 82 was formed as well (46 % yield). 
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Scheme 5. 29: Formation of the N-acetyl group at RT 
Unfortunately, the result could not be reproduced. Obviously, the carbamoyl group is so base-
labile that the conditions of the NaBH4 reduction are unsuitable for the selective removal of the 
N-trichloroacetyl group. 
Upon repeating the reaction under conditions which were 
considered to be identical with the above conditions, even the 
carbamoyl group was removed preferentially furnishing 80 (65 
% yield). The reaction was further studied in dry isopropanol at 
RT for 17 h, and in a mixture of dry THF-MeOH (4:1) at 5 °C 
for 19 h, and afforded only 80 in 73 % and 68 % yield, 
respectively.  
OAc
AcO
NHCOCCl3
OAcO
CONH2
AcO
O
O
AcO
Br
80  
Figure 5. 4: Compound 80 
It should be mentioned here that in the course of the synthesis of moenomycin analogues, the 
introduction of the carbamoyl group in the case of 3,4-diol grouping in a D-galacto-derived unit F 
has been achieved getting benefit of the methods34,44,110 which failed to give the urethane in this 
work (Schemes 5.22, 5.23). Worth mentioning is that the carbamoyl group survives the 
hydrolysis of the acetyl groups with LiOH in the last step of the synthesis. 
It is possible that the transition from O-glycoside to C-glycoside results in problems in introducing 
the carbamoyl group and in its high base sensitivity. 
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Reduction of the N-trichloroacetyl group avoiding the undesired interaction of the other base 
sensitive groups under milder conditions led us to investigate the use of sodium 
cyanoborohydride. However, trials to reduce the N-trichloroacetyl group in 80 as a model 
substance by NaBH3CN in the presence of HCl-ether were fruitless. 80 was conducted with 1 
eq NaBH3CN catalysed with HCl-dry ether. TLC showed a product formation, and the product 
of this step was acetylated. The reaction should give 82, but the spectral data of the acetylated 
product were in accordance with those of 80. Such a result may be explained by a possible 
cleavage of acetyl group(s) during the reduction step, followed by acetylation of the free hydroxyl 
group(s) thus recovering the starting material.  
 
5.2.7 Phosphonate formation 
Applying the Arbuzov reaction,56 compound 82 was refluxed with triethylphosphite under an 
argon atmosphere, affording the expected product 85 (70 %). 
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Scheme 5. 30: Phosphonate formation of compound 85 
The phosphite was stirred with 3 Å molecular sieves, and degassed under argon atmosphere for 1 
h before use. 
5.2.8 Conclusion and suggestions for further work 
In conclusion, we were able to convert b-D-galactose-pentaacetate into galactoheptonamides. In 
this work, we developed the method to obtain the first C-glycosidic disaccharide analogues of 
moenomycin A12 with all the substituents on unit F that fulfil the requirements of the moenomycin 
A12 biological activity. This method can be used to prepare other analogues, as will be discussed 
in the coming section. 
However, the synthetic method employed in this part warrants further investigation toward 
obtaining suitable conditions for the conversion of the N-trichloroacetyl group in compound 74 
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into an N-acetyl group, which will enable us to apply the Arbuzov reaction, giving a compound 
that should lead to the target molecule. 
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5.3 Synthesis of the trisaccharide building block 19 
5.3.1 Trials to prepare 87 based on oxazoline 42 
Chitobiose octaacetate 86 can be prepared in moderate yield from chitin by microbial 
degradation followed by acetylation, or by chemical degradation.62 The conversion of 86 into 
oxazoline 42 can be achieved with many reagents,62 the best yield was obtained using 
trimethylsilyl trifluoromethanesulfonate-triethylamine.124 
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Scheme 5. 31: Synthesis of the oxazoline 42 
 
42 has been used as a key intermediate for the preparation of various 2-acetamido-2-deoxy-â-D-
glycosides.62 In trifluoromethanesulfonic acid (TfOH)62 as well as camphorsulfonic acid (CSA)46 
promoted couplings, the yields were usually moderate. 
The glycosylation reaction of 42 with the glycosyl acceptor 53 was intensely studied varying 
reaction times, reaction temperatures, and acceptor-donor ratios. When camphorsulfonic acid 
and trimethylsilyl trifluoromethanesulfonate (TMSOTf) were used as promoters, there was no 
reaction, and the glycosyl donor was recovered. In the case of trifluoromethanesulfonic acid, 
decomposition products were obtained as shown by TLC and NMR. Clearly the nucleophilicity 
of 53 is too low for the reaction with the notoriously unreactive oxazoline 42.57 
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Scheme 5. 32: Glycosylation trial based on the oxazoline 42 
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5.3.2 Synthesis based on the trichloroacetamidate donor 88 
5.3.2.1 Synthesis of the donor 88 
Compound 88 has recently been prepared in our 
group,125 and has successfully been used as a 
glycosyl donor. It generates units C and E in the 
target product, while the acceptor represents unit 
F. 
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Figure 5. 5: Glycosyl donor 88 
88 was prepared in 14 steps from glucosamine hydrochloride 32 as shown in the following 
Scheme.  
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Scheme 5. 33: Synthesis of the donor 88 
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88 is more reactive than the oxazoline derivative 42. It survives the glycosylation conditions with a 
lower degree of decomposition and couples with the accessible glycosyl acceptor in moderate 
yields. The 2-phthalimido group directs the attack predominantly to the â face and prevents the 
formation of 1,2-oxazolines during the glycosylation.60a,126 However, removal of the phthalimido 
group is often connected with problems.126 
One of the primary hydroxyl groups in this donor is protected as the t-butyldiphenylsilyl ether, the 
same protecting group for the primary hydroxyl group in acceptor 53, that we used for the 
synthesis of the disaccharide 68 (Scheme 5.15). 
This would lead to a trisaccharide with two identical 
protecting groups at the primary hydroxyl groups which 
would have to be differentiated (as in Scheme 5.39) in 
the course of the synthesis of the uronamide 93. In order 
to avoid deprotection complications we decided to use 
another glycosyl acceptor. 
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Figure 5. 6: Glycosyl acceptor 53 
5.3.2.2 Synthesis of the glycosyl acceptor 92 
As discussed in section 1.5, the amide group at position 1 in unit F is essential for the biological 
activity. Therefore, acceptor 53 was converted into galacturanamide derivative 92, which would 
be used as an alternative glycosyl acceptor. The conversion of 53 into 92 is shown in the 
following scheme.  
 
O
HO
O
O OTBDPS
Br
Ac2O
pyridine
88 %
O
AcO
O
O OTBDPS
Br
87 %
TBAF / THF O
AcO
O
O OH
Br
95 %
a) CDI, CH2Cl2
b) NH3(g), 
NaClO2
0 °C
1. TE MPO, NaOCl, KBr
2. 
3. 
CONH2
O
AcO
O
O
Br
quant.
CH3OH
CH3ONa
CONH2
O
HO
O
O
Br
53 89 90
91 92
 
Scheme 5. 34: Synthesis of the acceptor 92 
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The free hydroxyl group in compound 53 was protected as an acetate group on reaction with 
acetic anhydride in pyridine in the presence of DMAP. Compound 89 was obtained in 88 % 
yield. The silyl ether in 89 was cleaved with TBAF, as previously discussed, affording compound 
90 in 87 % yield. The free hydroxyl group was then subjected to an oxidation using the TEMPO 
method affording the aldehyde which was in turn oxidised to the corresponding acid. The acid 
was converted to the amide 91, making use of Staab's method, in an overall yield of 95 %. The 
required glycosyl acceptor 92 was obtained in quantitative yield by cleavage of the ester bond at 
position 5 under Zemplén conditions. 
5.3.2.3 Glycosylation trial based on acceptor 92 
It was hoped that the glycosylation reaction would take place according to Scheme 5.35 giving 
trisaccharide 93, a precursor of the desired synthetic intermediate 19. 
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Scheme 5. 35: Attempted trisaccharide formation based on acceptor 92 
Unfortunately, the coupling reaction between acceptor 92 and donor 88 was unsuccessful. The 
reactants were submitted to glycosylation conditions that have been used for the disaccharide 
formation. TMSOTf and 3 Å molecular sieves in 1,2-dichloroethane and a mixture of 1,2-
dichloroethane-ether were used. The reaction time, the reaction temperature and the molar ratios 
of acceptor-donor were varied, with no change in the result. TLC showed complete 
decomposition of the donor. 
The reason is probably the low nucleophilicity of acceptor 92, arising from the presence of the 
electron-withdrawing amide group. To confirm this assumption we allowed 92 to react with 
donor 67. This glycosylation or even the inverse glycosylation reactions should give the previously 
prepared 72 (see Scheme 5.19). 
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Scheme 5. 36: Attempted disaccharide formation based on acceptor 92 
Again, there was no reaction between 92 and 67. Only decomposition of the donor 67 was 
observed confirming the low reactivity of 92.  
Thus, we had to look for another acceptor more reactive than the amide, in which the primary 
hydroxyl group is protected with a protecting group different from TBDPS. The TBDMS group 
was selected for this purpose. 
5.3.2.4 Synthesis of the glycosyl acceptor 95  
Compound 62 was converted in 87 % yield into its silyl ether derivative 94 upon reaction with t-
butyldimethylsilyl chloride (TBDMSCl) at 0 °C in the presence of imidazole in dry DMF. 
Compound 94 has been subjected to acetonide formation, thus protecting the free hydroxyl 
groups at positions 3 and 4 furnishing the new acceptor 95 (90 %). 
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Scheme 5. 37: Synthesis of acceptor 95 
5.3.2.5 Glycosylation based on acceptor 95 
The glycosidation reaction of donor 88 and the new acceptor 95 is shown in Scheme 5.38. The 
donor and a slight excess of the acceptor (1.2 eq) were dissolved in dry 1,2-dichloroethane 
containing 3 Å molecular sieves. Under the normal glycosylation conditions (TMSOTf-TEA, 0 
°C), compound 96 was obtained in 10 % yield after chromatography. However, using low 
temperatures (-30 °C) the yield of the coupling reaction rose to 50 %, The reaction was 
accompanied by donor decomposition.  
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Scheme 5. 38: Synthesis of the trisaccharide 96 
The required reaction time to furnish the main product in a satisfying yield is not longer than 5 min. 
It was noticed by TLC that on longer reaction times decomposition occurs to give many 
products, and the desired trisaccharide is obtained in low yields. Such behaviour reflects the high 
reactivity of the glycosyl donor 88. 
5.3.3 Cleavage of the TBDMS group in 96 
Selective deprotection of the TBDMS group in compound 96 was accomplished with TBAF at 
low temperatures. Thus, compound 96 was subjected to 1 eq of TBAF (1 M in THF) at -10 °C, 
and stirred at this temperature for ca 6 h. The solution was washed with water, extracted with 
chloroform, and evaporated. The residue which should be 97 was taken to the next reaction 
without further purification.  
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Scheme 5. 39: Selective cleavage of the TBDMS group in 96 
5.3.4 Synthesis of uronamide 93 
The free hydroxyl group of 97 was subjected to an oxidation using the TEMPO method affording 
the aldehyde. After oxidation of the aldehyde with sodium chlorite, the corresponding acid was 
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converted according to Staab's method into the amide 93 in an overall yield of 95 % (based on 
96). 
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Scheme 5. 40: TEMPO, sodium chlorite oxidation and amide formation 
5.3.5 Synthesis trial of 103 
Cleavage of the TBDPS group, cleavage of the phthalimido group and acetylation of the hydroxyl 
groups as well as the primary amines are required to convert 93 into 103 (Scheme 5.41). The 
first step in this synthesis could be the cleavage of the TBDPS group in compound 93. This could 
be accomplished with a molar solution of TBAF in THF at room temperature to give 98. After 
work up, the residue was taken to the next reaction without further purification. The next step 
should be the cleavage of the phthalimido group in the crude product 98 which could be achieved 
by heating it with ethylenediamine in n-butanol. When the reaction was complete, the solvents 
were coevaporated with toluene and the residue was allowed to react with acetic anhydride in dry 
pyridine in the presence of a catalytic amount of DMAP. After chromatography, the overall yield 
of the separated product was 49 % (based on 93). Unfortunately, the reaction did not proceed as 
wished. Instead of 103, compound 102 with an elimination of HBr was obtained. HBr should be 
eliminated during the cleavage of the phthalimido group, since in an another experiment, leaving 
the TBDPS group at the moment, cleavage of the phthalimido group in 93 followed by acetylation 
led again to HBr elimination, thus giving 101 (58 %, based on 93) instead of the expected 
compound 100. This result may reflect the greater lability of the bromide group under the 
conditions that are required for the cleavage of the phthalimido group. 
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Scheme 5. 41: Trials to prepare 100 and 103 
5.3.6 Conclusion and suggestions for further work 
In conclusion we were able to synthesize the C-glycosidic trisaccharide analogues of moenomycin 
A12, but we faced difficulty in removing the phthalimido group. This reaction warrants further 
investigation toward looking for the suitable reagent that does not harm the bromine, since this 
group seems to be an important precursor for applying the Arbuzov reaction, or even looking for 
another N-protecting groups in the donor 88. 
 
We notice that in both di- and trisaccharides, the presence of 
the bromide limits us to find the suitable reagents for the 
removal of the N-protecting groups. We suggest to protect the 
hydroxyl group in compound 35 rather than converting it into its 
corresponding halide derivative, and to follow the same 
sequence of reactions discussed previously. After conversion of 
the N-protecting group into the desired N-acetyl group, Br 
AcO
AcO
O
AcO OAc
OH35  
Figure 5.7: Compound 35 
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could be introduced. 
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6 SUMMARY 
The moenomycin-type compounds are known to inhibit selectively the enzyme penicillin binding 
protein 1b (PBP 1b) that catalyses the transglycosylation reaction in the biosynthesis of bacterial 
cell wall peptidoglycan. The moenomycins (see moenomycin A12) have been shown to interfere 
with this biosynthetic step interacting with the enzyme(s). 
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Figure 6.1: Moenomycin A12 
 
The moenomycins do not induce resistance readily. A weak point in this respect may, however, 
be the phosphate bond to unit F. Its cleavage by a yet poorly characterized enzyme is the only 
enzymatic degradation reaction of the moenomycins that is known to-date. With this in mind we 
started a programme aimed at synthesizing trisaccharide analogues of moenomycin A12 in which 
the phosphate oxygen at C-1 of unit F is replaced by a CH2 group. It seemed important to retain 
all other functional groups in ring F as present in moenomycin since they are known to be of 
major importance as far as antibiotic activity is concerned. 
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Figure 6.2: Target molecule 
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It appeared that the commercially available and cheap b-D-galactose-pentaacetate 30 would be 
an interesting starting material for this synthesis. In this work, the synthesis began with the 
introduction of the C-glycoside appendage at position 1 according to Giannis et al., thus forming 
the allyl C-galactopyranoside 34, a substance that represents the first C-glycosyl backbone for 
the synthesis of the glycosyl acceptors. The total synthesis of the glycosyl acceptors is shown in 
Scheme 6.1. 
We wanted to convert the C-allyl glycoside 34 into its propenyl analogue. Attempts to achieve 
this with singlet oxygen and palladium-mediated reaction proved fruitless. On the other hand, ene 
reaction of 34 with 4-phenyltriazolin-3,5-dione in CH2Cl2 provided 56 in 83 % yield. Ozonolysis 
of this alkene (-70 °C, MeOH-CH2Cl2) and subsequent quenching with dimethyl sulfide, followed 
by reduction of the crude aldehyde with sodium acetoxyborohydride (prepared from NaBH4 and 
AcOH in THF) furnished the primary alcohol 35 (85 %). This alcohol was converted into the 
mesylate 60 (60 %), and this in turn into the bromide 61 (80 %) by heating it at 80 °C with 
tetrabutylammonium bromide in toluene. The acetate groups were hydrolysed using Zemplén 
conditions to furnish 62 quantitatively. The primary hydroxyl group in 62 was protected as a 
tBuPh2Si ether 63 (85 %) on reaction with TBDPSCl in DMF at 0 °C, and as a tBuMe2Si ether 
94 (87 %) on reaction with TBDMSCl in DMF at 0 °C in the presence of imidazole. PTS-
catalysed isopropylidenation of the 3,4-diols 63 and 94 with 2,2-dimethoxypropane in dry 
acetone gave the 3,4-O-acetonide derivatives 53 (88 %) and 95 (90 %), respectively. 
On the other hand, the glycosyl acceptor 53 was converted into the glycosyl acceptor 92. The 
free hydroxyl group in compound 53 was protected as an acetate group on reaction with acetic 
anhydride in pyridine in the presence of DMAP giving 89 (88 %). The silyl ether in 89 was 
cleaved with a molar solution of TBAF in THF affording compound 90 in 87 % yield. The free 
hydroxyl group in 90 was then subjected to an oxidation using the TEMPO method affording the 
aldehyde which was in turn oxidised with sodium chlorite to the corresponding acid. The acid was 
converted to the amide 91, making use of Staab's method, in which the acid was activated with 
CDI in dichloromethane to give the imidazolide, which upon reaction with ammonia furnished the 
amide 91 in an overall yield of 95 %. The required glycosyl acceptor 92 was obtained in 
quantitative yield by cleavage of the ester bond at position 5 under Zemplén conditions. 
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Scheme 6.1: Synthesis of the glycosyl acceptors 
Disaccharide formation was achieved employing the Jacquinet and Blatter method, which 
involves the use of glycosyl donor 67 and TMSOTf. No reaction was observed between this 
donor and acceptor 92, which may reflect the low nucleophilicity of the acceptor. On the 
contrary, glycosylation with acceptor 53 gave 68 (79 %). Deprotection of the silyl group in the 
disaccharide 68 was easily accomplished on treatment with a molar solution of TBAF in THF at 
RT affording 71 (89 %). Synthesis of the uronamide 72 was achieved after three major steps, in 
an overall yield of 98 %. Oxidation of the primary hydroxyl group in unit F to the corresponding 
aldehyde was accomplished with sodium hypochlorite and TEMPO. Oxidation of the crude 
aldehyde to the carboxylic acid with sodium chlorite followed by amide formation according to 
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Staab gave 72. Removal of the isopropylidene group from 72 with trifluoroacetic acid (TFA) at 
RT furnished the diol 73 (89 %). 
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Scheme 6.2: Synthesis of disaccharide 73 
 
Introduction of the carbamoyl group at C-4F position was achieved in two steps. Conversion of 
the diol 73 into the cyclic carbonate 76 with CDI in CH2Cl2 (84 %) and subsequent ring opening 
of this carbonate by bubbling a stream of gaseous ammonia into the CH2Cl2 solution at 0 °C gave 
74 (62 %) as well as its isomer 77 (21 %). 
Dehalogenation of the N-trichloroacetyl group was intensively studied, but interactions of other 
functional groups in the studied substances could not be avoided. The base-labile carbonate in 76 
and the carbamoyl group in urethane 74 were cleaved under the reaction conditions. Hydrolysis 
of 76 with 0.5 M LiOH in MeOH-THF (1:1) followed by acetylation gave 80 (73 %), while its 
reduction with NaBH4 in ethanol followed by acetylation gave 82 (60 °C, 85 %; RT, 83 %). On 
the other hand, reduction of 74 with NaBH4 in ethanol at 60 °C followed by acetylation gave 82 
(78 %), while performing the reduction step at 5 °C (THF-MeOH 4:1) or at RT (ethanol or 
isopropanol) gave 80 in an average yield of 65 %. In a non reproducible reaction (NaBH4, 
EtOH, RT, then Ac2O, pyridine, RT), the desired compound 83 (42 %) was obtained 
accompanied by 82 (46 %) The reaction between the N-trichloroacetyl group and NaBH3CN 
was also fruitless. The phosphonate grouping was installed making use of Arbuzov reaction 
furnishing 85 (70 %). 
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Scheme 6.3: from diol 73 to phosphonate 85 
6. SUMMARY 60
Trisaccharides could not be obtained from the oxazoline donor 42 (prepared from chitobiose 
octaacetate 86) through its reaction with acceptor 53. There was also no coupling product 
between the recently synthesized donor 88 and the acceptor 92. However, in this work, 
trisaccharide formation was achieved through the glycosylation reaction of donor 88 and acceptor 
95 in 50 % yield (-30 °C, 1,2-dichloroethane, 3 Å, TMSOTf-TEA). Selective deprotection of 
the TBDMS group in compound 96 was accomplished at -10 °C with 1 eq of a molar solution of 
TBAF in THF. The free hydroxyl group of 97 was subjected to an oxidation using the TEMPO 
method affording the aldehyde. After oxidation of the aldehyde with sodium chlorite, the resulting 
carboxylic acid was converted according to Staab's method into the amide 93 in an overall yield 
of 95 % (based on 96). There were difficulties in converting the N-phthalimido group in 93 to the 
N-acetyl group which is necessary for biological activity of moenomycin-type compounds, since 
the reactions were accompanied by elimination of HBr.  
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Scheme 6.4: Trisaccharide synthesis 
In conclusion, the synthetic methods employed in this work allow to prepare the di- and 
trisaccharides C-phosphonate analogues of moenomycin A12. 
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7 EXPERIMENTAL PART 
7.1 Devices, Methods and Materials 
7.1.1 Devices used  
NMR spectra were recorded on: 
- Gemini 200 (Varian, 1H: 199.975 MHz, 13C: 50.289 MHz) 
- Gemini 2000 (Varian, 1H: 200.041 MHz, 13C: 50.305 MHz) 
- Gemini 300 (Varian, 1H: 300.075 MHz, 13C: 75.462 MHz, 31P: 121.5 MHz) 
- Avance DRX-400 (Bruker, 1H: 399.952 MHz, 13C: 100.577 MHz) 
- DRX-600 (Bruker, 1H: 600.133 MHz, 13C: 150.918 MHz). 
APT measurements were used to differentiate secondary and quaternary carbons from primary 
and tertiary carbons, which give rise to inverted signals (+ and -). The C- and CH2- groups are 
marked as (+), while the CH- and CH3 are marked as (-). 
The 31P-NMR shifts are based on external phosphoric acid. Chemical shifts are given in d values 
(ppm) relative to tetramethylsilane = 0. The spectra were measured at 299 K, using 5 mm sample 
tubes. The deuterated solvents are given for each compound, separately. 
Coupling constants (J) are reported in Hz, and have the following precision: (200 MHz-spectra ± 
0.4, 300 MHz-spectra ± 0.3, 400 MHz-spectra ± 0.2, 600 MHz-spectra ± 0.2).  
IR-spectra were determined on a Specord M80 grating spectrophotometer (Carl Zeiss Jena) 
and a FT-IR spectrometer (ATI Mattson Genesis). Solid compounds (ca 1 mg) were measured 
as KBr pellets, oily compounds (ca 1 mg) as films. 
FAB MS spectra were recorded using VG AutoSpec FAB-mass-spectrometer (Fisons, cesium 
ion gun, 30 KeV, 1 mA primary-carrier flow, matrix: lactic acid or 3-nitrobenzyl alcohol).  
ESI MS spectra were recorded using the FT-ICR-MS Apex II (Bruker Daltonics) in positive 
and negative modes.  
Two molecular masses are always communicated; the first was calculated using the International 
Atomic Masses; the second refers to 12C, 1H, 16O, 14N, 31P, 35Cl, 80Br, 32S, 28Si, 127I (mono-
isotopic masses).  
Carbon and proton numbering in the subunits, as shown in the NMR data, follows the 
moenomycin nomenclature.21 
Melting points were determined in capillary tubes, using a Büchi (B-540) melting point 
apparatus, and are corrected. 
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Specific optical rotation, [a ]: the optical activity of a solution of the sample was observed in a 
Perkin-Elmer Model 141 polarimeter at a cell length of 0.5 dm, and measured as a rotation value, 
a. It is reported as specific rotation [a] obtained at a certain temperature, °C, and wavelength, 
l. The observed a and the specific [a] are related in the manner shown in the formula 
cl
C
C
.
.010][
°
°
= l
l
aa  
where 
l: the length of the cell in decimeters, 
c: the concentration of the compound in g per 100 mL,  
l: the wavelength used, usually being the wavelength of    
    sodium-D (double line), 589 nm.  
Since the observed rotation value a depends on the concentration of the sample, the temperature 
and wavelength used, specific rotation values are reported together with these specifications, for 
example:  
=][
23
a D +46 (c 0.26, CH2Cl2) 
Ozonolysis was carried out using a Fischer Ozone Generator 500, connected to a dried- oxygen 
stream (ca 40 L/h), thus affording ozone (ca 2 g/h). 
Photochemical reactions  were performed in quartz tubes, an external Philips halogen lamp 
(1000W) was used. 
Ultrasound (Bandelin, Sonorex Super RK 106) was used to degass the solvents when required, 
or to increase the solubility in the case of a suspension.  
 
7.1.2 Methods used  
O2- and/or moisture-sensitive reactions  were performed in an argon atmosphere, using 
glassware oven-preheated at 130 °C, sealed with septa (size NS 29 and NS 14.5), evacuated, 
and cooled down under argon pressure. Liquids and solutions were transferred by syringe. During 
the reaction, a constant argon pressure was ensured. Small-scale reactions were performed in 
Wheaton serum bottles (1, 2, 5, 10 mL) sealed with aluminium caps with open top Teflon-faced 
septum (Aldrich). 
O2- and/or moisture-sensitive reagents were taken either under a positive pressure of argon, 
or under an argon bell. 
Analytical TLC was used to monitor reactions for completeness: 
- Normal phase TLC: Merck precoated silica gel, 60F254 plates, 0.2 mm. 
- Reversed phase TLC: Merck RP-18 precoated silica gel, F254S plates, 0.2 mm. 
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Visualization of TLC plates was accomplished by one or several suitable detection methods; 
spots were identified: 
- by UV light absorption at l 254 and 366 nm, as far as the substances absorb UV, 
- and by dipping into a solution of p-anisaldehyde (1mL) and conc. H2SO4 (4 mL) in ethanol (95 
mL),127 and subsequent heating at 140 °C, 
- or in a molybdatophosphoric acid/ Ce(IV)-sulphate dipping reagent {Ce(SO4)2´4H2O (10 g) 
and H3[PO4(Mo3O9)4]´H2O (25 g) in water (940 mL) and conc. H2SO4 (60 mL)},128 and 
subsequent heating at 140 °C to colour the TLC-plates. 
Column Chromatography was used for the purification of the compounds: 
- Flash-Chromatography (FC)129,130 was performed using columns of diameters of 1 cm (ca 6 g 
silica gel), 2 cm (ca 25 g silica gel), 3 cm (ca 55 g silica gel), 4 cm (ca 100 g silica gel), 5 cm (ca 
150 g silica gel). When not mentioned, 32-63 µm silica gel (ICN Biomedicals) was used. To 
produce pressure, optima pump (Model 10007) was used in this process. The samples were 
dissolved in a small amount of the eluent, or dissolved in a suitable solvent, and deposited on 
twice their weights of Kieselguhr (Merck). 
- Medium-Pressure Liquid Chromatography (MPLC) was carried out using a column of size 
B, filled with 35-70 µm Silica gel (75 g, about 3000 plates, Amicon). The samples were 
deposited on twice their weights Kieselguhr (Merck), and were applied to a pre-column (3-5 g 
kieselgel, 63-100 µm) and were eluted at a pressure of 2-3 bar using a dosage pump (Kronlab, 
Chromatographie und Labortechnik, Sinsheim). 
Distilled solvents, at least technical degree of purity, were used for chromatography. The high-
boiling fraction of petroleum ether (80-120 °C) was used. 
Organic solvent evaporations  were performed in vacuo at water bath temperature of 40 °C 
using a rotatory evaporator. Evaporation of dimethyl sulfide, and triethylphosphite was carried out 
in an effective fume hood. Water was removed by lyophilization using the Leybold-Heraeus 
GT2, and the Christ Alpha 1-2 apparatus. 
Low temperatures down to -78 °C were achieved either by isopropanol-dry ice bath, or by 
using a cryostat Model RL6 CS (Lauda). 
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7.1.3 Chemicals and solvents used 
All commercial materials were used without further purification unless otherwise stated. 
Compounds  3459, 4262, 6761, 88125 were prepared according to the literature. 
Drying of the solvents have been carried using standard procedures:  
For the reactions performed under anhydrous conditions, the solvents have been dried according 
to the following standard procedures: 
- acetonitrile, 1,2-dichloroethane, dichloromethane, N,N -´dimethylformamide, diethyl ether, 
pyridine, toluene, and triethylamine were refluxed over calcium hydride (3 h), and distilled 
immediately prior to use. 
- THF was refluxed with sodium; and distilled immediately before use; benzophenone was used 
as an indicator. 
- acetone was refluxed over P2O5. 
- ethanol (absolute) was left overnight over activated 3 Å molecular sieves. 
- methanol was refluxed with Mg chips, distilled and kept over 3 Å molecular sieves. 
- isopropanol was refluxed over sodium and phthalic acid diethyl ester, distilled, and further dried 
over 4 Å molecular sieves. 
- acetic acid was refluxed over phosphorous pentoxide, and distilled. 
Degassing of the solvents, when required, was performed in an ultrasound bath (Bandelin, 
Sonorex Super RK 106) under an argon atmosphere.  
Argon, oxygen, or ammonia gas streams were allowed to pass over phosphorous pentoxide 
before use. When not mentioned, ammonia was bubbled directly into the reaction solution.  
Non volatile carbohydrates, fused in O2- and/or moisture-sensitive reactions and before the 
analysis, were dried at 0.1 mbar in a dynamic oil pump vacuum over phosphorus pentoxide at RT 
for 12 h. 
Molecular sieves were activated for 24 h at 320 °C in a Muffel oven at 0.1 mbar in a dynamic 
oil pump vacuum, and kept in a dessiccator over phosphorous pentoxide. 
Dowex 50 WX 2 was regenerated with 5 % HCl, and was then washed neutral with bidistilled 
water.  
CSA was dried at 0.1 mbar in a dynamic oil pump vacuum at 100 °C for 12 h over phosphorus 
pentoxide. 
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Anhydrous MgSO4 was used as the drying agent for the organic layers in the extraction steps. 
7.2 Preparation of the glycosyl acceptor 53 
7.2.1 Preparation of 3459 
AJ 1-05 
b-D-Galactose-pentaacetate (3.12 g, 8.0 mmol) was dissolved in dry acetonitrile (40 mL) under 
an argon atmosphere. Allyltrimethylsilane (3.82 mL, 3.0 eq; 24.0 mmol) and BF3.Et2O (7.65 mL, 
5.0 eq; 40.0 mmol) were added at 4 °C. The reaction mixture was stirred at this temperature for 
48 h. The orange mixture was poured into a saturated aqueous solution of sodium 
hydrogencarbonate. The product was extracted with CH2Cl2 (3 ´ 40 mL). The combined organic 
phases were dried, and the solvent was evaporated leaving a crude oil, which was repeatedly 
chromatographed (FC) eluting with petroleum ether-ethyl acetate-toluene 2 : 2 : 1 to give 34 as 
an oil (2.00 g, 67 % yield), which slowly crystallized to a pale yellow solid. Spectral data (1H 
NMR, 13C NMR, MS) agree with those in the literature.59 
1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7,8,9-trideoxy-D-glycero-L-galacto-non-8-enitol (34) 
AcO
AcO
O
OAc OAc
7
1
23
4
5 6
8
9  
 
[372.37]
[372.14]
C17H24O9
Ecact Mass  
7.2.2 Double bond rearrangement reaction of 34  
7.2.2.1 Photooxygenation reaction of 34 
7.2.2.1.1 using methylene blue 
AJ 1-07 
Compound 34 (0.100 g, 0.26 mmol) was added to a solution of methylene blue (0.007 g) in 
methanol (10 mL). The mixture was placed into a flask with an inlet for a dry oxygen gas stream, 
and illuminated with a halogen lamp (1000 W). Irradiation was continued for 9 h. The reaction 
was controlled by TLC (different eluents); no reaction was observed. 
 
AJ 1-12 
The same procedure was repeated in CH2Cl2. TLC showed also that no reaction had occurred. 
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7.2.2.1.2 using Rose bengal 
AJ 1-08 
Compound 34 (0.100 g, 0.26 mmol) was added to a solution of Rose bengal (0.007 g) in 
methanol (10 mL). The mixture was placed into a flask with an inlet for a dry oxygen gas stream, 
and illuminated with a halogen lamp (1000 W). Irradiation was continued for 9 h. The reaction 
was controlled by TLC (different eluents); no reaction was observed. 
 
AJ 1-11 
The same procedure was repeated in CH2Cl2, irradiation continued for 9 h. After 7 h, the 
reaction mixture was supported with excess amount of Rose bengal. TLC showed that there was 
no reaction. 
 
7.2.2.2 Palladium catalytic reaction of 34 
AJ 1-13 
Compound 34 (0.960 g, 2.58 mmol) was added to a solution of bis(benzonitrile)-palladium(II) 
chloride (0.100 g, 0.1 eq; 0.26 mmol) in dry toluene (40 mL) under an argon atmosphere. The 
reaction mixture was refluxed for 63 h, and the reaction progress was controlled by TLC (ethyl 
acetate-petroleum ether 1 : 2) which showed the presence of a major spot with the same Rf value 
as the reactant 34. The reaction mixture was filtered, evaporated, and chromatographed twice 
with ethyl acetate-petroleum ether 1 : 2. Evaporation of the solvents gave 0.4 g of a yellow oil, 
which appeared as a single spot, but really it was a mixture of both the reactant, 34, and the 
product, 54, in an equal ratio as indicated by 13C NMR. 
 
AJ 1-19, AJ 1-21, AJ 1-25 
The same procedure was repeated with 15 % mol percent of the catalyst. Thus, compound 34 
(1.00 g, 2.69 mmol) was added to a solution of bis(benzonitrile)palladium(II) chloride (0.15 gm, 
0.15 eq; 0.40 mmol) in dry toluene (200 mL) under an argon atmosphere. The reaction mixture 
was refluxed for 5 days. Then it was filtered, evaporated, and applied to FC eluting with ethyl 
acetate-petroleum ether 1 : 2, giving an impure yellow oil (0.98 g). 13C NMR showed that it was 
a mixture of an equal ratio of 34 and 54. The by-product 55 was obtained (0.005 g). 
 
1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7,8,9-trideoxy-D-glycero-L-galacto-non-6-enitol (55) 
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[372.37]
[372.14]
C17H24O9
Exact Mass  
· colour and physical state: white solid  
· Rf: 0.26 (ethyl acetate-petroleum ether 1:2) 
·  ESI-MS: m/z 373.1 [M+H]+, 395.1 [M+Na]+ 
· IR (KBr): n~  = 1754 cm-1 
· 1H NMR (HH-COSY, 200 MHz, CDCl3): 
d = 0.95 (t, 3H, CH3-9, J 7.6), 2.00, 2.06, 2.12, 2.15 (4s, 12H, 4 ´ CH3COO), 2.22-2.25 (m, 
2H, CH2-8), 3.95 (ddd, 1H, 2-H, J 1.7, 5.7, 7.2), 4.14 (dd, 1H, 1-H, J 5.7, 11.4), 4.24 (dd, 
1H, 1-H´, J 7.2, 11.4), 4.89 (dt, 1H, 7-H, J 1.8, 7.4), 5.02 (dd, 1H, 4-H, J 3.4, 9.9), 5.50 (dd, 
1H, 3-H, J 1.7, 3.4), 5.62 (m, 1H, 5-H) 
· 13C NMR (50.30 MHz, CDCl3): 
d = 14.48 (C-9), 17.99 (C-8), 21.04, 21.21 (4 ´ CH3COO), 62.13 (C-1), 67.68, 68.12, 
71.97, 75.88, 114.71 (C-7), 145.56 (C-6), 170.08, 170.56, 170.71, 171.02 (4 ´ CH3COO) 
 
7.2.2.3 Ene reaction of compound 34 with PTAD  
AJ 1-36 
To a solution of compound 34 (0.518 g, 1.39 mmol) in dry dichloromethane (20 mL), a solution 
of PTAD (0.244 g, 1.0 eq; 1.39 mmol) in dichloromethane (20 mL) was added slowly via a 
dropping funnel with stirring. The reaction mixture was stirred at RT overnight, until the red colour 
had disappeared. The reaction progress was controlled by TLC (ethyl acetate-petroleum ether 1 : 
1). Evaporation of the solvent left a slightly yellow semisolid, which was purified by FC eluting 
with a gradient ethyl acetate-petroleum ether  2 : 1 ® ethyl acetate . Evaporation left 56 (0.631 
g, 83 %). Unreacted 34 (0.067 g, 13 %) was recovered. 
 
 
 
(7E)-1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7,8,9-trideoxy-9-(3,5-dioxo-4-phenyl-1,2,4-
triazolidin-1-yl)-D-glycero-L-galacto-non-7-enitol (56) 
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C25H29N3O11
Exact Mass
[547.52]
[547.18] 
· colour and physical state: pale yellow solid 
· M.p.: 75-76 °C (ethyl acetate-petroleum ether) 
· =][
23
a D +46.15 (c 0.26, CH2Cl2) 
· Rf: 0.36 (ethyl acetate) 
· FAB-MS: m/z 548.1 [M+H]+, 570.1 [M+Na]+ 
· ESI-MS: m/z 548.2 [M+H]+, 570.0 [M+Na]+ 
· IR (KBr): n~  = 1229, 1709, 1749, 3440 cm-1 
· 1H NMR (HH-COSY, 300 MHz, CDCl3): 
d = 2.06, 2.07, 2.09, 2.18 (4s, 12H, 4 ´ CH3COO), 3.99 (m, 1H, 1-H), 4.13 (m, 1H, 1-H´), 
4.23 (m, 1H, 2-H), 4.28-4.32 (m, 2H, CH2-9), 4.84 (m, 1H, 6-H), 5.13 (dd, 1H, 4-H, J 3.3, 
9.9), 5.32 (m, 1H), 5.36 (m, 1H), 5.96-6.02 (m, 2H, 7-H, 8-H), 7.50-7.54 (m, 5H, aromatic)  
· 13C NMR (APT, HETCOR, 75.45 MHz, CDCl3): 
d = 20.96, 21.00, 21.05, 21.09 (-, 4 ´ CH3COO), 49.04 (+, C-9), 62.14 (+, C-1), 68.07 (-), 
68.19 (-), 68.62 (-, C-4), 68.88 (-, C-2), 71.99 (-, C-6), 125.85, 128.52, 128.68, 128.76, 
129.49 (-, 5 ´ CAr, C-7 and C-8), 131.35 (+, NCAr), 153.00, 154.20 (+, 2 ´ NCON), 170.26, 
170.34, 170.39 (+, 4 ´ CH3COO) 
 
7.2.3 Preparation of alcohol 35 
AJ 1-26 
A mixture of compounds 34 and 54 (0.24 g, 0.645 mmol) was dissolved in dry dichloromethane 
(30 mL) and dry methanol (3 mL), the solution was cooled to -70 °C. Ozone was bubbled 
through the solution for ca 1 h, when the solution became saturated with the gas. Progress of the 
reaction was controlled by TLC (ethyl acetate-petroleum ether 1 : 1). Excess ozone was 
removed by purging with oxygen and then with argon. Dimethyl sulfide (2 mL) was added, and 
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the solution was left overnight at RT. The solvents were evaporated, and the crude product was 
redissolved in THF (10 mL), and added to a mixture of sodium borohydride (0.027 g, 1.1 eq; 
0.710 mol) and acetic acid (44 ìL, 1.1 eq; 0.710 mmol) in THF (2 mL). The mixture was left 
overnight, diluted with brine, and extracted with ethyl acetate (3 ´ 20 mL). The extract was dried, 
evaporated leaving 0.19 g as a crude mixture. TLC (ethyl acetate-petroleum ether 2 : 1) showed 
many products, the major two with similar Rf values. Upon repeated FC, no pure samples were 
obtained. 
 
AJ 1-42 
Compound 56 (0.254 g, 0.464 mmol) was dissolved in dry dichloromethane (20 mL) and dry 
methanol (2 mL), the solution was cooled to -70 °C. Ozone was bubbled through the solution for 
ca 1 h, when the solution became saturated with the gas. Progress of the reaction was controlled 
by TLC (ethyl acetate-petroleum ether, 1 : 1). Excess ozone was removed by purging with 
oxygen and with argon. Dimethyl sulfide (1 mL) was added, and the solution was left overnight at 
RT. The solvents were evaporated, and the crude product was redissolved in THF (10 mL), and 
added to a mixture of sodium borohydride (0.019 g, 1.1 eq; 0.510 mol) and acetic acid (40 ìL, 
1.1 eq; 0.510 mmol) in THF (2 mL). The mixture was left overnight, diluted with brine, and 
extracted with ethyl acetate (3 ´ 20 mL). The extract was dried, evaporated and left 0.192 gm as 
a crude, which was chromatographed, eluting with ethyl acetate-petroleum ether 2 : 1. 
Evaporation left 58 (0.070 g, 50 %) and 35 (0.071 g, 42 %). 
 
AJ 1-44 
Compound 56 (0.116 g, 0.212 mmol) was dissolved in dry dichloromethane (20 mL) and dry 
methanol (2 mL), the solution was cooled to -70 °C. Ozone was bubbled through the solution for 
ca 10 min, when the solution became saturated with the gas. The reaction was judged complete 
by the disappearance of the starting material (TLC, ethyl acetate-petroleum ether 1 : 1). Excess 
ozone was removed by purging with oxygen and with argon. Dimethyl sulfide (1 ml) was added, 
and the solution was left overnight at RT. The solvents were evaporated, and the crude product 
was redissolved in freshly distilled THF (10 mL), and added to a mixture of sodium borohydride 
(0.009 g, 1.1 eq; 0.233 mmol) and freshly distilled acetic acid (18 ìL, 1.1 eq; 0.233 mmol) in 
dry THF (10 mL). The mixture was left overnight, diluted with brine, and extracted with ethyl 
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acetate (3 ´ 15 mL). The extract was dried, evaporated and chromatographed, eluting with ethyl 
acetate-petroleum ether 1 : 1 to give 35 (0.065 g, 85 %). 
4,5,7-Tri-O-acetyl-2,6-anhydro-3-deoxy-D-lyxo-hept-2-enose (58) 
O
OAc
OAc
CHO
AcO
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2
3
4
5 6
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C13H16O8
Exact Mass
[300.27]
[300.08] 
· colour and physical state: pale yellow oil 
· Rf: 0.60 (ethyl acetate) 
· 1H NMR (200 MHz, CDCl3): 
d = 2.07, 2.09, 2.12 (3s, 9H, 3 ´ CH3COO), 4.28-4.34 (m, 2H), 4.45 (m, 1H), 5.51 (m, 1H), 
5.70 (m, 1H), 5.77 (m, 1H), 9.23 (s, 1H, 1-H) 
· 13C NMR (50.30 MHz, CDCl3): 
d = 21.03, 21.09, 21.19 (3 ´ CH3COO), 61.76, 62.98, 65.16, 74.31, 116.23 (C-3), 152.54 
(C-2), 170.39, 170.52, 170.89 (3 ´ CH3COO), 185.69 (C-1) 
 
1,3,4,5-Tetra-O-acetyl-2,6-anhydro-D-glycero-L-galacto-heptitol (35) 
1
23
4
5 6
7 OH
AcO
AcO
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C15H22O10
Exact Mass
[362.33]
[362.12] 
· colour and physical state: pale yellow oil  
· =][
23
a D +44.44 (c 0.18, CH2Cl2) 
· Rf: 0.45 (ethyl acetate) 
· FAB-MS: m/z 303.1 [M+H-AcOH]+, 345.1 [M+H-H2O]+, 363.1 [M+H]+, 385.1 [M+Na]+ 
· ESI-MS: m/z 385.1 [M+Na]+ 
· IR (Film): n~  = 1080, 1142, 1296, 1724, 2929, 3491 cm-1 
· 1H NMR (HH-COSY, 200 MHz, CDCl3): 
d = 2.05, 2.06, 2.10, 2.11 (4s, 12H, 4 ´ CH3COO), 3.65 (dd, 1H, 7-H, J 4.6, 12.0), 3.83 (dd, 
1H, 7-H´, J 7.5, 12.0), 4.07 (dd, 1H, 1-H, J 4.0, 11.0), 4.27 (m, 1H, 6-H), 4.31 (m, 1H, 2-H), 
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4.41 (dd, 1H, 1-H´, J 7.8, 11.0), 5.27 (m, 1H, 5-H), 5.29 (m, 1H, 4-H), 5.44 (t, 1H, 3-H, J 
3.0) 
·  13C NMR (APT, HETCOR, 50.29 MHz, CDCl3): 
d = 21.15, 21.22 (-, 4 ´ CH3COO), 60.37 (+, C-7), 61.48 (+, C-1), 67.50 (-, C-3), 68.37 (-, 
C-4), 68.58 (-, C-5), 70.82 (-, C-2), 71.77 (-, C-6), 170.20, 170.40, 170.63, 171.30 (+, 4 ´ 
CH3COO) 
 
7.2.4 Preparation of methanesulfonate 60  
AJ 1-56 
Compound 35 (0.046 g, 0.127 mmol) was dissolved in dry pyridine (4 mL) containing DMAP 
(0.002 g, cat) and the mixture was cooled to 4 °C. Methanesulfonyl chloride (12 ìL, 1.2 eq; 
0.152 mmol) was added, and the orange-red mixture was stirred at 4°C for 5 h (TLC, ethyl 
acetate). The mixture was diluted with dichloromethane and 2 M sulfuric acid. The organic layer 
was washed with aqueous sodium hydrogencarbonate and with brine. Drying, evaporation, and 
FC eluting with ethyl acetate-petroleum ether 1 : 1 gave 60 (0.034 g, 60 %). 
1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7-O-methysulfonyl-D-glycero-L-galacto-heptitol (60) 
AcO
AcO
O
AcO OAc
OSO2CH3
1
23
4
5 6
7
 
 
C16H24O12S
Exact Mass
[440.42]
[440.10] 
· colour and physical state: pale yellow oil 
· =][
23
a D +39.28 (c 0.56, CH2Cl2) 
· Rf: 0.56 (ethyl acetate) 
· FAB-MS: m/z 345.1 [M+H-MeSO3H]+, 381.0 [M+H-AcOH]+, 441.1 [M+H]+, 463.0 
[M+Na]+ 
· ESI-MS: m/z 463.1 [M+Na]+ 
· IR (Film): n~  = 1055, 1175, 1227, 1367, 1749, 3446 cm-1 
· 1H NMR (HH-COSY, 200 MHz, CDCl3): 
d = 2.05, 2.06, 2.11, 2.12 (4s, 12H, 4 ´ CH3COO), 3.09 (s, 3H, SO2CH3), 4.11 (dd, 1H, 1-
H, J 2.6, 8.8), 4.20 (m, 1H, 2-H), 4.30 (m, 1H, 1-H´), 4.32 (m, 1H, 7-H), 4.48 (m, 1H, 6-H), 
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4.51 (m, 1H, 7-H´), 5.21 (dd, 1H, 4-H, J 3.1, 8.5), 5.31 (dd, 1H, 5-H, J 4.0, 8.5), 5.43 (m, 
1H, 3-H) 
· 13C NMR (APT, HETCOR, 50.29 MHz, CDCl3): 
d = 20.73, 20.79, 20.84 (-, 4 ´ CH3COO), 38.05 (-, SO2CH3), 60.95 (+, C-1), 65.59 (+, C-
7), 67.02 (-, C-3), 67.11 (-, C-5), 67.81 (-, C-4), 69.81 (-, C-6), 70.36 (-, C-2), 169.64, 
169.69, 169.89, 170.64 (-, 4 ´ CH3COO) 
 
7.2.5 Preparation of the halide derivatives 59 and 61 
7.2.5.1 Preparation of compound 61 
AJ 1-63 
The methanesulfonate 60 (0.054 g, 0.122 mmol) was dissolved in dry toluene (5 mL) containing 
tetrabutylammonium bromide (0.098 g, 2.5 eq; 0.305 mmol), and the mixture was heated at 80 
°C for 20 h (TLC, ethyl acetate-petroleum ether 80 : 20). The mixture was partitioned between 
water (10 mL) and ethyl acetate (20 mL), the organic layer was washed with aqueous sodium 
hydrogencarbonate, and with brine. Drying and evaporation left a crude mixture, which was 
chromatographed eluting with ethyl acetate-petroleum ether 80 : 20, to give 61 (0.042 g, 80 %). 
1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7-bromo-7-deoxy-D-glycero-L-galacto-heptitol (61) 
1
23
4
5 6
7
AcO
AcO
O
AcO OAc
Br  
 
C15H21BrO9
Exact Mass
[425.23]
[424.04] 
· colour and physical state: pale yellow oil 
· =][
23
a D +64.86 (c 0.3, CH2Cl2)  
· Rf: 0.60 (ethyl acetate-petroleum ether 80:20) 
· FAB-MS: m/z 345.1 [M+H-HBr]+, 365.0 [M+H-AcOH]+, 425.0 [M+H]+, 447.0 [M+Na]+ 
· ESI-MS: m/z 447.1 [M+Na]+ 
· IR (Film): n~  = 1049, 1227, 1371, 1749, 3435 cm-1 
· 1H NMR (HH-COSY, 200 MHz, CDCl3): 
d = 2.05, 2.08, 2.11, 2.13 (4s, 12H, 4 ´ CH3COO), 3.44 (dd, 1H, 7-H, J 5.1, 11.4), 3.55 (dd, 
1H, 7-H´, J 9.2, 11.4), 4.11 (m, 1H, 2-H), 4.16 (m, 1H, 1-H), 4.30 (m, 1H, 1-H´), 4.45 (m, 
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1H, 6-H), 5.19 (dd, 1H, 4-H, J 3.3, 8.7), 5.35 (dd, 1H, 5-H, J 4.9, 8.7), 5.43 (t, 1H, 3-H, J 
2.9) 
· 13C NMR (APT, HETCOR, 50.29 MHz, CDCl3): 
d = 20.77, 20.82 (-, 4 ´ CH3COO), 27.49 (+, C-7), 61.06 (+, C-1), 67.22 (-, C-3), 67.71 (-, 
C-5), 68.13 (-, C-4), 69.39 (-, C-2), 71.74 (-, C-6), 169.62, 169.79, 170.02, 170.74 (+, 4 ´ 
CH3COO) 
 
7.2.5.2 Preparation of compound 59 
AJ 1-61  
Iodine (0.028 g, 1.3 eq; 0.112 mmol) was added at RT to a mixture of 35 (0.031 g, 0.086 
mmol), chlorodiphenylphosphine (0.02 mL, 1.3 eq; 0.112 mmol) and imidazole (0.013 g, 2.2 eq; 
0.189 mmol) in toluene (5 mL). The reaction mixture was stirred at 50 °C for 4 h (TLC, ethyl 
acetate). The reaction mixture was poured at RT into an equal volume of saturated aqueous 
sodium hydrogencarbonate in a separating funnel, and shacked for few minutes, while adding 
iodine portionwise, until the organic layer remained iodine-coloured. The organic layer was 
separated, washed with aqueous sodium thiosulphate, to remove the excess iodine, and washed 
with water. Drying, and evaporation left a crude product, which was chromatographed eluting 
with ethyl acetate-petroleum ether 80 : 20 to give 59 (0.013 g, 31 %). 
 
AJ 1-62 
The methanesulfonate 60 (0.077 g, 0.175 mmol) was dissolved in toluene (10 mL) containing 
tetrabutylammonium iodide (0.161 g, 2.5 eq; 4.37 mmol), and the mixture was heated at 80 °C 
for 20 h (TLC, ethyl acetate-petroleum ether 80 : 20). The mixture was partitioned between 
water (10 mL) and ethyl acetate (30 mL), the organic layer was washed with aqueous sodium 
hydrogencarbonate, and with brine. Drying and evaporation left a crude mixture, which was 
chromatographed eluting with ethyl acetate-petroleum ether 80 : 20, to give 59 (0.054 g, 65 %). 
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1,3,4,5-Tetra-O-acetyl-2,6-anhydro-7-deoxy-7-iodo-D-glycero-L-galacto-heptitol (59) 
1
23
4
5 6
7
AcO
AcO
O
AcO OAc
I  
 
C15H21IO9
Exact Mass
[472.23]
[472.02] 
· colour and physical state: pale yellow oil 
· =][
23
a D +70 (c 0.20, CH2Cl2) 
· Rf: 0.60 (ethyl acetate-petroleum ether 80:20) 
· FAB-MS: m/z 345.1 [M+H-HI]+, 413.0 [M+H-AcOH]+, 473.0 [M+H]+, 494.9 [M+Na]+ 
· ESI-MS: m/z 495.0 [M+Na]+ 
· IR (Film): n~  = 1057, 1227, 1745 cm-1 
· 1H NMR (HH-COSY, 300 MHz, CDCl3): 
d = 2.03, 2.09, 2.10, 2.13 (4s, 12H, 4 ´ CH3COO), 3.28-3.38 (m, 2H, CH2-7), 4.03 (ddd, 
1H, 2-H, J 2.6, 4.9, 7.7), 4.13 (dd, 1H, 1-H, J 4.9, 11.6), 4.27 (dd, 1H, 1-H´, J 7.7, 11.6), 
4.36 (m, 1H, 6-H), 5.18 (dd, 1H, 4-H, J 3.3, 9.3), 5.33 (dd, 1H, 5-H, J 5.2, 9.3), 5.42 (t, 1H, 
3-H, J 3.1) 
· 13C NMR (APT, HETCOR, 50.29 MHz, CDCl3): 
d = 0.20 (+, C-7), 21.00, 21.04, 21.16, 21.25 (-, 4 ´ CH3COO), 61.63 (+, C-1), 67.77 (-, C-
3), 67.88 (-, C-4), 68.42 (-, C-5), 69.02 (-, C-2), 72.84 (-, C-6), 170.12, 170.36, 170.55, 
171.16 (+, 4 ´ CH3COO) 
 
7.2.6 Hydrolysis of the acetate group in 61 
AJ 1-68 
To a solution of compound 61 (0.050 g, 0.118 mmol) in dry methanol (10 mL) at 0 °C, a 
solution of sodium methoxide (0.013 g, 2.0 eq; 0.236 mmol) in dry methanol (5 mL) was added. 
The reaction mixture was stirred at RT for about 3 h until the reactant was accomplished, as 
shown by TLC (CH3OH-CHCl3 15 : 85). The mixture was diluted with methanol, neutralized 
with Dowex 50-W X2 (H+). The mixture was stirred for a few minutes, and then the resin was 
filtered off, washed with methanol (3 ´ 5 mL). The combined filtrate was concentrated. The 
residue was applied to FC eluting with CH3OH-CHCl3 15 : 85, and provided after solvent 
evaporation 62 (0.030 g, quant).  
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2,6-Anhydro-7-bromo-7-deoxy-D-glycero-L-galacto-heptitol (62)  
1
23
4
5 6
7
HO
HO
O
HO OH
Br  
 
C7H13BrO5
Exact Mass
[257.08]
[255.99] 
· colour and physical state: white solid 
· M.p.: 115-116 °C (EtOH-petroleum ether) 
· =][
23
a D +73.68 (c. 0.38, EtOH) 
· Rf: 0.16 (CHCl3 -MeOH 85:15) 
· FAB-MS: m/z 257.0 [M+H]+ 
· ESI-MS: m/z 278.8 [M+Na]+ 
· IR (KBr): n~  = 1055, 1080, 3365, 3419 cm-1 
· 1H NMR (HH-COSY, 200 MHz, pyridine-d5): 
d = 4.20-4.30 (m, 2H, CH2-7), 4.32-4.38 (m, 2H), 4.52-4.55 (m, 2H, CH2-1), 4.75-4.85 (m, 
3H) 
· 13C NMR (APT, HETCOR, 50.29 MHz, pyridine-d5): 
d = 31.09 (+, C-7), 61.40 (+, C-1), 69.44 (-), 69.77 (-), 71.79 (-), 74.51 (-), 76.03 (-) 
 
7.2.7 Preparation of the silyl ether 63 
AJ 2-01 
To a solution of 62 (0.032 g, 0.125 mmol) in dry pyridine (3 mL) and dry triethylamine (3 mL) at 
0 °C TBDPSCl (26 mL, 1.2 eq; 0.150 mmol) and DMAP (0.002 g, cat) were added. The 
solution was stirred at 0 °C, and after about 4 h the reaction came to completion as indicated by 
TLC (CH3OH-CHCl3 10 : 90). The reaction mixture was quenched at 0 °C with MeOH (2mL), 
and then coevaporated with toluene. The residue was purified by FC (CH3OH-CHCl3 5 : 95) to 
yield 63 (0.020 g, 33 % yield). 
 
AJ 2-10 
To a cold (0 °C, bath) stirred solution of 62 (0.200 g, 0.781 mmol) and imidazole (0.105 g, 2.0 
eq; 1.56 mmol) in dry DMF (4 mL) TBDPSCl (0.16 mL, 1.2 eq; 0.937 mmol) was added. The 
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mixture was stirred at 0 °C for about 2 h until the reaction was complete (TLC, CH3OH-CHCl3 
10 : 90). The mixture was poured into ice-water (10 mL) and extracted with chloroform (5 ´ 20 
mL). The organic layer was extracted with saturated aqueous sodium hydrogencarbonate, water, 
dried, and evaporated. The residue was applied to FC, and eluted with a gradient CHCl3 ® 
CH3OH-CHCl3 2 : 98. On evaporation, the fractions corresponding to the product afforded 63 
(0.328 g, 85 %). 
2,6-Anhydro-7-bromo-1-O-(tert-butyldiphenylsilyl)-7-deoxy-D-glycero-L-galacto-heptitol 
(63) 
1
23
4
5 6
7
HO
HO
O
HO O
Br
Si
 
 
 
C23H31BrO5Si
Exact Mass
[495.49]
[494.11] 
· colour and physical state: white solid 
· M.p.: 77-78 °C (CHCl3-petroleum ether) 
· =][
23
a D +50 (c 0.24, CH2Cl2) 
· Rf: 0.42 (CHCl3-MeOH 90:10) 
· FAB-MS: m/z 413.2 [M+H-HBr]+, 437.1 [M+Na-HBr]+, 495.0 [M+H]+, 517.0 [M+Na]+ 
· IR (KBr): n~  = 703, 1079, 1110, 2930, 3405-3456 cm-1 
· 1H NMR (HH-COSY, 200 MHz, CDCl3): 
d = 1.07 (s, 9 H, (CH3)3CSi), 3.38 (m, 1H, 7-H), 3.50-3.55 (m, 2H), 3.65 (dd, 1H, 7-H´, J 
3.4, 11.6), 3.80-3.91 (m, 2H, CH2-1), 4.08-4.10 (m, 2H), 4.25 (m, 1H), 7.26-7.43 (m, 6H, 
aromatic), 7.66-7.73 (m, 4H, aromatic) 
· 13C NMR (APT, HETCOR, 50.29 MHz, CDCl3): 
d = 19.54 (+, (CH3)3CSi), 27.25 (-, (CH3)3CSi), 28.24 (+, C-7), 64.04 (+, C-1), 69.45 (-), 
70.29 (-), 71.15 (-), 71.59 (-), 76.24 (-), 128.39, 128.44, 130.51 (-, CAr), 133.18, 133.40 (+, 
SiCAr), 136.10, 136.22 (-, CAr) 
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7.2.8 Preparation of the acceptor 53 
AJ 2-08 
To a solution of compound 63 (0.045 g, 0.091 mmol) in dry acetone (5 mL) 2,2-
dimethoxypropane (2 mL) and p-toluenesulfonic acid monohydrate (0.009 g, cat) were added. 
The reaction mixture was stirred at RT for 2 h until the starting material was consumed (TLC, 
ethyl acetate-petroleum ether 1 : 1). The reaction mixture was neutralized by adding triethylamine, 
and concentrated. The residue was applied to FC, eluting with ethyl acetate-petroleum ether 1 : 1 
to give 53 (0.043 g, 88 %). 
2,6-Anhydro-7-bromo-1-O-(tert-butyldiphenylsilyl)-3,4-O-isopropylidene-7-deoxy-D-
glycero-L-galacto-heptitol (53) 
1
23
4
5 6
7
O
O
O O
Br
HO
Si
 
 
 
C26H35BrO5Si
Exact Mass
[535.55]
[534.14] 
· colour and physical state: pale yellow oil 
· =][
23
a D +12.5 (c 0.32, CH2Cl2) 
· Rf: 0.50 (ethyl acetate-petroleum ether 1:1) 
· FAB-MS: m/z 535.1 [M+H]+, 557.1 [M+Na]+ 
· IR (Film): n~  = 1225, 1745 cm-1 
· 1H NMR (HH-COSY, 200 MHz, CDCl3): 
d = 1.06 (s, 9H, (CH3)3CSi), 1.36, 1.46 (2s, 6H, (CH3)2COO), 3.37 (dd, 1H, 7-H, J 5.4, 9.9), 
3.51 (dd, 1H, 7-H´, J 8.8, 9.9), 3.78-3.84 (m, 2H, CH2-1), 4.12 (m, 1H, 2-H), 4.17 (m, 1H, 6-
H), 4.18 (m, 1H, 5-H), 4.36 (dd, 1H, 4-H, J 2.6, 7.6), 4.47 (dd, 1H, 3-H, J 1.6, 7.6), 7.33-
7.43 (m, 6H, aromatic), 7.66-7.73 (m, 4H, aromatic) 
· 13C NMR (APT, HETCOR, 50.30 MHz, CDCl3): 
d = 19.76 (+, (CH3)3CSi), 24.91, 27.11 (-, (CH3)2COO), 27.31 (-,(CH3)3CSi), 30.46 (+, C-
7), 63.63 (+, C-1), 67.53 (-,  C-5), 71.24 (-), 71.33 (-), 72.11 (-), 74.59 (-), 110.02 (+, 
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(CH3)2COO), 128.05, 128.12, 130.10 (-, CAr), 134.04, 134.07 (+, SiC Ar), 136.11, 136.15 (-, 
CAr) 
 
 
 
 
7.3 Disaccharide synthesis 
7.3.1 Formation of disaccharide 68 
AJ 2-12 
A mixture of 53 (0.019 g, 0.035 mmol), 67 (0.025 g, 1.2 eq; 0.042 mmol) and activated 3 Å 
molecular sieves in anhydrous 1,2-dichloroethane (8 mL) was stirred for 1 h at RT under a dry 
argon atmosphere, then cooled to 0 °C. Trimethylsily triflate (1 µL, 0.1 eq; 0.004 mmol) was 
added, and the mixture was stirred at 0 °C for ca 10 min (TLC, ethyl acetate-petroleum ether 1 : 
1). Triethylamine (0.1 mL) was added, and the mixture was diluted with CH2Cl2 (10 mL) and 
filtered. The molecular sieves were washed with CH2Cl2 (3 ´ 5 mL), and the combined filtrate 
was concentrated. The residue was chromatographed eluting with petroleum ether-ethyl acetate 1 
: 1 to give 69 (0.028 g, 44 %).  
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-1-O-(trimethylsilyl)-D-glycero-L-galacto-
heptitol (69) 
OAc
AcO
NHCOCCl3
OAcO
O
O
O
O O
Br
Si1
23
4
5 6
7
1
2
3
4
5
6
F
E
 
 
 
C27H41BrCl3NO13Si                     
Exact Mass                 
           [801.97]
           [799.05]  
· colour and physical state: white solid 
· Rf: 0.35 (ethyl acetate-petroleum ether 1:1) 
· FAB-MS: m/z 800 [M+H]+, 823 [M+Na]+ 
· 1H NMR (HH-COSY, 600 MHz, CDCl3): 
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d = 0.06 (s, 9H, Si(CH3)3), 1.21, 1.38 (2s, 6H, (CH3)2COO), 1.92, 1.93, 2.00 (3s, 9H, 3 ´ 
CH3COO), 3.25 (dd, 1H, 7F-H, J 6.0, 9.9), 3.34 (dd, 1H, 7F-H´, J 7.8, 9.9), 3.64 (m, 1H, 5E-
H), 3.73 (m, 1H, 2F-H), 3.78 (dd, 1H, 4F-H, J 3.4, 12.0), 3.82 (bs, 1H, 3F-H), 3.97 (m, 1H, 
2E-H), 4.01 (m, 1H, 6F-H), 4.05 (m, 1H, 5F-H), 4.06-4.08 (2H, CH2-1F), 4.09 (m, 1H, 6E-H), 
4.21 (dd, 1H, 6E-H´, J 4.5, 12.3), 4.90 (d, 1H, 1E-H, J 8.4), 5.04 (dd, 1H, 4EH, J 9.4, 9.9), 
5.13 (dd, 1H, 3E-H, J 9.4, 10.5), 6.77 (d, 1H, NHCOCCl3, J 8.9) 
· 13C NMR (APT, HETCOR, 150.91 MHz, CDCl3): 
d = 0.51 (-, Si(CH3)3), 20.93, 20.94, 21.16 (-, 3 ´ CH3COO), 24.62, 26.91 (-, (CH3)2COO), 
33.27 (+, C-7F), 56.17 (-, C-2E), 62.35 (+, C-6E), 68.41 (-, C-3F), 68.69 (-, C-4E), 70.04 (+, 
C-1F), 70.88 (-, C-4F, C-2F), 71.34 (-, C-6F), 72.45 (-, C-3E), 72.58 (-, C-5E), 74.61 (-, C-
5F), 93.00 (+, NHCOCCl3), 101.66 (-, C-1E), 110.40 (+, (CH3)2COO), 162.55 (+, 
NHCOCCl3), 169.89, 171.34 (+, 3 ´ CH3COO) 
 
AJ 2-19  
A mixture of 53 (0.034 g, 0.064 mmol), 67 (0.045 g, 1.2 eq; 0.077 mmol) and activated 3 Å 
molecular sieves in anhydrous 1,2-dichloroethane (5 mL) was stirred for 1 h at RT under an 
argon atmosphere, then cooled to 0 °C. Trimethylsilyl triflate (1.5 µL, 0.1 eq, 0.006 mmol) was 
added, and the mixture was stirred at 0 °C for ca 5 min (TLC, ethyl acetate-petroleum ether 1 : 
1). Triethylamine (0.1 mL) was added to stop the reaction, and the mixture was diluted with 
CH2Cl2 (10 mL) and filtered. The molecular sieves were washed with CH2Cl2 (3 ´ 5 mL) and the 
combined filtrate was concentrated. The residue was subjected to FC eluting with petroleum 
ether-ethyl acetate 2 : 1 to furnish 68 (0.048 g, 79 %). 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-1-O-(tert-butyldiphenylsilyl)-D-glycero-
L-galacto-heptitol (68) 
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1
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C40H51BrCl3NO13Si
Exact Mass
[968.19]
[965.14] 
· colour and physical state: white solid 
· M.p.: 227-228 °C (CHCl3-petroleum ether), decomposition 
· =][
23
a D -16 (c 0.25, CH2Cl2) 
· Rf: 0.36 (ethyl acetate-petroleum ether 1:1)  
· FAB-MS: m/z 966.1 [M+H]+, 988.1 [M+Na]+ 
· ESI-MS: m/z calculated [M+NH4]+ 983.17169, found 983.17325 
· IR (KBr): n~  = 1047, 1108, 1237, 1526, 1750, 3437 cm-1 
· 1H NMR (HH-COSY, 300 MHz, CDCl3): 
d = 1.03 (s, 9H, SiC(CH3)3), 1.31, 1.46 (2s, 6H, (CH3)2COO), 2.05 (s, 6H, 2 ´ CH3COO), 
2.09 (s, 3H, CH3COO), 3.30 (dd, 1H, 7F-H, J 5.9, 10.0), 3.55 (dd, 1H, 7F-H´, J 8.1, 10.0), 
3.75 (m, 1H, 5E-H), 3.77-3.80 (m, 2H, CH2-1F), 3.94 (m, 1H, 2E-H), 4.02 (m, 1H, 2F-H), 4.10 
(m, 1H, 5F-H), 4.15 (m, 1H, 6F-H), 4.21 (m, 1H, 4F-H), 4.24-4.27 (m, 2H, CH2-6E), 4.47 (dd, 
1H, 3F-H, J 1.4, 7.1), 4.89 (d, 1H, 1E-H, J 8.5), 5.14 (dd, 1H, 4EH, J 9.6, 9.9), 5.39 (dd, 1H, 
3E-H, J 9.6, 10.7), 7.02 (d, 1H, NHCOCCl3, J 8.8), 7.35-.7.41 (m, 6H, aromatic), 7.65-7.70 
(m, 4H, aromatic) 
· 13C NMR (APT, HETCOR, 75.45 MHz, CDCl3): 
d= 19.51 (+, SiC(CH3)3), 20.85, 20.91, 21.09 (-, 3 ´ CH3COO), 24.62, 27.15 (-, 
(CH3)2COO), 27.06 (-, SiC(CH3)3), 30.33 (+, C-7F), 56.42 (-, C-2E), 62.29 (+, C-6E), 63.05 
(+, C-1F), 68.55 (-, C-4E), 70.19 (-), 71.09 (-, C-6F), 71.69 (-, C-3E), 71.96 (-, C-3F), 72.37 
(-,  C-4F), 72.49 (-,  C-5E), 75.29 (-), 93.00 (+, NHCOCCl3), 99.92 (-, C-1E), 109.86 (+, 
(CH3)2COO), 127.87, 127.93, 129.87, 129.91 (-, C-Ar), 133.60, 133.67 (+, SiC Ar), 135.86, 
135.97 (-, C-Ar), 162.19 (+, NHCOCCl3), 169.60, 171.05, 171.34 (+, 3 ´ CH3COO) 
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7.3.2 Cleavage of the silyl ethers in 68 and 69 
7.3.2.1 Reaction of compound 69 with Dowex resin  
AJ 2-14 
To a solution of 69 (0.021 g, 0.027 mmol) in dry methanol (7 mL), Dowex 50-W X-8 (H+) resin 
(0.060 g) was added at RT. The mixture was stirred for 1 h and the reaction progress was 
monitored by TLC (ethyl acetate-petroleum ether 1 : 1). The reaction mixture was filtered, the 
resin was washed with CH2Cl2 (3 ´ 5 mL), and the combined filtrate was evaporated. The 
residue was purified by FC eluting with petroleum ether-ethyl acetate 1 : 1 to furnish after solvent 
evaporation 71 (0.018 g, 95 %). 
 
 
 
7.3.2.2 Reaction of compound 68 with TBAF 
AJ 2-21 
To a solution of 68 (0.300 g, 0.311 mmol) in THF (30 mL) a TBAF solution (1.0 M in THF, 
0.37 mL, 1.2 eq; 0.373 mmol) was added. The mixture was stirred at RT for 21 h (TLC, ethyl 
acetate-petroleum ether 1 : 1). Water (15 mL) was added and the mixture was extracted with 
chloroform (5 ´ 10 mL). The combined organic layers were dried, and the solvent was 
evaporated. The residue was chromatographed (FC) eluting with petroleum ether-ethyl acetate 1 
: 1 to give 71 (0.201 g, 89 %).  
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-heptitol (71) 
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C24H33BrCl3NO13
Exact Mass
[729.79]
[727.02] 
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· colour and physical state: white solid 
· M.p.: 230-231 °C (CHCl3-petroleum ether), decomposition. 
· =][
23
a D -30 (c 0.20, CH2Cl2) 
· Rf: 0.13 (ethyl acetate-petroleum ether 1:1) 
· FAB-MS: m/z 728.0 [M+H]+, 750.0 [M+Na]+ 
· ESI-MS: m/z calculated [M+Na]+ 750.00931, found 750.00868 
· IR (KBr): n~  = 1044, 1109, 1162, 1236, 1374, 1529, 1750, 2923, 3393, 3492 cm-1 
· 1H NMR (HH-COSY, 200 MHz, pyridine-d5): 
d = 1.32, 1.54 (2s, 6H, (CH3)2COO), 2.01, 2.02. 2.10 (3s, 9H, 3 ´ CH3COO), 3.79 (dd, 1H, 
7F-H, J 7.0, 10.3), 3.92 (dd, 1H, 7F-H´, J 6.6, 10.3), 4.05 (ddd, 1H, 5E-H, J 2.2, 4.8, 9.9), 
4.21 (m, 1H, 1F-H), 4.24 (m, 1H, 1F-H´), 4.35 (m, 1H, 2E-H), 4.41 (m, 1H, 6E-H), 4.51 (m, 
1H, 3F-H), 4.53 (m, 1H, 6E-H´), 4.58 (m, 1H, 2F-H), 4.58 (m, 1H, 6F-H), 4.74 (dd, 1H, 4F-H, 
J 3.1, 7.2), 4.88 (dd, 1H, 5F-H, J 1.3, 7.2), 5.51 (m, 1H, 4EH), 5.67 (d, 1H, 1E-H, J 8.4), 6.14 
(dd, 1H, 3E-H, J 9.2, 10.6), 10.67 (d, 1H, NHCOCCl3, J 8.1) 
· 13C NMR (APT, HETCOR, 50.29 MHz, pyridine-d5): 
d = 20.49, 20.65 (-, 3 ´ CH3COO), 24.55, 27.09 (-, (CH3)2COO), 31.86 (+, C-7F), 57.18 (-, 
C-2E), 62.08 (+, C-1F), 62.43 (+, C-6E), 69.61 (-, C-4E), 71.73 (-, C-3E, C-2F), 71.96 (-, C-
6F), 72.39 (-, C-5E), 72.82 (-, C-4F), 72.92 (-, C-5F), 75.51 (-, C-3F), 93.73 (+, NHCOCCl3), 
99.37 (-, C-1E), 109.78 (+, (CH3)2COO), 163.28 (+, NHCOCCl3), 169.81, 170.36, 170.43 
(+, 3 ´ CH3COO) 
 
7.3.3 Preparation of the uronamide 72 
AJ 2-27  
a. Tempo oxidation  
To a mixture of 71 (0.068 g, 0.094 mmol), TEMPO (0.016 g, 1.06 eq; 0.099 mmol), 
tetrabutylammonium chloride (0.026 g, 1.0 eq; 0.094 mmol), potassium bromide (0.011 g, 1.0 
eq; 0.095 mmol) and dichloromethane (2 mL) at 0 °C, a mixture of satd. aq. sodium chloride (1 
mL), satd. aq. sodium hydrogencarbonate (1.1 mL), and satd. aq. sodium hypochlorite (1 mL, 
12-14 % active chlorine) was added slowly. The reaction mixture was vigorously stirred at RT 
for 3 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The pH was adjusted to 2-3 with conc. 
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HCl. The organic layer was separated and the aqueous layer was extracted with dichloromethane 
(5 ´ 10 mL). The combined organic extracts were dried, and the solvent was removed.  
b. Sodium chlorite oxidation 
The crude product of the TEMPO oxidation (max 0.094 mmol), sodium chlorite (0.085 g, 10 eq; 
0.94 mmol), and sodium dihydrogenphosphate monohydrate (0.097 g, 7.5 eq; 0.70 mmol) were 
placed in a reaction flask, and with stirring successively 2-methyl-2-butene (0.4 mL), t-butanol 
(1.8 mL) and water (0.7 mL) were added. The reaction mixture was stirred at RT for 4 h (TLC, 
petroleum ether-CHCl3-EtOH 5 : 2 : 2), then it was diluted with water (2 mL) and 
dichloromethane (5 mL). The organic layer was separated, and the aqueous layer was extracted 
with dichloromethane (4 ´ 10 mL). The aqueous layer was adjusted to pH 2 with conc. HCl, and 
extracted with dichloromethane (3 ´ 10 mL). The combined organic extracts were dried, and the 
solvent was removed. The residue was dried at 0.1 mbar for ca 2 h. 
c. Amide formation according to Staab 
The crude acid (max 0.094 mmol), and CDI (0.039 g, 2.5 eq; 0.24 mmol) were dissolved in dry 
dichloromethane (10 mL), and the mixture was stirred at RT for 5 h. Through this solution at 0 
°C, gaseous ammonia was bubbled for 40 min (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2), 
then the mixture was stirred at RT for 1 h. The solvent was evaporated, and the residue was 
chromatographed eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to furnish amide 72 
(0.068g, 98 % based on 71). 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-1-O-D-glycero-L-galacto-heptonamide 
(72) 
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C24H32BrCl3N2O13
Exact Mass
[742.78]
[740.02] 
· colour and physical state: white solid 
· M.p.: 152-153 °C (CHCl3-petroleum ether), decomposition 
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· =][
23
a D -80 (c 0.15, CH2Cl2) 
· Rf: 0.49 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 741.0 [M+H]+, 763.0 [M+Na]+ 
· ESI-MS: m/z [M+H]+ (calculated 741.022261, found 741.02190), [M+Na]+ (calculated 
763.00456, found 763.00636) 
· IR (KBr): n~  = 1046, 1108, 1148, 1233, 1374, 1531, 1685, 1750, 3378, 3475 cm-1 
· 1H NMR (HH-COSY, 600 MHz, CDCl3): 
d = 1.33, 1.48 (2s, 6H, (CH3)2COO), 2.03, 2.05, 2.11 (3s, 9H, 3 ´ CH3COO), 3.45, (dd, 1H, 
7F-H, J 6.5, 10.2), 3.57 (dd, 1H, 7F-H´, J 7.1, 10.2), 3.77 (ddd, 1H, 5E-H, J 2.5, 4.7, 9.9), 
3.95 (m, 1H, 2E-H), 4.07 (m, 1H, 5F-H), 4.21 (dd, 1H, 6E-H, J 2.5, 12.2), 4.25 (dd, 1H, 6E-
H´, J 4.7, 12.2), 4.29 (m, 1H, 6F-H), 4.37 (d, 1H, 2F-H, J 2.1), 4.41 (dd, 1H, 4F-H, J 2.4, 7.6), 
4.70 (dd, 1H, 3F-H, J 1.6, 7.3), 4.95 (d, 1H, 1E-H, J 8.4), 5.12 (dd, 1H, 4EH, J 9.4, 9.9), 5.39 
(dd, 1H, 3E-H, J 9.4, 10.5), 6.07, 6.72 (2d, 2H, H2NCO, J 3.7), 7.66 (d, 1H, NHCOCCl3, J 
8.4) 
 
· 13C NMR (APT, HETCOR, HMBC, HMQC, 150.92 MHz, CDCl3): 
d = 20.99, 21.05, 21.21 (-, 3 ´ CH3COO), 24.65, 26.97 (-, (CH3)2COO), 31.30 (+, C-7F), 
56.60 (-, C-2E), 62.36 (+, C-6E), 68.75 (-, C-4E), 71.41 (-, C-6F), 71.49 (-, C-2F), 71.55 (-, 
C-4F), 71.84 (-, C-3E), 72.75 (-, C-5E), 73.04 (-, C-3F), 74.08 (-, C-5F), 92.65 (+, 
NHCOCCl3), 99.48 (-,  C-1E), 110.85 (+, (CH3)2COO), 162.97 (+, NHCOCCl3), 169.92, 
171.26, 171.49 (+, 3 ´ CH3COO), 172.28 (+, H2NCO) 
 
7.3.4 Removal of the isopropylidene group from 72 
AJ 2-29 
Compound 72 (0.015 g, 0.02 mmol) was dissolved in 80 % AcOH-H2O (10 mL), and stirred at 
RT for 17 h, after which no reaction was observed (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 
2). The solution was coevaporated 3 times with toluene (2 mL). The residue was submitted to 
FC, eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to recover the starting material (0.013 g) 
 
AJ 2-30 
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Compound 72 (0.040 g, 0.054 mmol) was dissolved in CH2Cl2 (10 mL) and trifluoroacetic acid 
(21 ìL, 5 eq; 0.270 mmol) was added. The reaction mixture was stirred at RT for 2 h (TLC, 
petroleum ether-CHCl3-EtOH 5 : 2 : 2). The solution was coevaporated 3 times with toluene (3 
mL). The residue was submitted to FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to give 
73 (0.034 g, 89 %). 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-7-deoxy-D-glycero-L-galacto-heptonamide (73) 
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C21H28BrCl3N2O13
Exact Mass
[702.72]
[699.98]
 
· colour and physical state: white solid 
· M.p.: 241-242 °C (EtOH-petroleum ether), decomposition 
· =][
23
a D -50 (c 0.12, CH2Cl2) 
· Rf: 0.23 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 700.9 [M+H]+, 722.9 [M+Na]+ 
· ESI-MS: m/z calculated [M+Na]+ 722.97326, found 722.97544 
· IR (KBr): n~  = 1635, 1678, 1746, 3443 cm-1 
· 1H NMR (HH-COSY, 400 MHz, pyridine-d5): 
d = 1.96, 1.99, 2.07 (3s, 9H, 3 ´ CH3COO), 3.82 (ddd, 1H, 5E-H, J 2.5, 4.6, 9.8), 4.12 (dd, 
1H, 7F-H, J 3.7, ca 11.7), 4.25 (dd, 1H, 7F-H´, J 3.0, ca 11.7), 4.42-4.50 (m, 2H, CH2-6E), 
4.51 (m, 1H, 5F-H), 4.65 (dd, 1H, 2E-H, J 8.6, 10.6), 4.79 (d, 1H, 3F-H, J 2.4), 4.83 (m, 1H, 
2F-H), 4.91 (m, 1H, 6F-H), 5.01 (m, 1H, 4F-H), 5.49 (m, 1H, 4EH), 5.58 (d, 1H, 1E-H, J 8.4), 
5.95 (dd, 1H, 3E-H, J 9.3, 10.6), 8.00, 8.78 (2bs, 2 H, H2NCO), 10.63 (d, 1H, NHCOCCl3, J 
8.6) 
· 13C NMR (APT, HMBC, HMQC 100.58 MHz, pyridine-d5): 
d = 20.28, 20.37, 20.48 (-, 3 ´ CH3COO), 30.83 (+, C-7F), 56.64 (-, C-2E), 62.15 (+, C-6E), 
69.40 (-, C-4E), 69.86 (-, C-4F), 70.07 (-, C-5F), 72.00 (-, C-5E), 72.55 (-, C-3E), 73.39 (-, 
86                                                                                             7. EXPERIMENTAL PART 
C-3F), 75.11 (-, C-6F), 78.19 (-, C-2F), 93.76 (+, NHCOCCl3), 101.46 (-, C-1E), 163.18 (+, 
NHCOCCl3), 169.63, 170.30, 170.38 (+, 3 ´ CH3COO), 173.59 (+, H2NCO) 
 
7.3.5 Preparation of cyclic carbonate 76 
AJ 2-34 
To a solution of 73 (0.313 g, 0.45 mmol) in dry CH2Cl2 (20 mL), CDI (0.146 g, 2.0 eq; 0.90 
mmol) and DMAP (0.055 g, 1.0 eq; 0.45 mmol) were added. The reaction mixture was stirred at 
RT for 2 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). Evaporation, FC eluting with 
petroleum ether-CHCl3-EtOH 8 : 2 : 2 afforded 76 (0.272 g, 84 %). 
 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-3,4-O-carbonyl-7-deoxy-D-glycero-L-galacto-heptonamide (76) 
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C22H26BrCl3N2O14
Exact Mass
[728.72]
[725.96] 
· colour and physical state: white solid 
· M.p: 153-154°C (CHCl3-petroleum ether) 
· =][
23
a D -13.33 (c 0.15, CH2Cl2) 
· Rf: 0.41 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 727.1 [M+H]+ ,749.1 [M+Na]+ 
· ESI-MS: m/z [M+Na]+ (calculated 748.95252, found 748.95186), [M+K]+ (calculated 
764.92646, found 764.92556) 
· IR (KBr): n~  = 1047, 1069, 1236, 1696, 1749, 1816, 3420, 3439 cm-1 
· 1H NMR (HH COSY, 400 MHz, pyridine-d5): 
d = 2.02, 2.03, 2.12 (3s, 9H, 3 ´ CH3COO), 3.76 (dd, 1H, 7F-H, J 7.9, 10.9), 3.92 (dd, 1H, 
7F-H´, J 5.9, 10.9), 4.12 (ddd, 1H, 5E-H, J 2.6, 4.8, 9.9), 4.38 (dd, 1H, 2E-H, J 8.1, 10.6), 
4.47 (dd, 1H, 6 E-H, J 2.6 12.0), 4.51 (dd, 1H, 6E-H´, J 4.8, 12.0), 4.63 (ddd, 1H, 6F-H, J 3.7, 
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5.9, 7.9), 4.93 (t, 1H, 5F-H, J 3.7), 5.01 (d, 1H, 2F-H, J 1.7), 5.53 (m, 1H, 4EH), 5.59 (m, 1H, 
4F-H), 5.82 (d, 1H, 1E-H, J 8.4), 5.95 (dd, 1H, 3F-H, J 1.7, 8.4), 6.17 (dd, 1H, 3E-H, J 9.2, 
10.6), 7.92, 8.90 (2s, 2H, H2NCO), 10.78 (d, 1H, NHCOCCl3, J 8.6) 
· 13C NMR (APT, HMBC, HMQC, 100.57 MHz, pyridine-d5): 
d = 21.60, 21.77 (-, 3 ´ CH3COO), 31.79 (+, C-7F), 58.11 (-, C-2E), 63.42 (+, C-6E), 70.64 
(-, C-4E), 72.02 (-, C-2F), 72.72 (-, C-3E), 73.28 (-, C-5F), 73.43 (-, C-4F), 73.76 (-, C-5E), 
74.66 (-, C-6F), 76.52 (-, C-3F), 94.70 (+, NHCOCCl3), 100.08 (-, C-1E), 155.16 (+, 
OCOO), 164.80 (+, NHCOCCl3), 170.71 (+, H2NCO), 171.00, 171.57, 171.60 (+, 3 ´ 
CH3COO) 
 
 
 
 
7.3.6 Synthesis of urethane 74 
7.3.6.1 Trial based on TAI 
AJ 2-32  
A solution of 73 (0.046 g, 0.066 mmol) in dry dichloromethane (8 mL) was refluxed over 
activated 3 Å molecular sieves under an argon atmosphere for 2 h, then it was cooled to -5 °C. 
Trichloroacetylisocyanate, TAI, (5 mL, 1.0 eq, 0.071 mmol) was added, and the solution was 
stirred at -5 °C for 6 h, during which TLC (petroleum ether-CHCl3-EtOH 5 : 2 : 2) showed no 
reaction. The temperature was raised gradually to RT, with addition of excess of TAI (10 eq), but 
also no reaction was observed. Excess reagent was destroyed with MeOH (2 mL). Solvents 
were evaporated, and the residue was taken to a FC, and eluted with petroleum ether-CHCl3-
EtOH 8 : 2 : 2. Solvent evaporation provided reactant recovery (0.039 g). 
 
7.3.6.2 Trial based on phenyl carbonate  
AJ 2-36 
A solution of 73 (0.020 g, 0.028 mmol) and DMAP (0.004 g, 1.0 eq; 0.028 mmol) in dry 
CH2Cl2 (5 mL) was cooled to 0 °C, then dry triethylamine (4 mL, 1.0 eq; 0.028 mmol) was 
added. Phenyl chloroformate (3.8 mL, 1.1 eq, 0.031 mmol) was added dropwise at 0 °C, and 
the reaction mixture was stirred at RT for 1 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The 
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solvent was evaporated, and the residue was separated by FC, eluting with petroleum ether-
CHCl3-EtOH 8 : 2 : 2 to give compound 76 (0.015 g, 72 %). 
 
7.3.6.3 Ring opening of 76 with ammonia 
AJ 2-35 
Dry gaseous ammonia was bubbled through a solution of 76 (0.313 g, 0.43 mmol) in dry ethanol 
(20 mL) at 0 °C for 1 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The solvent was 
evaporated, and the residue was separated by repeated MPLC eluting with petroleum ether-ethyl 
acetate-EtOH 5 : 2 : 1 to give the two isomers 74 (0.058 g, 18 %) and 77 (0.064 g, 20 %).  
 
 
 
AJ 2-45 
Dry ammonia gas was bubbled through a solution of 76 (0.150 g, 0.207 mmol) in CH2Cl2 (10 
mL) at 0 °C for 6 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The solvent was evaporated, 
and the residue was separated using repeated MPLC eluting with petroleum ether-ethyl acetate-
EtOH 5 : 2 : 1 to give 74 (0.095 g, 62 %) and 77 (0.032 g, 21 %). 
 
AJ 2-46 
76 (0.250 g, 0.344 mmol) was dissolved at 0 °C in 0.5 M ethanolic ammonia (10 mL), and 
stirred at this temperature for 5 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The solvent was 
evaporated, and the residue was separated by repeated MPLC eluting with petroleum ether-ethyl 
acetate-EtOH 5 : 2 : 1 to leave 74 (0.008 g, 3 %) and 77 (0.122 g, 48 %). 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-4-carbamoyl-7-deoxy-D-glycero-L-galacto-heptonamide (74) 
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C22H29BrCl3N3O14
Exact Mass
[745.74]
[742.99] 
· colour and physical state: white solid 
· M.p.: 261-262 °C (EtOH-petroleum ether), decomposition 
· Rf: 0.14 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 744.2 [M+H]+, 766.2 [M+Na]+ 
· ESI-MS: m/z calculated [M+H]+ 743.99712, found 743.99616 
· IR (KBr): n~  = 1690, 1706, 1743, 3310-3521 cm-1 
· 1H NMR (HH-COSY, 400 MHz, pyridine-d5): 
d = 2.00, 2.03, 2.10, (3s, 9H, 3 ´ CH3COO), 3.84 (m, 1H, 5E-H), 4.10 (dd, 1H, 7F-H, J 3.3, 
11.4), 4.30 (dd, 1H, 7F-H´, J < 1, 11.4), 4.31 (m, 1H, 6E-H,), 4.42 (m, 1H, 6E-H´), 4.43 (m, 
1H, 2E-H), 4.84 (d, 1H, 2F-H, J 1.8), 4.96 (m, 1H, 6F-H), 5.03 (m, 1H, 5F-H), 5.40 (dd, 1H, 
3F-H, J 1.8, 3.5), 5.50 (dd, 1H, 4EH, J 9.5, 9.9), 5.57 (d, 1H, 1E-H, J 8.4), 5.68 (dd, 1H, 4F-
H, J 3.5, 8.3), 6.08 (dd, 1H, 3E-H, J 9.5, 10.6), 7.50 (bs, 2H, H2NCOO), 7.80, 8.49 (2s, 2H, 
H2NCO), 10.57 (d, 1H, NHCOCCl3, J 8.1) 
· 13C NMR (APT, HMBC, HMQC, 100.58 MHz, pyridine-d5): 
d = 20.12, 20.21, 20.31 (-, 3 ´ CH3COO), 30.32 (+, C-7F), 56.76 (-, C-2E), 61.83 (+, C-6E), 
67.63 (-, C-3F), 69.27 (-, C-4E), 71.58 (-, C-3E), 71.73 (-, C-5E), 72.71 (-, C-4F), 73.17 (-, 
C-2F), 75.11 (-, C-5F), 75.66 (-, C-6F), 93.46 (+, NHCOCCl3), 100.57 (-, C-1E), 156.83 (+, 
H2NCOO), 162.89 (+, NHCOCCl3), 169.43, 170.06, 170.14 (+, 3 ´ CH3COO), 171.98 (+, 
H2NCO) 
 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-2,6-
anhydro-7-bromo-3-carbamoyl-7-deoxy-D-glycero-L-galacto-heptonamide (77) 
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C22H29BrCl3N3O14
Exact Mass
[745.74]
[742.99] 
· colour and physical state: white solid 
· M.p.: 257-258 °C (EtOH-petroleum ether), decomposition 
· Rf: 0.12 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 744.2 [M+H]+,766.2 [M+Na]+ 
· ESI-MS: m/z calculated [M+H]+ 743.99712, found 743.99605 
· IR (KBr): n~  = 1721, 3306-3445 cm-1 
· 1H NMR (HH-COSY, 400 MHz, pyridine-d5): 
d = 2.01, 2.06, 2.10, (3s, 9H, 3 ´ CH3COOO), 3.84 (m, 1H, 5E-H), 4.17 (dd, 1H, 7F-H, J 
3.2, 11.5), 4.29 (dd, 1H, 7F-H´, J < 1, 11.5), 4.34 (m, 1H, 6E-H), 4.47 (dd, 1H, 6E-H, J 4.7, 
12.2), 4.64 (m, 1H, 4F-H), 4.65 (m, 1H, 5F-H), 4.71 (ddd, 1H, 2E-H, J 8.5, 8.8, 10.4), 4.95 
(m, 1H, 6F-H), 5.47 (d, 1H, 1E-H, J 8.5), 5.01 (d, 1H, 2F-H, J 1.7), 5.52 (dd, 1H, 4EH, J 9.6, 
9.9), 5.93 (dd, 1H, 3E-H, J 9.6, 10.4), 6.47 (bs, 1H, 3F-H), 7.60 (bs, 2H, H2NCOO), 7.88, 
8.54 (2s, 2H, H2NCO), 10.73 (d, 1H, NHCOCCl3, J 8.8)  
· 13C NMR (APT, HMBC, HMQC, 100.58 MHz, pyridine-d5): 
d = 20.28, 20.40, 20.53 (-, 3 ´ CH3COO), 29.83 (+, C-7F), 56.48 (-, C-2E), 62.24 (+, C-6E), 
68.71 (-, C-4F), 69.40 (-, C-4E), 71.93 (-, C-2F), 72.14 (-, C-5E), 72.54 (-, C-3F), 72.71 (-, 
C-3E), 76.52 (-, C-6F), 78.58 (-, C-5F), 93.79 (+, NHCOCCl3), 102.20 (-, C-1E), 157.78 (+, 
H2NCOO), 163.22 (+, NHCOCCl3), 169.60, 170.32, 170.45 (+, 3 ´ CH3COO), 170.84 (+, 
H2NCO) 
 
7.3.7 Dehalogenation of the trichloroacetamido group  
7.3.7.1 Trials based on 76 
7.3.7.1.1 Hydrolysis with LiOH  
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AJ 2-43  
Compound 76 (0.015 g, 0.021 mmol) was treated with 0.5 M LiOH in THF- MeOH 1 : 1 (10 
mL) for 2 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The solution was diluted with EtOH 
(10 mL), cooled to 0 °C and neutralized with dry acetic acid. The solution was coevaporated 
with MeOH (3 ´ 2 mL). The crude product was dissolved in dry pyridine (5 mL) and stirred 
overnight with Ac2O (5 mL). The solution was coevaporated with toluene, and the residue was 
purified by FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to give 80 (0.012 g, 73 %). 
3,4,6-Tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-b -D-glucopyranosyl-(1®5)-3,4-
di-O-acetyl-2,6-anhydro-7-bromo-7-deoxy-D-glycero-L-galacto-heptonamide (80) 
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C25H32BrCl3N2O15
Exact Mass
[786.80]
[784.00] 
· colour and physical state: white solid 
· =][
23
a D +61.54 (c 0.13, CH2Cl2) 
· Rf: 0.44 (petroleum ether-CHCl3-EtOH 5:2:2) 
· ESI-MS: m/z calculated [M+Na]+ 806.99439, found 806.99427 
· IR (KBr): n~  = 1043, 1234, 1749, 3558 cm-1   
· 1H NMR (HH-COSY, 400 MHz, pyridine-d5): 
d = 2.01, 2.02, 2.05, 2.13, 2.21 (5s, 15H, 5 ´ CH3COO), 4.05 (m, 1H, 5E-H), 4.15 (dd, 1H, 
7F-H, J 3.3, 11.7), 4.27 (m, 1H, 2E-H), 4.43-4.47 (m, 2H, CH2-6E), 4.54 (dd, 1H, 7F-H´, J < 
1, 11.7), 4.90 (m, 1H, 5F-H), 5.07 (m, 1H, 6F-H), 5.09 (d, 1H, 2F-H, J 1.5), 5.52 (dd, 1H, 4E-
H, J 9.2, 9.9), 5.77 (d, 1H, 1E-H, J 8.1), 5.87 (dd, 1H, 4F-H, J 3.6, 10.6), 6.20 (dd, 1H, 3E-H, 
J 9.2, 10.6), 6.57 (dd, 1H, 3F-H, J 1.5, 3.6), 8.02, 8.84 (2s, 2H, H2NCO), 10.67 (d, 1H, 
NHCOCCl3, J 7.7) 
· 13C NMR (APT, HMBC, HMQC, 100.58 MHz, pyridine-d5): 
d = 20.04, 20.08, 20.12, 20.26, 20.94 (-, 5 ´ CH3COO), 29.45 (+, C-7F), 57.24 (-, C-2E), 
62.20 (+, C-6E), 69.52 (-, C-4E), 69.77 (-, C-3F), 70.22 (-, C-4F), 70.94 (-, C-2F), 71.38 (-, 
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C-3E), 72.24 (-, C-5E), 75.04 (-, C-5F), 76.79 (-, C-6F), 93.00 (+, NHCOCCl3), 100.85 (-, 
C-1E), 162.67, 169.44, 169.84, 169.90, 169.98, 170.08 (+, 5 ´ CH3COO, NHCOCCl3, 
H2NCO) 
 
7.3.7.1.2 Reduction with NaBH4 
AJ 2-40  
A solution of 76 (0.040 g, 0.055 mmol) and NaBH4 (0.002 g, 1.0 eq; 0.055 mmol) in dry 
ethanol (10 mL) was stirred for 8 h at 60 °C. The reaction progress was controlled by TLC 
(petroleum ether-CHCl3-EtOH 5 : 2 : 2). The solution was diluted with dry EtOH (10 mL), 
cooled to 0 °C and neutralized with dry acetic acid. The solution was coevaporated with MeOH 
(3 ´ 2 mL). The crude product was dissolved in dry pyridine (5 mL), and stirred overnight with 
Ac2O (3 mL). The solution was coevaporated with toluene, and the residue was purified by FC 
eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to give 82 (0.032 g, 85 %).  
 
AJ 2-42 
A solution of 76 (0.025g, 0.034 mmol) and NaBH4 (0.001 g, 1.0 eq; 0.034 mmol) in dry ethanol 
(10 mL) was stirred at 0 °C for 15 h. The reaction progress was controlled by TLC (petroleum 
ether-CHCl3-EtOH 5 : 2 : 2), which showed no reaction. 
The temperature was then raised to RT, and the reaction mixture was stirred for further 10 h. The 
solution was diluted with dry EtOH (10 mL), cooled to 0 °C and neutralized with dry acetic acid. 
The solution was coevaporated twice with MeOH (5 mL portions), and taken up in dry pyridine 
(5 mL), and stirred overnight with Ac2O (3 mL). The solution was coevaporated with toluene, 
and the residue was purified by FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to furnish 
82 (0.023 g, 83 %).  
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b -D-glucopyranosyl-(1®5)-3,4-di-O-acetyl-2,6-
anhydro-7-bromo-7-deoxy-D-glycero-L-galacto-heptonamide (82) 
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C25H35BrN2O15
Exact Mass
[683.46]
[682.12] 
· colour and physical state: white solid 
· M.p.: 179-180 °C (CHCl3-petroleum ether), decomposition 
· =][
23
a D +142.8 (c 0.07, CH2Cl2) 
· Rf: 0.28 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 683.1 [M+H]+, 705.11 [M+Na]+ 
· ESI-MS: m/z [M+H]+ (calculated 683.12936, found 683.12523), [M+Na]+ (calculated 
705.11185, found 705.11001) 
· IR (KBr): n~  = 1236, 1745, 3423 cm-1 
· 1H NMR (HH-COSY, 400 MHz, pyridine-d5): 
d = 2.00, 2.01, 2.04, 2.05, 2.09, 2.16 (6s, 18H, 5 ´ CH3COO, NHCOCH3), 4.03 (m, 1H, 5E-
H), 4.08 (m, 1H, 2E-H), 4.15 (m, 1H, 7F-H), 4.43-4.44 (m, 2H, CH2-6E), 4.55 (m, 1H, 7F-H´), 
4.80 (dd, 1H, 5F-H, J 3.3, 10.5), 5.02 (m, 1H, 6F-H), 5.08 (d, 1H, 2F-H, J 1.5), 5.45 (dd, 1H, 
4E-H, J 9.5, 10.3), 5.64 (d, 1H, 1E-H, J 8.4), 5.85 (dd, 1H, 4F-H, J 3.4, 10.5), 6.08 (dd, 1H, 
3E-H, J 9.5, 10.6), 6.48 (dd, 1H, 3F-H, J 1.5, 3.4), 7.90, 8.80 (2bs, 2H, H2NCO), 9.27 (d, 1H, 
NHCOCH3, J 8.1) 
· 13C NMR (APT, HMBC, HMQC 100.58 MHz, pyridine-d5): 
d = 20.45, 20.49, 20.49, 20.67, 20.83 (-, 5 ´ CH3COO), 23.13 (-, NHCOCH3), 29.52 (+, C-
7F), 56.15 (-, C-2E), 62.50 (+, C-6E), 69.68 (-, C-4E), 69.87 (-, C-3F, C-4F), 71.04 (-, C-2F), 
72.09 (-, C-5E), 72.55 (-, C-3E), 75.72 (-, C-5F), 76.83 (-, C-6F), 101.89 (-, C-1E), 169.84, 
169.87, 170.14, 170.47 (+, 5 ´ CH3COO, NHCOCH3, H2NCO) 
 
7.3.7.2 Reduction of 74 with NaBH4 
AJ 2-39 
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A solution of 74 (0.041 g, 0.055 mmol) and NaBH4 (0.002 g, 1.0 eq; 0.055 mmol) in dry 
ethanol (10 mL) was stirred at 60 °C for 9 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The 
solution was diluted with dry EtOH (6 mL), cooled to 0 °C and neutralized with dry acetic acid. 
The solution was coevaporated with MeOH (3 ´ 2 mL). The crude product was dissolved in dry 
pyridine (10 mL), and stirred overnight with Ac2O (3 mL). The solution was coevaporated with 
toluene, and the residue was purified by FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 
giving 82 (0.029 g, 78 %).  
 
AJ 2-41 
A solution of 74 (0.040 g, 0.054 mmol) and NaBH4 (0.002 g, 1.0 eq; 0.054 mmol) in dry 
ethanol (10 mL) was stirred at 0 °C for 48 h, after which TLC (petroleum ether-CHCl3-EtOH 5 : 
2 : 2) showed no reaction.  
The temperature was then raised to RT, and the solution was stirred for further 17 h. The solution 
was diluted with dry EtOH (6 mL), cooled to 0 °C and neutralized with dry acetic acid. The 
solution was coevaporated with MeOH (2 ´ 2 mL). The crude product was dissolved in dry 
pyridine (10 mL), and stirred overnight with Ac2O (3 mL). The solution was coevaporated with 
toluene, and the residue was purified by FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 
furnishing 82 (0.017 g, 46 %) and 83 (0.015 g, 42 %).  
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b -D-glucopyranosyl-(1®5)-3-O-acetyl-2,6-
anhydro-7-bromo-4-O-carbamoyl-7-deoxy-D-glycero-L-galacto-heptonamide (83) 
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C24H34BrN3O15
Exact Mass
[684.45]
[683.12] 
· colour and physical state: white solid 
· Rf: 0.12 (petroleum ether-CHCl3-EtOH 5:2:2) 
· ESI-MS: m/z calculated [M+Na]+ 706.106551, found 706.10766 
· 1H NMR (HH-COSY, 400 MHz, pyridine-d5): 
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d = 1.99, 2.00, 2.06, 2.07, 2.16 (5s, 15H, 4 ´ CH3COO, NHCOCH3), 4.00 (m, 1H, 5E-H), 
4.08 (m, 1H, 2E-H), 4.14-4.18 (m, 2H, CH2-7F), 4.40-4.45 (m, 2H, CH2-6E), 4.76 (dd, 1H, 
5F-H, J 6.4, 10.8), 4.97 (m, 1H, 6F-H), 5.07 (d, 1H, 2F-H, J 1.5), 5.43 (dd, 1H, 4E-H, J 9.1, 
10.2), 5.70 (d, 1H, 1E-H, J 8.2), 5.93 (dd, 1H, 4F-H, J 3.2, 11.0), 6.20 (dd, 1H, 3E-H, J 9.1, 
10.8), 6.65 (dd, 1H, 3F-H, J 1.5, 3.2), 7.70 (bs, 2H, H2NCOO), 7.90, 8.60 (2s, 2H, H2NCO), 
9.31 (d, 1H, NHCOCH3, J 7.8) 
· 13C NMR (APT, HETCOR, 100.63 MHz, pyridine-d5): 
d = 20.60, 20.71, 20.95 (-, 4 ´ CH3COO), 23.29 (+, NHCOCH3), 29.92 (+, C-7F), 56.34 (-, 
C-2E), 62.53 (+, C-6E), 69.73, 69.87 (-, C-4F, C-4E), 70.32 (-, C-3F), 71.32 (-, C-5F), 71.96 
(-, C-2F), 72.46 (-, C-5E), 76.66 (-, C-3E), 77.01 (-, C-6F), 102.09 (-, C-1E), 157.08 (+, 
H2NCOO), 169.51, 169.89, 170.11, 170.40, 170.50, 171.01 (-, 4 ´ CH3COO, NHCOCH3, 
H2NCO) 
 
This reaction could not be reproduced. Repeating the previous reaction using the same scale and 
under conditions considered to be identical gave only 80 in an average yield of 65 %.  
 
AJ 2-52 
A solution of 74 (0.025 g, 0.034 mmol) and NaBH4 (0.001 g, 1.0 eq; 0.034 mmol) in dry 
isopropanol (8 mL) was stirred at RT for 17 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). 
The solution was diluted with dry isopropanol (6 mL), cooled to 0 °C and neutralized with dry 
acetic acid. The solution was coevaporated with toluene (2 ´ 2 mL). The crude product was 
dissolved in dry pyridine (10 mL), and stirred overnight with Ac2O (4 mL). The solution was 
coevaporated with toluene, and the residue was purified by FC eluting with petroleum ether-
CHCl3-EtOH 8 : 2 : 2 to provide 80 (0.019 g, 73 %). 
 
AJ 2-53 
A solution of 74 (0.021 g, 0.028 mmol) and NaBH4 (0.001 g, 1.0 eq; 0.028 mmol) in a mixture 
of dry THF-MeOH 4 : 1 (5 mL) was stirred at 5 °C for 19 h (TLC, petroleum ether-CHCl3-
EtOH 5 : 2 : 2). The solution was diluted with dry THF (5 mL), and neutralized with dry acetic 
acid. The solution was coevaporated with toluene (2 ´ 2 mL). The crude product was dissolved 
in dry pyridine (10 mL), and stirred overnight with Ac2O (3 mL). The solution was coevaporated 
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with toluene, and the residue was purified by FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 
: 2 to furnish 80 (0.015 g, 68 %). 
 
7.3.7.3 Reduction of 80 with NaBH3CN  
AJ 2-54 
Compound 80 (0.010 g, 0.013 mmol) was dissolved in dry THF (5 mL), then 4 Å molecular 
sieves and NaBH3CN (0.001 g, 1.0 eq; 0.013 mmol) were added. After stirring at RT for 20 
min, the mixture was added to a saturated HCl-dry ether solution (0.5 mL) until the bubbles 
disappeared. The mixture was stirred for another 2 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 
2). The mixture was diluted with ether (10 mL) and filtered. The molecular sieves were washed 
with ether (3 ´ 5 mL) and the combined filtrate was concentrated. The residue was dissolved in 
dry pyridine (5 mL), and stirred overnight with Ac2O (2 mL). The solution was coevaporated 
with toluene, and the residue was purified by FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 
: 2 to recover 80 (0.015 g, 68 %). The spectral data (ESI-MS, 1H NMR, 13C NMR) of the 
separated product agree with those of the starting material 80. 
7.3.8 Synthesis of phosphonate 85 
AJ 2-47 
Compound 82 (0.010 g, 0.015 mmol) was dissolved in degassed triethyl phosphite (5 mL) and 
heated overnight in an oil bath to 180 °C, while purging the solution with an argon stream. The 
solution was cooled, and triethyl phosphite was coevaporated with toluene under reduced 
pressure. FC eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 gave 85 (0.007 g, 70 %). 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b -D-glucopyranosyl-(1®5)-3,4-di-O-acetyl-2,6-
anhydro-7-deoxy-7-(diethoxyphosphoryl)-D-glycero-L-galacto-heptonamide (85) 
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C29H45N2O18P
Exact Mass
[740.65]
[740.24] 
· colour and physical state: white solid 
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· Rf: 0.19 (petroleum ether-CHCl3-EtOH 5:2:2) 
· FAB-MS: m/z 741.2 [M+H]+, 763.2 [M+Na]+ 
· ESI-MS: m/z [M+H]+ (calculated 741.24778, found 741.24687), [M+Na]+ (calculated 
763.22972, found 763.22925) 
· IR (KBr): n~  = 1236, 1747, 3437 cm-1 
· 1H NMR (HH-COSY, 600 MHz, pyridine-d5): 
d = 1.22 (t, 3H, POCH2CH3, J 7.0), 1.26 (t, 3H, POCH2CH3, J 7.0), 2.00, 2.03, 2.04, 2.08, 
2.11, 2.19 (6s, 18H, 5 ´ CH3COO; NHCOCH3), 2.69 (m, 1H, 7F-H), 3.06 (m, 1H, 7F-H´), 
4.03 (m, 1H, 5E-H), 4.06 (m, 1H, 2E-H), 4.17-4.22 (m, 4H, PO(OCH2CH3)2), 4.39 (dd, 1H, 
6E-H, J 2.4, 12.2), 4.53 (dd, 1H, 6E-H´, J 4.4, 12.2), 4.75 (m, 1H, 5F-H), 5.16 (m, 1H, 2F-H, 
partially hidden by the water signal), 5.34 (m, 1H, 6F-H), 5.45 (t, 1H, 4EH, J 9.7), 5.68 (d, 1H, 
1E-H, J 8.4), 5.89 (dd, 1H, 4F-H, J 3.3, 9.9), 6.11 (t, 1H, 3E-H, J 9.8), 6.48 (m, 1H, 3F-H), 
8.22, 8.62 (2s, 2H, H2NCO), 9.36 (d, 1H, NHCOCH3, J 8.1) 
· 13C NMR (50.29 MHz, pyridine-d5): 
d = 16.44 (d, CH3CH2OP, 3JC,P 6.1), 16.51 (d, CH3CH2OP, 3JC,P 6.1), 20.45, 20.52, 20.61, 
20.61, 20.94 (5 ´ CH3COO), 23.16 (NHCOCH3), 26.98 (C-7F), 56.20 (C-2E), 61.59 (d, 
CH3CH2OP, 2JC,P 6.5), 61.91 (d, CH3CH2OP, 2JC,P 6.5), 62.57 (C-6E), 69.54, 70.58, 71.80, 
72.03, 72.54 (probably more than one signal), 75.67, 75.96, 101.85 (C-1E), 169.84, 170.21, 
170.27, 170.44, 170.47, 170.60 (5 ´ CH3COO, NHCOCH3, H2NCO) 
· 31P NMR (121.5 MHz, pyridine-d5): 
d = 27.94 
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7.4 Trisaccharide synthesis 
7.4.1 Trials to prepare trisaccharide 87 based on oxazoline 42 
7.4.1.1 Synthesis of the oxazoline donor 4262 
AJ 3-00  
A solution of chitobiose octaacetate 86 (0.082 g, 0.12 mmol) in dry 1,2-dichloroethane (10 mL) 
containing activated 3 Å molecular sieves was treated with trimethylsilyl trifluoromethanesulfonate 
(25 ìL, 1.08 eq; 0.13 mmol) under an argon atmosphere, and the mixture was stirred for 5 h at 
50 °C. Triethylamine (1 mL) was added, and the mixture was applied to FC eluting with CHCl3-
MeOH 20 : 1 to give 42 (0.066 g, 90 %). The spectral data agree with those in the literature.62 
 
7.4.1.2 Trials based on the oxazoline 42 
AJ 3-01 
To a solution of 53 (0.260 g, 4.0 eq; 0.48 mmol) in dry CH2Cl2 (10 mL) containing activated 4 Å 
molecular sieves, anhydrous camphorsulfonic acid (0.011 g, 0.4 eq; 0.005 mmol) dissolved in dry 
CH2Cl2 (2 mL) was added, and 2.5 mL of a solution of 42 (0.074 g, 0.12 mmol) in dry CH2Cl2 
(5 mL). The mixture was stirred at 60 °C under an argon atmosphere for 3 h, after which the 
remaining portion of the solution of 42 was added. No reaction was observed (TLC, CHCl3-
MeOH 20 : 1). Triethylamine (1 mL) was added, and stirring was continued for 10 min at RT. 
Solvent evaporation followed by FC led to the recovery of compound 42 (0.065 g). 
 
AJ 3-02  
To a solution of 42 (0.021 g, 0.034 mmol) and 53 (0.200 g, 11 eq; 0.37 mmol) in dry CH2Cl2 (7 
mL) containing activated 4 Å molecular sieves, trifluoromethanesulfonic acid (3 ìL, 0.4 eq; 0.016 
mmol) was added. The mixture was stirred at RT under an argon atmosphere for 2 h (TLC, 
CHCl3-MeOH 20 : 1). Triethylamine (1 mL) was added and stirring was continued for 10 min at 
RT. Solvent evaporation followed by FC furnished many products in small fractions. 1H NMR 
and 13C NMR spectra proved that they were decomposition products. No effort was made to 
identify them.  
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AJ 3-03 
A mixture of 42 (0.042 g, 0.068 mmol), 53 (0.400 g, 11 eq, 0.75 mmol) and activated 3 Å 
molecular sieves in anhydrous 1,2-dichloroethane (5 mL) was stirred for 1 h at RT under a dry 
argon atmosphere, then cooled to 0 °C. Trimethylsilyl triflate (12 µL, 1 eq; 0.068 mmol) was 
added, and the mixture was stirred 1 h at 0 °C and further 3 h at RT. No reaction was observed 
as indicated by TLC (CHCl3-MeOH 20 : 1). Triethylamine (0.5 mL) was added, and the mixture 
was diluted with CH2Cl2 (10 mL), filtered, concentrated and applied to FC. 42 (0.035 g) was 
recovered. 
 
7.4 2 Preparation of the acceptor 92 
7.4.2.1 Acetylation of compound 53 
AJ 3-11 
Compound 53 (1.00 g, 1.87 mmol) was dissolved in dry pyridine (10 mL) and acetic anhydride 
(5 mL) and was stirred at RT for 3 h, during which the reaction progress was monitored by TLC 
(petroleum ether-ethyl acetate 2 : 1). Coevaporation with toluene, followed by FC eluting with 
petroleum ether-ethyl acetate 2 : 1 gave the acetylated compound 89 (0.950 g, 88 %). 
5-O-Acetyl-2,6-anhydro-7-bromo-1-O-(tert-butyldiphenylsilyl)-7-deoxy-3,4-O-
isopropylidene-D-glycero-L-galacto-heptitol (89) 
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C28H37BrO6Si
Exact Mass
[577.59]
[576.15] 
· colour and physical state: pale yellow oil 
· =][ 23a D -16.67 (c 0.48, CH2Cl2) 
· Rf: 0.51 (ethyl acetate-petroleum ether 2:1) 
· ESI-MS: m/z calculated [M+Na]+ 599.14350, found 599.14379 
· IR (Film): n~  = 1068, 1105, 1153, 1221,1751, 2854, 3498 cm-1 
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· 1H NMR (HH-COSY, 600 MHz, CDCl3): 
d = 1.08 (s, 9H, (CH3)3CSi), 1.35, 1.49 (2s, 6H, (CH3)2COO), 2.14 (s, 3H, CH3COO), 3.27-
3.31 (m, 2H, CH2-7), 3.83 (dd, 1H, 1-H, J 6.2, 9.9), 3.86 (dd, 1H, 1-H´, J 7.7, 9.9), 3.98 (m, 
1H, 2-H), 4.29 (ddd, 1H, 6-H, J 2.6, 6.2, 8.7), 4.34 (dd, 1H, 4-H, J 2.6, 7.5), 4.45 (dd, 1H, 
3-H, J 1.3, 7.5), 5.25 (t, 1H, 5-H, J 2.6), 7.38-7.44 (m, 6H, aromatic), 7.68-7.76 (m, 4H, 
aromatic) 
· 13C NMR (APT, HMBC, HMQC, 100.58 MHz, CDCl3): 
d = 19.42 (+, (CH3)3CSi), 20.98 (-, CH3COO), 24.48, 26.68 (-,  (CH3)2COO), 26.99 (-, 
(CH3)3CSi), 29.39 (+, C-7), 63.26 (+, C-1), 68.63 (-, C-5), 70.08 (-, C-6), 71.19 (-, C-2), 
71.56 (-, C-3), 71.76 (-, C-4), 110.02 (+, (CH3)2COO), 127.70, 127.75 , 129.71, 129.78 (-, 
CAr), 133.62, 133.74 (+, SiC Ar), 135.72, 135.77 (-, CAr), 169.51 (+, CH3COO) 
 
7.4.2.2 Cleavage of the silyl group in 89 
AJ 3-12 
To a solution of compound 89 (0.550 g, 0.955 mmol) in THF (20 mL) at RT a TBAF solution 
(1.0 M in THF, 1.15 mL, 1.2 eq; 1.146 mmol) was added. The reaction was stirred at RT for 3 
h (TLC, petroleum ether-ethyl acetate 1 : 1). Water was added and the mixture was extracted 
with chloroform (5 ´ 20 mL). The combined organic layers were dried, and the solvent was 
removed by evaporation. The residue was submitted to FC eluting with petroleum ether-ethyl 
acetate 1 : 1, and gave 90 (0.281 g, 87 %). 
 
5-O-Acetyl-2,6-anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-
heptitol (90) 
1
23
4
5 6
7
O
AcO
O
O OH
Br  
 
C12H19BrO6
Exact Mass
[339.18]
[338.04] 
· colour and physical state: pale yellow oil 
· =][ 23a D +8 (c 0.25, CH2Cl2) 
· Rf: 0.28 (ethyl acetate-petroleum ether 1:1) 
· ESI-MS: m/z calculated [M+Na]+ 361.02572, found 361.02609 
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· IR (Film): n~  = 1061, 1221, 1745 cm-1 
· 1H NMR (HH-COSY, 400 MHz, CDCl3): 
d = 1.26, 1.43 (2s, 6H, (CH3)2COO), 2.06 (s, 3H, CH3COO), 2.50 (bs, 1H, OH), 3.25-3.35 
(m, 2H, CH2-7), 3.67 (dd, 1H, 1-H, J 4.7, 11.6), 3.78 (dd, 1H, 1-H´, J 6.7, 11.6), 3.93 (ddd, 
1H, 2-H, J 1.6, 4.7, 6.7), 4.23 (dd, 1H, 3-H, J 1.6, 7.5), 4.27 (m, 1H, 4-H), 4.30 (m, 1H, 6-
H), 5.21 (m, 1H, 5-H) 
· 13C NMR (APT, HMBC, HMQC, 100.57 MHz, CDCl3): 
d = 20.91(-, CH3COO), 24.36, 26.46 (-, (CH3)2COO), 29.31 (+, C-7), 63.10 (+, C-1), 67.98 
(-, C-5), 70.13 (-, C-4), 70.99 (-, C-2), 71.70 (-, C-6), 72.35 (-, C-3), 110.47 (+, 
(CH3)2COO), 169.54 (+, CH3COO) 
 
7.4.2.3 Preparation of the uronamide 91 
AJ 3-13 
a. Tempo oxidation 
To a mixture of 90 (0.330 g, 0.940 mmol), TEMPO (0.161 g, 1.06 eq; 0.996 mmol), 
tetrabutylammonium chloride (0.261 g, 1.0 eq; 0.940 mmol), potassium bromide (0.113 g, 1.0 
eq; 0.95 mmol) and dichloromethane (20 mL) at 0 °C, a mixture of satd. aq. sodium chloride (10 
mL), satd. aq. sodium hydrogencarbonate (11 mL), and satd. aq. sodium hypochlorite (1 mL, 
12-14 % active chlorine) was added slowly. The reaction mixture was vigorously stirred at RT 
for 3 h (TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). The pH was adjusted to 2-3 with conc. 
HCl. The organic layer was separated and the aqueous layer was extracted five times with 
dichloromethane (10 mL portions). The combined organic extracts were dried, and the solvent 
was removed. 
b. Sodium chlorite oxidation 
The crude product of the TEMPO oxidation (max 0.940 mmol), sodium chlorite (0.846 g, 10.0 
eq; 9.4 mmol), and sodium dihydrogenphosphate monohydrate (0.97 g, 7.5 eq; 7.0 mmol) were 
placed in a reaction flask, and with stirring successively 2-methyl-2-butene (4.0 mL), t-butanol 
(18 mL) and water (7.0 mL) were added. The reaction mixture was stirred at RT for 4 h (TLC, 
petroleum ether-CHCl3-EtOH 5 : 2 : 2), and then it was diluted with water (20 mL) and 
dichloromethane (50 mL). The organic layer was separated and the aqueous layer was extracted 
with dichloromethane (2 ´ 20 mL). The aqueous layer was adjusted to pH 2 with conc. HCI and 
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extracted with dichloromethane (3 ´ 10 mL). The combined organic extracts were dried, and the 
solvent was removed. The residue was dried at 0.1 mbar for ca 2 h. 
c. Amide formation according to Staab 
The crude acid (max 0.94 mmol), and CDI (0.386 g, 2.5 eq; 2.4 mmol) were dissolved in dry 
dichloromethane (30 mL), and the mixture was stirred at RT for 5 h. Through this solution at 0 
°C, gaseous ammonia was bubbled for 40 min (TLC, petroleum ether-CHC13-EtOH 5 : 2 : 2), 
then the mixture was stirred at RT for 1 h. The solvent was evaporated, and the residue was 
separated by FC eluting with petroleum ether-CHC13-EtOH 8 : 2 : 2 to give amide 91 (0.286 g, 
95 % based on 90). 
5-O-Acetyl-2,6-anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-
heptonamide (91) 
1
23
4
5 6
7
CONH2
O
AcO
O
O
Br  
 
C12H18BrNO6
Exact Mass
[352.18]
[351.04] 
· colour and physical state: pale yellow oil 
· =][ 23a D -18.18 (c 0.22, CH2Cl2) 
· Rf: 0.50 (petroleum ether-CHCl3-EtOH 5:2:2) 
· ESI-MS: m/z [M+H]+(calculated 352.03903, found 352.03928), [M+Na]+ (calculated 
374.02097, found 374.02106), [M+K]+ (calculated 389.99491, found 389.99513) 
· IR (Film): n~  = 1752, 1697, 1367, 1215, 1151, 1060 cm-1 
· 1H NMR (HH-COSY, 400 MHz, CDCl3): 
d = 1.26, 1.43 (2s, 6H, (CH3)2COO), 2.06 (s, 3H, CH3COO), 3.26-3.36 (m, 2H, CH2-7), 
4.31 (dd, 1H, 4-H, J 2.7, 7.5), 4.35 (d, 1H, 2-H, J 1.6), 4.37 (dd, 1H, 6-H, J 2.2, 7.0), 4.65 
(dd, 1H, 3-H, J 1.6, 7.5), 5.15 (t, 1H, 5-H, J 2.2), 6.15, 6.65 (2bs, 2H, H2NCO) 
· 13C NMR (APT, HMBC, HMQC, 100.57 MHz, CDCl3): 
d = 20.82 (-, CH3COO), 24.19, 26.50 (-, (CH3)2COO), 30.06 (+, C-7), 68.38 (-, C-5), 70.47 
(-, C-6), 71.56 (-, C-4), 71.67 (-, C-2), 72.50 (-, C-3), 110.60 (+, (CH3)2COO), 169.33 (+, 
CH3COO), 171.50 (+, H2NCO) 
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7.4.2.4 Preparation of the acceptor 92  
AJ 3-14 
A solution of compound 91 (0.300 g, 0.855 mmol) in dry methanol (10 mL) was treated at RT 
with sodium methoxide (0.092 g, 2.0 eq; 1.71 mmol). The reaction mixture was stirred for 1 h 
(TLC, petroleum ether-CHCl3-EtOH, 5 : 2 : 2). The mixture was diluted with methanol and 
neutralized with Dowex 50-W X2 (H+). The mixture was stirred for a few minutes, and then the 
resin was filtered off, washed with methanol (5 ´ 10 mL), and the filtrate concentrated. The 
residue was chromatographed (FC) eluting with petroleum ether-CHCl3-EtOH 8 : 2 : 2 to furnish 
compound 92 (0.264 g, quant). 
2,6-Anhydro-7-bromo-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-heptonamide 
(92) 
1
23
4
5 6
7
CONH2
O
HO
O
O
Br  
 
C10H16BrNO5
Exact Mass
[310.14]
[309.02] 
· colour and physical state: pale yellow oil 
· =][ 23a D -31.58 (c 0.19, CH2Cl2) 
· Rf: 0.47 (petroleum ether-CHCl3-EtOH 5:2:2) 
· ESI-MS: m/z [M+H]+ (calculated 310.02846, found 310.02861), [2M+H]+ (calculated 
619.05019, found 619.05060) 
· IR (Film): n~  = 1687, 3432 cm-1 
· 1H NMR (HH-COSY, 400 MHz, CDCl3): 
d = 1.27, 1.41 (2s, 6H, (CH3)2COO), 3.41 (dd, 1H, 7-H, J 6.6, 10.2), 3.48 (dd, 1H, 7-H´, J 
7.8, 10.2), 4.07 (bs, 1H, 5-H), 4.20 (m, 1H, 6-H), 4.35 (dd, 1H, 4-H, J 2.5, 7.8), 4.50 (bs, 
1H, 2-H), 4.66 (d, 1H, 3-H, J 7.8), 5.74, 6.64 (2bs, 2H, H2NCO) 
· 13C NMR (APT, HMBC, HMQC, 100.57 MHz, CDCl3): 
d = 24.28, 26.52 (-, (CH3)2COO), 30.98 (+, C-7), 66.39 (-, C-5), 71.33 (-, C-2), 71.65 (-, 
C-6), 72.69 (-, C-3), 73.83 (-, C-4), 110.11 (+, (CH3)2COO), 172.69 (+, H2NCO) 
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7.4.3 Trials to prepare trisaccharide 93 based on acceptor 92 
AJ 3-15-A 
A mixture of 92 (0.019 g, 0.061 mmol), 88 (0.084 g, 1.2 eq; 0.073 mmol) and activated 3 Å 
molecular sieves in anhydrous 1,2-dichloroethane (5 mL) was stirred for 1 h at RT under an 
argon atmosphere, then cooled to 0 °C. Trimethylsilyl triflate (1.1 mL, 0.1 eq, 0.006 mmol) was 
added, and the mixture was stirred at 0 °C for ca 20 min (TLC, petroleum ether-ethyl acetate 1 : 
1) after which only composition of the glycosyl donor was observed. 
AJ 3-15-B 
The reaction was repeated using a mixture of dry ether and 1,2-dichloroethane (1 : 1) as the 
reaction solvent, with no change in the result. 
 
Trials to prepare compound 72  
AJ 3-16-A 
A mixture of 92 (0.019 g, 0.061 mmol), 67 (0.043 g, 1.2 eq; 0.073 mmol), and activated 3 Å 
molecular sieves in anhydrous 1,2-dichloroethane (5 mL) was stirred for 1 h at RT under an 
argon atmosphere, then cooled to 0 °C. Trimethylsilyl triflate (1.1 mL, 0.1 eq; 0.006 mmol) was 
added, and the mixture was stirred at 0 °C for ca 20 min (TLC, petroleum ether-ethyl acetate 1 : 
1), after which decomposition of the donor was observed. 
 
AJ 3-16-B 
The glycosyl acceptor 92 (0.065 g, 0.210 mmol) was dissolved in anhydrous 1,2-dichloroethane 
(5 mL) and stirred with activated 3 Å molecular sieves for 1 h at RT under an argon atmosphere, 
and the solution was cooled to 0 °C. Trimethylsily triflate (3.8 mL, 0.1 eq; 0.021 mmol) was 
added. The donor 67 (0.150 g, 1.2 eq; 0.252 mmol) was then added, and the mixture was 
stirred at 0 °C for ca 10 min (TLC, petroleum ether-ethyl acetate 1 : 1). TLC indicated that there 
was only donor decomposition.  
 
7.4.4 Synthesis of the acceptor 95 
7.4.4.1 Preparation of the silyl ether 94 
AJ 3-18 
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To a solution of compound 62 (0.500 g, 1.95 mmol) in dry pyridine (20 mL) containing DMAP 
(0.010 g, cat) at 0 °C TBDMSCl (0.320 g, 1.1 eq; 2.15 mmol) was added, and the reaction was 
stirred at 0 °C (TLC, MeOH-CHC13 15 : 85). After 5 h, the reaction mixture was coevaporated 
with toluene. FC of the residue eluting with MeOH-CHC13 15 : 85 afforded compound 94 
(0.630 g, 87 %).  
 
 
 
 
2,6-Anhydro-7-bromo-1-O-(tert-butyldimethylsilyl)-7-deoxy-D-glycero-L-galacto-heptitol 
(94) 
HO
O
HO O
Br
HO
Si
1
23
4
5 6
7
 
 
C12H18BrNO6
Exact Mass
[371.34]
[370.08]  
· colour and physical state: white oil 
· =][
23
a D +56.25 (c 0.32, CH2Cl2) 
· Rf: 0.35 (CHCl3-MeOH 95:15) 
· ESI-MS: m/z calculated [M+H]+ 371.08839, found 371.08867 
· IR (Film): n~  = 839, 1082, 2929, 3392 cm-1 
· 1H NMR (HH-COSY, 300 MHz, pyridine-d5): 
d = 0.15, 0.17 (2s, 6H, Si(CH3)2), 0.95 (s, 9H, SiC(CH3)3), 4.23-4.35 (m, 4H containing CH2-
7), 4.38-4.43 (m, 2H), 4.63 (m, 1H, 3-H), 4.71-4.81 (m, 2H) 
· 13C NMR (APT, HETCOR, 75.45 MHz, pyridine-d5): 
d = -5.41, -5.22 (-, Si(CH3)2), 18.74 (+, SiC(CH3)3), 26.34 (-, SiC(CH3)3), 31.52 (+, C-7), 
62.68 (+, C-1), 69.41 (-), 70.23 (-), 72.32 (-), 74.75 (-), 76.60 (-, C-3) 
 
7.4.4.2 Preparation of the acceptor 95 
AJ 3-19 
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To a solution of compound 94 (0.40 g, 1.08 mol) in dry acetone (10 mL) and 2,2-
dimethoxyacetone (4 mL) p-toluenesulfonic acid monohydrate (0.015 g, cat) was added and the 
mixture was stirred at RT. After 1 h (TLC, petroleum ether-ethyl acetate, 1 : 1) the reaction 
mixture was neutralized with triethylamine, the solvents were evaporated, and the residue was 
submitted to FC eluting with petroleum ether-ethyl acetate 2 : 1 to afford compound 95 (0.40 g, 
90 %). 
 
 
 
 
 
2,6-Anhydro-7-bromo-1-O-(tert-butyldimethylsilyl)-7-deoxy-3,4-O-isopropylidene-D-
glycero-L-galacto-heptitol (95) 
1
23
4
5 6
7
O
O
O O
Br
HO
Si
 
 
C16H31BrO5Si
Exact Mass
[411.41]
[410.11] 
· colour and physical state: pale yellow oil 
· =][
23
a D -12.90 (c 0.31, CH2Cl2) 
· Rf: 0.62 (ethyl acetate-petroleum ether 1:1) 
· ESI-MS: m/z calculated [M+H]+ 411.11969, found 411.12010 
· IR (Film): n~  = 839, 1255, 2929, 3494 cm-1 
· 1H NMR (HH-COSY, 300MHz, CDCl3,): 
d = 0.06 (s, 6H, Si(CH3)2), 0.88 (s, 9H, SiC(CH3)3), 1.32, 1.47 (2s, 6H, (CH3)2COO), 2.22 
(d, 1H, OH, J 4.7), 3.39 (dd, 1H, 7-H, J 5.5, 9.9), 3.52 (dd, 1H, 7-H´, J < 1, 9.9), 3.69 (dd, 
1H, 1-H, J 6.3, 9.5), 3.75 (dd, 1H, 1-H´, J 7.3, 9.5), 4.03 (m, 1H, 2-H), 4.14 (m, 1H, 5-H), 
4.16 (m, 1H, 6-H), 4.34 (dd, 1H, 4-H, J 2.3, 7.7), 4.36 (dd, 1H, 3-H, J 1.1, 7.7) 
· 13C NMR (APT, HETCOR, 75.45 MHz, CDCl3): 
d = -5.02, -5.17 (-, Si(CH3)2), 18.60 (+, SiC(CH3)3), 24.63, 26.91 (-, (CH3)2COO), 26.14 (-, 
SiC(CH3)3), 30.27 (+, C-7), 63.72 (+, C-1), 67.27 (-, C-5), 71.07 (-), 71.11 (-), 71.76 (-, C-
3), 74.33 (-, C-4), 109.77 (+, (CH3)2COO) 
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7.4.5 Preparation of trisaccharide 96 based on acceptor 95 
AJ 3-20 
A mixture of 95 (0.043 g, 1.2 eq; 0.105 mmol), 88 (0.101 g, 1.0 eq; 0.088 mmol) and activated 
3 Å molecular sieves in anhydrous 1,2-dichloroethane (5 mL) was stirred for 1 h at RT under an 
argon atmosphere, then cooled to 0 °C. Trimethylsilyl triflate (1.6 mL, 0.1 eq; 0.009 mmol) was 
added, and the mixture was stirred at 0 °C for ca 5 min (TLC, petroleum ether-ethyl acetate 1 : 
1). The reaction mixture was neutralized with triethylamine, the solvents were evaporated, and the 
residue was submitted to FC eluting with petroleum ether-ethyl acetate 2 : 1 to give 96 (0.012 g, 
10 %). 
 
AJ 3-21 
A mixture of 95 (0.190 g, 1.2 eq; 0.463 mmol), 88 (0.443 g, 1.2 eq; 0.385 mmol) and activated 
3 Å molecular sieves in anhydrous 1,2-dichloroethane (5 mL) was stirred for 1 h at RT under an 
argon atmosphere, then cooled to -30 °C. Trimethylsilyl triflate (8 mL, 0.1 eq; 0.039 mmol) was 
added, and the mixture was stirred at -30 °C for ca 5 min (TLC, petroleum ether-ethyl acetate 1 : 
1). The reaction mixture was neutralized with triethylamine, the solvents were evaporated, and the 
residue was submitted to FC eluting with petroleum ether-ethyl acetate 2 : 1 to provide 
compound 96 (0.269 g, 50 %). 
 
3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-b -D-glucopyranosyl-(1®4)-3-O-acetyl-6-O-
(tert-butyldiphenylsilyl)-2-deoxy-2-phthalimido-b -D-glucopyranosyl-(1®5)-2,6-anhydro-
7-bromo-1-O-(tert-butyldimethylsilyl)-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-
heptitol (96) 
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C68H83BrN2O21Si2
Exact Mass
[1400.48]
[1398.42]  
· colour and physical state: white solid 
· =][
23
a D -22.22 (c 0.18, CH2Cl2) 
· Rf: 0.36 (ethyl acetate-petroleum ether 1:1) 
· ESI-MS: m/z calculated [M+H]+ 1399.42830, found 1399.43009 
· IR (KBr): n~  = 1045, 1072, 1106, 1151, 1226, 1384, 1720,1751 cm-1 
 
 
· 1H NMR (HH-COSY, 600 MHz, CDCl3): 
d = -0.07 (s, 6H, Si(CH3)2C(CH3)3), 0.77 (s, 9H, Si(CH3)2C(CH3)3), 1.02, 1.28 (2s, 6H, 
(CH3)2COO), 1.12 (s, 9H, SiPh2C(CH3)3), 1.83, 1.96, 2.01, 2.06 (4s, 12H, 4 ´ CH3COO), 
3.10 (dd, 1H, 7F-H, J 8.4, 10.8), 3.19 (dd, 1H, 7F-H´, J 5.4, 10.8), 3.44 (m, 1H, 5E-H), 3.47 
(m, 1H, 2F-H), 3.54-3.55 (m, 2H, CH2-1F), 3.60 (ddd, 1H, 5C-H, J 2.1, 4.5, 9.9), 3.77 (dd, 
1H, 6E-H, J 3.3, 11.7), 3.80 (t, 1H, 5F-H, J 3.6), 3.82 (dd, 1H, 3F-H, J 1.5, 7.2), 3.86 (dd, 1H, 
4F-H, J 3.6, 7.2), 3.87 (m, 1H, 6E-H´), 3.97 (ddd, 1H, 6F-H, J 3.3, 5.4, 8.4), 4.03 (dd, 1H, 6C-
H, J 1.8, 12.6), 4.19 (2dd, 2H, 2C-H and 2E-H, J 8.4, 10.8), 4.37 (dd, 1H, 6C-H´, J 4.5, 12.3), 
4.38 (t, 1H, 4E-H, J 9.6), 5.10 (dd, 1H, 4C-H, J 9.0, 10.2), 5.35 (d, 1H, 1E-H, J 8.4), 5.56 (d, 
1H, 1C-H, J 9), 5.69 (dd, 1H, 3C-H, J 8.7, 11.1), 5.72 (dd, 1H, 3E-H, J 9.3, 10.5), 7.43-7.44 
(m, 3H, aromatic), 7.47-7.48 (m, 3H, aromatic), 7.70-7.74 (m, 6H, aromatic), 7.78-7.80 (m, 
4H, aromatic), 7.83-7.84 (m, 2H, aromatic) 
· 13C NMR (APT, HETCOR, HMBC, HSQC, 75.45 MHz, CDCl3): 
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d = -5.51, -5.26 (-, Si(CH3)2C(CH3)3), 18.32 (+, Si(CH3)2C(CH3)3), 19.74 (+, SiPh2C(CH3)3) 
20.55, 20.71, 20.75, 20.78 (-, 4 ´ CH3COO), 24.47, 26.89 (-,  (CH3)2COO), 25.93 (-, 
Si(CH3)2C(CH3)3), 27.07 (-, SiPh2C(CH3)3), 30.81(+, C-7F), 55.02 (+, C-2C), 55.28 (-, C-2E), 
61.72 (+, C-6C), 62.08 (+, C-1F), 62.51 (+, C-6E), 68.68 (-, C-4C), 70.06 (-, C-2F), 70.44 (-, 
C-3E), 70.80 (-, C-3C), 71.73, 71.80 (-, C-3F, C-4F, C-5C, C-6F), 72.71 (-, C-4E), 75.44 (-, 
C-5F), 75.73 (-, C-5E), 96.02 (-, C-1C), 97.53 (-, C-1E), 109.47 (+, (CH3)2COO), 123.54, 
123.78, 127.83, 127.92, 129.96, 129.99 (-, CAr), 131.42 (+, 4 ´ NCOCAr), 133.19, 133.58 
(+, 2 ´ SiCAr), 134.46, 136.00, 136.11 (-, CAr), 167.53 (+, 4 ´ NCOCAr), 169.58, 170.23, 
170.72 (+, 4 ´ CH3COO) 
 
7.4.6 Cleavage of the TBDMS ether in 96 
AJ 3-22 
Compound 96 (0.100 g, 0.072 mmol) was dissolved in THF (10 mL), and the solution was 
cooled to -10 °C. The reaction mixture was treated with a TBAF solution (1.0 M in THF, 86 ìL, 
1.2 eq, 0.086 mmol). After 6 h (TLC, petroleum ether-ethyl acetate 1 : 1) water was added and 
the mixture was extracted with chloroform (3 ´ 20 mL). The combined organic layers were dried, 
evaporated and the residue (97) taken to the next step without further purification. 
 
3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-b -D-glucopyranosyl-(1®4)-3-O-acetyl-6-O-
(tert-butyldiphenylsilyl)-2-deoxy-2-phthalimido-b -D-glucopyranosyl-(1®5)-2,6-anhydro-
7-bromo-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-heptitol (97) 
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C68H83BrN2O21Si2
Exact Mass
[1286.22]
[1284.33] 
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7.4.7 Synthesis of the uronamide 93 
AJ 3-23 
a. Tempo oxidation 
To a mixture of crude 97 (max 0.072 mmol), TEMPO (0.012 g, 1.06 eq; 0.076 mmol), 
tetrabutylammonium chloride (0.020 g, 1.0 eq; 0.072 mmol), potassium bromide (0.009 g, 1.0 
eq; 0.076 mmol) and dichloromethane (10 mL) at 0 °C, a mixture of satd. aq. sodium chloride 
(0.76 mL), satd. aq. sodium hydrogencarbonate (0.84 mL), and satd. aq. sodium hypochlorite 
(0.76 mL, 12-14 % active chlorine) was added slowly. The reaction mixture was vigorously 
stirred at RT for 1 h (TLC, petroleum ether-CHCl3-EtOH 5 : 5 : 2). The pH was adjusted to 2-3 
with conc. HCl. The organic layer was separated and the aqueous layer was extracted with 
dichloromethane (5 ´ 10 mL). The combined organic extracts were dried, and the solvent was 
removed. 
b. Sodium chlorite oxidation 
The crude product of the TEMPO oxidation (max 0.072 mmol), sodium chlorite (0.066 g, 10 eq; 
0.72 mmol), and sodium dihydrogenphosphate monohydrate (0.075 g, 7.5 eq; 0.54 mmol) were 
placed in a reaction flask, and with stirring successively 2-methyl-2-butene (0.31 mL), t-butanol 
(1.4 mL) and water (0.54 mL) were added. The reaction mixture was stirred at RT for 1 h (TLC, 
petroleum ether-CHCl3-EtOH 5 : 2 : 2), and then it was diluted with water (10 mL) and 
dichloromethane (20 mL). The organic layer was separated, and the aqueous layer was extracted 
with dichloromethane (2 ´ 10 mL). The aqueous layer was adjusted to pH 2 with conc. HCI, and 
extracted with dichloromethane (3 ´ 10 mL). The combined organic extracts were dried, and the 
solvent was removed. The residue was dried at 0.1 mbar for ca 2 h. 
c. Amide formation according to Staab 
The crude acid (max 0.072 mmol) and CDI (0.029 g, 2.5 eq; 0.18 mmol) were dissolved in dry 
dichloromethane (10 mL), and the mixture was stirred at RT for 1 h. Through this solution at 0 °C 
gaseous ammonia was bubbled for 40 min (TLC, petroleum ether-CHC13-EtOH 5 : 2 : 2), then 
the mixture was stirred at RT for 1 h. The solvent was evaporated, and the residue was 
chromatographed (FC), eluting with petroleum ether-CHC13-EtOH 8 : 2 : 2 to furnish the amide 
93 (0.089 g, 95 % based on 96). 
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3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-b -D-glucopyranosyl-(1®4)-3-O-acetyl-6-O-
(tert-butyldiphenylsilyl)-2-deoxy-2-phthalimido-b -D-glucopyranosyl-(1®5)-2,6-anhydro-
7-bromo-7-deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-heptonamide (93) 
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C62H68BrN3O21Si
Exact Mass
[1299.22]
[1297.33] 
· colour and physical state: white solid 
· =][
23
a D +42.86 (c 0.14, CH2Cl2) 
· Rf: 0.55 (petroleum ether-CHCl3-EtOH 5:2:2) 
· ESI-MS: m/z [M+H]+ (calculated 1298.33707, found 1298.33860), [M+NH4]+ (calculated 
1315.36362, found 1315.36310) 
· IR (KBr): n~  = 1049, 1228, 1383, 1718, 1749, 3469 cm-1 
· 1H NMR (HH-COSY, 300 MHz, CDCl3): 
d = 1.10 (s, 12H, SiPh2C(CH3)3, (CH3)(CH3)COO), 1.33 (s, 3H, (CH3)(CH3)COO), 1.82, 
1.95, 2.01, 2.06 (4s, 12H, 4 ´ CH3COO), 3.07 (dd, 1H, 7F-H, J 5.2, 10.5), 3.16 (dd, 1H, 7F-
H´, J 7.8, 10.5), 3.48 (m, 1H, 5E-H), 3.62 (m, 1H, 5C-H), 3.74 (m, 1H, 6E-H), 3.77 (t, 1H, 5F-
H, J 2.4), 3.81 (d, 1H, 2F-H, J 1.8), 3.88 (m, 1H, 6E-H´), 3.98 (dd, 1H, 4F-H, J 2.7, 7.5), 4.03 
(ddd, 1H, 6F-H, J 2.2, 4.4, 7.8), 4.04 (m, 1H, 6C-H), 4.12 (dd, 1H, 3F-H, J 1.8, 7.4), 4.17 (dd, 
1H, 2E-H, J 8.5, 10.7), 4.19 (dd, H, 2C-H, J 8.2, 10.7), 4.32 (t, 1H, 4E-H, J 9.8), 4.37 (dd, 1H, 
6C-H´, J 4.6, 13.0), 5.10 (dd, 1H, 4C-H, J 9.2, 10.0), 5.37 (d, 1H, 1E-H, J 8.5), 5.45, (d, 1H, 
HHNCO, J 4.0), 5.54 (d, 1H, 1C-H, J 8.3), 5.68 (dd, 1H, 3C-H, J 9.1, 10.7), 5.71 (dd, 1H, 3E-
H, J 9.1, 10.7), 6.55 (d, 1H, HHNCO, J 4.0) , 7.42-7.48 (m, 6H, aromatic), 7.69-7.88 (m, 
12H, aromatic) 
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· 13C NMR (APT, HETCOR, 50.33 MHz, CDCl3): 
d = 19.68 (+, SiPh2C(CH3)3), 20.51, 20.67, 20.71, 20.75 (-, 4 ´ CH3COO), 23.99, 26.46 (-, 
(CH3)2COO), 26.99 (-, SiPh2C(CH3)3), 32.00 (+, C-7F), 54.96 (+, C-2C), 55.10 (-, C-2E), 
61.64 (+, C-6C), 62.54 (+, C-6E), 68.59 (-, C-4C), 70.29 (-, C-3E), 70.79 (-, C-2F, C-3C, C-
4F), 71.17 (-, C-6F), 71.88 (-, C-5C), 72.30 (-, C-3F), 72.91 (-, C-4E), 73.72 (-, C-5F), 75.93 
(-, C-5E), 96.00 (-, C-1C), 96.71 (-, C-1E), 110.19 (+, (CH3)2COO), 123.76, 127.82, 127.92, 
130.01 (-, CAr), 131.34 (+, 4 ´ NCOCAr), 133.15, 133.44 (+, 2 ´ SiCAr), 133.83, 134.47, 
135.89, 136.00 (-, CAr), 167.51 (+, 4 ´ NCOCAr), 169.55, 170.21, 170.69 (+, 4 ´ 
CH3COO), 171.05 (+, H2NCO) 
 
7.4.8 Synthesis trial of 103 
a. Cleavage of the TBDPS ether in 93 (AJ 3-24) 
To a solution of compound 93 (0.076 g, 0.059 mmol) in THF (10 mL) a TBAF solution (1.0 M 
in THF, 71 ìL, 1.2 eq; 0.071 mmol) was added. The reaction mixture was stirred at RT for 3 h 
(TLC, petroleum ether-CHCl3-EtOH 5 : 2 : 2). Water was added and the mixture was extracted 
with chloroform (3 ´ 10 mL). The combined organic layers were dried, evaporated and the 
residue (98) was taken to the next step without further purification. 
b. Cleavage of the phthalimido group (AJ 3-25) 
The crude alcohol 98 (max 0.059 mmol) was dissolved in n-butanol (15 mL), followed by the 
addition of ethylenediamine (2 mL). The reaction mixture was heated at 90 °C. After 16 h (TLC, 
CHCl3-MeOH 85 : 15) total conversion of the starting material was observed. The solution was 
coevaporated with toluene, and the residue was taken to the next step without further purification.  
c. Acetylation (AJ 3-26) 
The crude compound (max 0.059 mmol) was dissolved in dry pyridine (12 mL) and acetic 
anhydride (2 mL) and stirred at RT for 5 h (TLC, CHCl3-MeOH 85 : 15). Coevaporation with 
toluene, followed by FC eluting with CHCl3-MeOH 90 : 10 left compound 102 (0.027 g, 49 % 
based on 93). 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b -D-glucopyranosyl-(1®4)-2-acetamimido-3,6-
di-O-acetyl-2-deoxy-b -D-glucopyranosyl-(1®5)-2,6-anhydro-7-deoxy-3,4-O-
isopropylidene-D-glycero-L-galacto-hept-6-enonamide (102) 
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C36H51N3O20
Exact Mass
[845.81]
[845.31] 
colour and physical state: white solid 
· =][
23
a D +35.29 (c 0.17, CH2Cl2) 
· Rf: 0.36 (CHCl3-MeOH 9:1) 
· ESI-MS: m/z calculated [M+H]+ 846.31447, found 846.31458 
· 1H NMR (HH-COSY, 400 MHz, CDCl3): 
d = 1.31, 1.40 (2s, 6H, (CH3)2COO), 1.92, 1.95, 1.99, 2.00, 2.04, 2.07, 2.11 (7s, 21H, 5 ´ 
CH3COO, 2 ´ NHCOCH3), 3.62-3.70 (m, 3H, 4E-H, 5C-H, 5E-H), 3.83 (q, 1H, 2C-H, J 9.3), 
3.94 (q, 1H, 2E-H, J 9.0), 4.01 (dd, 1H, 6C-H, J < 1, 10.7), 4.16 (d, 1H, 5F-H, J 2.0), 4.23 
(dd, 1H, 6E-H, J 5.9, 11.7), 4.29 (s, 1H, 7F-H), 4.31-4.38 (m, 2H, 6C-H´, 6E-H´), 4.49 (dd, 
1H, 4F-H, J 2.0, 7.7), 4.57 (s, 1H, 7F-H´), 4.60 (d, 1H, 1C-H, J 8.3), 4.71 (d, 1H, 1E-H, J 8.3), 
4.76 (d, 1H, 3F-H, J 7.7), 4.80 (s, 1H, 2F-H), 5.03 (t, 1H, 4C-H, J 9.7), 5.10 (t, 1H, 3E-H, J 
9.1), 5.20 (t, 1H, 3C-H, J 10.0), 6.10 (d, 1H, HHNCO, J 2.4), 6.37 (d, 1H, NHCOCH3, J 
8.8), 6.46 (d, 1H, NHCOCH3, J 8.8), 6.63 (d, 1H, HHNCO, J 2.4) 
· 13C NMR (HMBC, 100.62 MHz, CDCl3): 
d = 20.73, 20.77, 20.84, 21.07, 23.31 (5 ´ CH3COO, 2 ´ NHCOCH3), 24.73, 26.36 
((CH3)2COO), 53.91 (C-2E), 54.93 (C-2C), 62.00 (C-6C), 62.50 (C-6E), 68.33 (C-4C), 71.99 
(C-5C), 72.28 (C-4F), 72.54 (C-3C, C-3E), 72.92 (C-2F), 73.19 (C-3F, C-5E), 75.74 (C-5F), 
76.09 (C-4E), 94.45 (C-7F), 99.12 (C-1E), 101.20 (C-1C), 110.60 ((CH3)2COO), 152.46 (C-
6F), 169.46, 170.51, 170.69, 170.86, 170.95, 170.99, 171.13 (5 ´ CH3COO, 2 ´ 
NHCOCH3, H2NCO). 
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7.4.9 Synthesis trial of 100 
a. Cleavage of the phthalimido group (AJ 3-27) 
Compound 93 (0.015 g, 0.012 mmol) was dissolved in n-butanol (10 mL), followed by the 
addition of ethylenediamine (1 mL). The reaction mixture was heated at 90 °C for 15 h (TLC, 
CHCl3-MeOH 85 : 15). The solution was coevaporated with toluene, and the residue was taken 
to the next step without further purification. 
b. Acetylation (AJ 3-28) 
The crude compound (max 0.012 mmol) was dissolved in dry pyridine (8 mL) and acetic 
anhydride (2 mL) and stirred at RT for 4 h (TLC, CHCl3-MeOH 85 : 15). Coevaporation with 
toluene, followed by FC eluting with CHCl3-MeOH 90 : 10 left compound 101 (0.007 g, 58 % 
based on 93). 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b -D-glucopyranosyl-(1®4)-2-acetamimido-3-O-
acetyl-6-O-(tert-butyldiphenylsilyl)-2-deoxy-b -D-glucopyranosyl-(1®5)-2,6-anhydro-7-
deoxy-3,4-O-isopropylidene-D-glycero-L-galacto-hept-6-enonamide (101) 
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C50H67N3O19Si
Exact Mass
[1042.18]
[1041.41]  
· colour and physical state: white solid 
· Rf: 0.55 (petroleum ether-CHCl3-EtOH 5:2:2) 
· ESI-MS: m/z calculated [M+Na]+ 1064.40357, found 1046.40429 
· 1H NMR (HH-COSY, 600 MHz, CDCl3): 
d = 1.13 (s, 9H, SiPh2C(CH3)3), 1.33, 1.48 (2s, 6H, (CH3)2COO), 1.98, 2.00, 2.01, 2.04, 
2.05 (5s, 18H, 4 ´ CH3COO, 2 ´ NHCOCH3), 3.40 (m, 1H, 4F-H), 3.49 (m, 1H, 5C-H), 
3.58-3.60 (m, 2H, 2C-H, 5E-H), 3.74 (m, 1H, 3F-H), 3.82 (m, 1H, 5F-H), 3.95-3.99 (m, 3H, 
CH2-6E, 2F-H), 4.20 (s, 1H, 7F-H), 4.21-4.30 (m, 3H, CH2-6C, 2E-H), 4.61 (s, 1H, 7F-H´), 
4.77 (d, 1H, 1E-H, J 7.6), 4.85 (d, 1H, 1C-H, J 8.4), 4.97 (t, 1H, 4C-H, J 9.6), 5.03 (m, 1H, 
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4E-H), 5.23 (t, 1H, 3C-H, J 10.0), 5.35 (d, 1H, 3C-H, J 9.0), 5.65 (bs, 1H, HHNCO), 5.96-
6.02 (m, 2H, 2 ´ NHCOCH3), 6.60 (bs, 1H, HHNCO), 7.71-7.77 (m, 10H, aromatic)
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8 ABBREVIATIONS  
Ac  acetyl 
AJ  code of the reactions 
AIBN  a,a´-azoisobutyronitrile 
APT  attached proton test (NMR) 
aq.  aqueous 
Ar  aromatic 
 
bs  broad singlet (NMR) 
Bu  butyl 
 
cat  catalytic 
CDI  N,N´-carbonyldiimidazole 
conc.  concentrated 
COSY  correlated spectroscopy (NMR) 
CSA  DL-10-Camphersulfonic acid 
 
d  doublet (NMR) 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
dd  doublet of doublet (NMR) 
ddd  doublet of doublet of doublet (NMR) 
DDQ  2,3-dichloro-5,6-dicyano-benzoquinone 
DMAP  p-dimethylaminopyridine 
DMF  N,N´-dimethylformamide 
dt  doublet of triplet (NMR) 
 
E. coli  Escherichia Coli  
EEDQ  ethyl-2-ethoxy-1,2-dihydrochinoln-1-carboxylate 
eq  equivalent 
ESI  Electron Spray Ionisation (MS) 
Et  ethyl 
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FAB  fast atom bombardment (MS) 
FC flash chromatography 
 
h  hour(s) 
HETCOR 1H, 13C-Heterocorrelated spectroscopy (NMR) 
HMBC  Heteronuclear Multiple Bond Correlation (NMR) 
HMQC Heteronuclear Multiple Quantum Coherence (NMR) 
HSQC  Heteronuclear Single Quantum Coherence (NMR) 
 
IR  infrared spectroscopy, infrared spectrum 
 
J  coupling constant (NMR) given in hertz  
 
m  multiplet (NMR) 
m  meta 
M  molarity 
max  maximum  
Me  methyl 
MHz  Mega Hertz 
min  minute 
MS  mass spectroscopy, mass spectrum 
M.p.  melting point 
MPLC  medium-pressure liquid chromatography 
 
n  normal  
NMR  nuclear magnetic resonance 
 
o  ortho 
 
p  para 
PBP  penicillin-binding protein 
Ph  phenyl 
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PG  protecting group 
ppm  part per million (NMR) 
PTAD  4-phenyl-3H-1,2,4-triazoline-3,5-dione 
PTS  p-toluenesulfonic acid 
 
q  quartet (NMR) 
quant  quantitative 
 
R  Rest 
Rf  ratio of front 
RP  Reversed Phase (Column Chromatography)  
RT  room temperature 
 
s  singlet (NMR) 
satd.  saturated 
 
t  triplet (NMR) 
t  tertiary 
TAD  1,2,4-triazoline-3,5-diones  
TAI  trichloroacetylisocyanate 
TBAF  tetrabutylammonium fluoride 
TBDMSCl t-butyldimethylsilyl chloride 
TBDPSCl t-butyldiphenylsilyl chloride 
TEA  triethylamine 
TEMPO 2,2,6,6-tetramethyl-1-piperidinyloxy-radical 
TFA  trifluoroacetic acid  
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMS  trimethylsilyl 
TMSOTf trimethylsilyl triflate 
 
UV  ultra violet 
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X  halide 
Additionally, the IUPAC abbreviations for the amino acids were used. 
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